
<html lang="en"     class="pb-page"  data-request-id="b655933b-4f2b-4df2-98be-057a573b1093"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-4;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm401780b;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes" /></meta><meta name="dc.Creator" content="Ge  Xu" /></meta><meta name="dc.Creator" content="Binhua  Lv" /></meta><meta name="dc.Creator" content="Jacques Y.  Roberge" /></meta><meta name="dc.Creator" content="Baihua  Xu" /></meta><meta name="dc.Creator" content="Jiyan  Du" /></meta><meta name="dc.Creator" content="Jiajia  Dong" /></meta><meta name="dc.Creator" content="Yuanwei  Chen" /></meta><meta name="dc.Creator" content="Kun  Peng" /></meta><meta name="dc.Creator" content="Lili  Zhang" /></meta><meta name="dc.Creator" content="Xinxing  Tang" /></meta><meta name="dc.Creator" content="Yan  Feng" /></meta><meta name="dc.Creator" content="Min  Xu" /></meta><meta name="dc.Creator" content="Wei  Fu" /></meta><meta name="dc.Creator" content="Wenbin  Zhang" /></meta><meta name="dc.Creator" content="Liangcheng  Zhu" /></meta><meta name="dc.Creator" content="Zhongping  Deng" /></meta><meta name="dc.Creator" content="Zelin  Sheng" /></meta><meta name="dc.Creator" content="Ajith  Welihinda" /></meta><meta name="dc.Creator" content="Xun  Sun" /></meta><meta name="dc.Description" content="SGLT2 inhibitors deuterated at sites susceptible to oxidative metabolism were found to have a slightly longer tmax and half-life (t1/2), dose-dependent increase in urinary glucose excretion (UGE) i..." /></meta><meta name="Description" content="SGLT2 inhibitors deuterated at sites susceptible to oxidative metabolism were found to have a slightly longer tmax and half-life (t1/2), dose-dependent increase in urinary glucose excretion (UGE) i..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 12, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401780b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401780b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401780b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401780b" /></link>
        
    
    

<title>Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401780b" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0016.jpeg" /></meta><meta property="og:description" content="SGLT2 inhibitors deuterated at sites susceptible to oxidative metabolism were found to have a slightly longer tmax and half-life (t1/2), dose-dependent increase in urinary glucose excretion (UGE) in rats, and slightly superior effects on UGE in dogs while retaining similar in vitro inhibitory activities against hSGLT2. In particular, deuterated compound 41 has the potential to be a robust long-acting antidiabetic agent." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401780b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401780b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401780b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401780b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401780b&amp;href=/doi/10.1021/jm401780b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1236-1251</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401358b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401321v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Evaluation of Deuterated <i>C</i>-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ge++Xu">Ge Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Binhua++Lv">Binhua Lv</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacques+Y.++Roberge">Jacques Y. Roberge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Baihua++Xu">Baihua Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiyan++Du">Jiyan Du</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiajia++Dong">Jiajia Dong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuanwei++Chen">Yuanwei Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kun++Peng">Kun Peng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lili++Zhang">Lili Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinxing++Tang">Xinxing Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Feng">Yan Feng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++Xu">Min Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Fu">Wei Fu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenbin++Zhang">Wenbin Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liangcheng++Zhu">Liangcheng Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhongping++Deng">Zhongping Deng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zelin++Sheng">Zelin Sheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ajith++Welihinda">Ajith Welihinda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xun++Sun">Xun Sun</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">School of Pharmacy, Fudan University, 826 Zhangheng Road, Pudong New Area, Shanghai 201203, P. R. China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Egret Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Theracos Inc., 550 Del Rey Avenue, Sunnyvale, California 94805-3528, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: +86 21 51980003. Fax: +86 21 51980003. E-mail: <a href="/cdn-cgi/l/email-protection#96e5e3f8eee3f8f0d6e5fefbe3b8f3f2e3b8f5f8"><span class="__cf_email__" data-cfemail="6211170c1a170c0422110a0f174c0706174c010c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401780b&amp;href=/doi/10.1021%2Fjm401780b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1236–1251</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 23, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 August 2013</li><li><span class="item_label"><b>Published</b> online</span>12 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401780b" title="DOI URL">https://doi.org/10.1021/jm401780b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1236%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGe%2BXu%252C%2BBinhua%2BLv%252C%2BJacques%2BY.%2BRoberge%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D4%26contentID%3Djm401780b%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BDeuterated%2BC-Aryl%2BGlycoside%2Bas%2Ba%2BPotent%2Band%2BLong-Acting%2BRenal%2BSodium-Dependent%2BGlucose%2BCotransporter%2B2%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BType%2B2%2BDiabetes%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1251%26publicationDate%3DFebruary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401780b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3810</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">39</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401780b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ge&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Binhua&quot;,&quot;last_name&quot;:&quot;Lv&quot;},{&quot;first_name&quot;:&quot;Jacques&quot;,&quot;last_name&quot;:&quot;Y. Roberge&quot;},{&quot;first_name&quot;:&quot;Baihua&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Jiyan&quot;,&quot;last_name&quot;:&quot;Du&quot;},{&quot;first_name&quot;:&quot;Jiajia&quot;,&quot;last_name&quot;:&quot;Dong&quot;},{&quot;first_name&quot;:&quot;Yuanwei&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Kun&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Lili&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Xinxing&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Fu&quot;},{&quot;first_name&quot;:&quot;Wenbin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Liangcheng&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Zhongping&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Zelin&quot;,&quot;last_name&quot;:&quot;Sheng&quot;},{&quot;first_name&quot;:&quot;Ajith&quot;,&quot;last_name&quot;:&quot;Welihinda&quot;},{&quot;first_name&quot;:&quot;Xun&quot;,&quot;last_name&quot;:&quot;Sun&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1236-1251&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401780b&quot;},&quot;abstract&quot;:&quot;SGLT2 inhibitors deuterated at sites susceptible to oxidative metabolism were found to have a slightly longer tmax and half-life (t1/2), dose-dependent increase in urinary glucose excretion (UGE) in rats, and slightly superior effects on UGE in dogs while retaining similar in vitro inhibitory activities against hSGLT2. In particular, deuterated compound 41 has the potential to be a robust long-acting antidiabetic agent.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401780b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401780b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401780b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401780b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401780b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401780b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401780b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401780b&amp;href=/doi/10.1021/jm401780b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401780b" /></input><a href="/doi/pdf/10.1021/jm401780b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401780b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401780b%26sid%3Dliteratum%253Aachs%26pmid%3D24456245%26genre%3Darticle%26aulast%3DXu%26date%3D2014%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BDeuterated%2BC-Aryl%2BGlycoside%2Bas%2Ba%2BPotent%2Band%2BLong-Acting%2BRenal%2BSodium-Dependent%2BGlucose%2BCotransporter%2B2%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BType%2B2%2BDiabetes%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D4%26spage%3D1236%26epage%3D1251%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jmcmar.2014.57.issue-4/production/jmcmar.2014.57.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">SGLT2 inhibitors deuterated at sites susceptible to oxidative metabolism were found to have a slightly longer <i>t</i><sub>max</sub> and half-life (<i>t</i><sub>1/2</sub>), dose-dependent increase in urinary glucose excretion (UGE) in rats, and slightly superior effects on UGE in dogs while retaining similar in vitro inhibitory activities against <i>h</i>SGLT2. In particular, deuterated compound <b>41</b> has the potential to be a robust long-acting antidiabetic agent.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Diabetes has increasingly become a burden on the world’s population. In 2011, the WHO announced that 347 million people worldwide have diabetes, that an estimated 3.4 million people died from the complications of high blood sugar in 2004, and that diabetes deaths would double from 2005 to 2030.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Whereas type 1 diabetes is characterized by deficient insulin production, type 2 diabetes mellitus (DM2) is a complex disorder in which the interaction between environmental and genetic factors results in the development of insulin resistance (IR) and β-cell dysfunction.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Oral medications for DM2 include metformin,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> alpha-glucosidase inhibitors,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> sulfonylureas,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> glinides,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> thiazolidinediones,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> and DPP-4 inhibitors.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><div class="NLM_p">Sodium-dependent glucose cotransporters (SGLTs) rely on the electrochemical potential of sodium ions to transport extracellular glucose actively into the cytoplasm. SGLT2 is a low-affinity, high-capacity transporter located almost exclusively on the apical surface of renal epithelial cells, whereas SGLT1 is expressed not only in the kidney but also in the intestine and other tissues. Approximately 90% of filtered glucose is reabsorbed by SGLT2 in the early proximal convoluted tubule (S1 and S2 segments) in mice, and the rest is reabsorbed by SGLT1 in the late proximal straight tubule (S3 segment), although in the absence of SGLT2, SGLT1 appears to be capable of reabsorbing approximately 70% of filtered glucose.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12-15)</a> By promoting urinary glucose excretion (UGE), SGLT2 inhibitors allow treatment of DM2 by an insulin-independent mechanism that does not exacerbate the root cause, excess fat, implicated in the etiology of most cases of the disease. Because the natural <i>O</i>-aryl glycoside phlorizin (<b>1</b>) is a fairly potent SGLT2 inhibitor (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>),<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> early drug discovery efforts on SGLT2 inhibitors focused on <i>O</i>-aryl glycosides related to phlorizin, such as T-1095 (<b>2</b>),<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> sergliflozin (<b>3</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and remogliflozin (<b>4</b>),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> with the aim of increasing potency toward SGLT2 and minimizing activity toward SGLT1. Unfortunately, because of their susceptibility to the action of glycosidases and the ensuing poor pharmacokinetics, development of most <i>O</i>-aryl glycosides has ceased. The advent of <i>C</i>-aryl glycoside SGLT2 inhibitors, such as dapagliflozin (<b>5</b>, Bristol-Myers Squibb and AstraZeneca, approved by EMA in 2012),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> canagliflozin (<b>6</b>, Johnson & Johnson/Mitsubishi Tanabe, approved by FDA in 2013),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> ipragliflozin (ASP1941, <b>7</b>, Astellas, phase III),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> sotagliflozin (LX4211, <b>8</b>, Lexicon, phase II),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> ertugliflozin (PF-04971729, <b>9</b>, Pfizer, phase II),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and EGT0001442 (<b>10</b>, Theracos, phase II),<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> circumvented the problem of glycosidase susceptibility by removing the glycoside anomeric oxygen (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <i>O</i>-Aryl glycoside SGLT2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>C</i>-Aryl glycoside SGLT2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>5</b> was reported to display a favorable absorption, distribution, metabolism, and excretion (ADME) profile in rats and humans and to control the blood glucose level well.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, safety concerns<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> led an advisory committee to vote against the approval of <b>5</b> in January 2012, and drug approval in the United States was delayed even though it was approved in Europe in November 2012.</div><div class="NLM_p">The toxicity of a drug could arise because of its unique chemical structure, its pharmacokinetics and tissue distribution, and/or the presence of toxic metabolites.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> It was previously reported that excess quinones and methine-quinones might cause toxicities (e.g., hepatotoxicity).<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Benz et al. reported several novel pathways associated with quinone-induced stress in breast cancer cells.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> It is also known that <b>5</b> is extensively metabolized via three main oxidative metabolic pathways in addition to extensive formation of glucuronides (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), and only low levels of the unchanged parent drug are excreted in the urine or feces<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (main oxidative metabolites <b>11</b> and <b>12</b> are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Therefore, after analysis of the structures of <b>5</b> and its main metabolites, <b>11</b> and <b>12</b>, we hypothesized that <b>5</b> might eventually be converted into a methine-quinone derivative via <b>11</b> and/or <b>12</b> in vivo, which might be associated with possible adverse events (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Thus, we have attempted to block the potential metabolic hotspots on <b>5</b> and its close structural analogue <b>13</b> to increase their metabolic stability in vivo and to prevent or reduce the possibility of forming methine-quinone metabolites. As expected, compound <b>41</b> showed a much higher metabolic stability in vivo than <b>5</b> and was demonstrated to be a selective and long-acting SGLT2 inhibitor.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Metabolites of <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed mechanism of formation of the putative methine-quinone metabolite from <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Replacing a hydrogen atom with fluorine has been extensively used to block metabolic hotspots. Recently, a renewed interest in the use of deuterium has also been used to serve a similar purpose.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> By blocking a metabolic hotspot with deuteration, it is expected to not only reduce metabolite formation but also to improve the pharmacokinetic properties of drug candidates. Clinical studies with deuterated analogues of some known drugs have been initiated.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39 ref40">(36-40)</a> Because of the isotope effect, the rate of C–D bond cleavage could be up to 10 times slower than cleavage of the C–H bond, making the deuterium analogue more resistant to chemical or enzymatic cleavage.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">On the basis of the structure of <b>5</b>, we believed that it would go through oxidative metabolic transformation principally at three distinct sites (A–C, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>): methine-C5 (A site) on the glycoside, leading to alpha hydroxylation, C13 in diarylmethane (B site), leading to hydroxylation, and O6 (C site), leading to dealkylation. Potential metabolic sites B and C were also confirmed by a later report on <b>5</b>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Our efforts were therefore devoted to the design and synthesis of novel SGLT2 inhibitors with a deuterium atom at the potential metabolic sites on <b>5</b> and its analogue <b>13</b> whose metabolism at these sites presumably could lead to the formation of methine-quinone metabolites. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> depicts the deuterated analogues that were pursued in the current study.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Predicted metabolic sites (A–C) of <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Deuteration strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The designed deuterated analogues <b>34</b>–<b>43</b> together with their parent compounds <b>5</b> and <b>13</b> (depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) were prepared according to Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><div class="NLM_p">The synthesis of key intermediates <b>23</b> and <b>24</b> commenced from commercially available 5-bromo-2-chlorobenzoic acid (<b>14</b>), as illustrated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. <b>14</b> was first transformed into <b>15</b> via reaction with oxalyl chloride followed by a Friedel–Crafts acylation reaction using anisole and aluminum chloride, giving <b>16</b> in 83% yield after one crystallization from ethanol.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Starting from <b>16</b>, after reduction (to <b>17</b> and <b>18</b>), demethylation (to <b>19</b> and <b>20</b>), protection with <i>tert</i>-butyldimethylsilyl (TBDMS) (to <b>21</b> and <b>22</b>), and a final coupling with <span class="smallcaps smallerCapital">d</span>-gluconolactone, <b>23</b> and <b>24</b> were obtained. Reduction of <b>16</b> with sodium borohydride and aluminum chloride in THF provided <b>17</b> in 95% yield, and using sodium borodeuteride and aluminum chloride in THF under refluxing conditions, <b>18</b> was obtained from <b>16</b> in 95% yield and with 98% deuterium incorporation,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> thus leading to a nearly complete deuteration at the B site. It should be pointed out that we have also tried to use the following two treatments to achieve the transformation of <b>16</b> to <b>17</b> (or <b>18</b>) on a small scale, but they were not used in the current study because of the high cost of deuterated triethylsilane (Et<sub>3</sub>SiD) with boron trifluoride etherate (BF<sub>3</sub>·Et<sub>2</sub>O)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and triethylsilane (or Et<sub>3</sub>SiD) with trifluoroacetic acid.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> After removing the methyl group on <b>17</b> or <b>18</b> with boron tribromide in methylene chloride, <b>19</b> or <b>20</b> was obtained in 75% yield.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The phenolic hydroxyl group of <b>19</b> or <b>20</b> was then protected with TBDMS-Cl using triethylamine as the base, yielding <b>21</b> or <b>22</b>.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Further lithium–halogen exchange of bromodiarylmethane <b>21</b> or <b>22</b> followed by the addition of the resulting aryllithium to 2,3,4,6-tetra-<i>O</i>-trimethylsilyl-β-<span class="smallcaps smallerCapital">d</span>-gluconolactone and the subsequent etherification with methanol in the presence of hydrochloric acid provided desilylated <i>O</i>-methyl lactol <b>23</b> or <b>24</b>.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a></div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>23</b> and <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (COCl)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, DMF(cat.), 5–10 °C; (b) anisole, AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −10 to 0 °C; (c) AlCl<sub>3</sub>, NaBH<sub>4</sub>, THF, 70 °C; (d) AlCl<sub>3</sub>, NaBD<sub>4</sub>, THF, 70 °C; (e) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −20 to 0 °C; (f) <i>tert</i>-butylchlorodimethylsilane, triethylamine, acetonitrile, 0 to 5 °C; (g) <i>n</i>-BuLi, THF, PhCH<sub>3</sub>, −78 °C, then 2,3,4,6-tetra-<i>O</i>-trimethylsilyl-β-<span class="smallcaps smallerCapital">d</span>-gluconolactone followed by MeOH and concentrated hydrochloric acid.</p></p></figure><div class="NLM_p"><i>C</i>-Aryl glycosides <b>11</b>, <b>25</b>, <b>26</b>, and <b>27</b> were synthesized according to Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Stereoselective reduction of <b>23</b> and <b>24</b> using a combination of triethylsilane and boron trifluoride etherate (BF<sub>3</sub>·Et<sub>2</sub>O) in a mixture of methylene chloride and acetonitrile gave desired <i>C</i>-aryl glycosides <b>11</b> and <b>26</b> in 60–65% yield.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> Site-deuterated <i>C</i>-aryl glycosides <b>25</b> and <b>27</b> were prepared via a similar reduction of <b>23</b> and <b>24</b> with Et<sub>3</sub>SiD (97% D).</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>11</b> and <b>25</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (h) Et<sub>3</sub>SiH, BF<sub>3</sub>·OEt<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, −20 to −10 °C; (i) Et<sub>3</sub>SiD, BF<sub>3</sub>·OEt<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, −20 to −10 °C.</p></p></figure><div class="NLM_p">Tosylated compounds <b>29</b>–<b>33</b> were prepared from <i>p</i>-toluenesulfonyl chloride <b>28</b> and appropriate alcohols (ROH, R = CH<sub>2</sub>CH<sub>3</sub>, CD<sub>2</sub>CD<sub>3</sub>, CD<sub>2</sub>CH<sub>3</sub>, CH<sub>3</sub>, or CD<sub>3</sub>), as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The preparation of the target compounds <b>5</b>, <b>13</b>, and <b>34</b>–<b>43</b> was finally achieved according to Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Coupling of <b>11</b> with <b>29</b>–<b>33</b> prepared above using cesium carbonate in DMF gave <i>C</i>-aryl glycosides <b>5</b>, <b>34</b>–<b>35</b>, <b>13</b>, and <b>41</b>.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Under similar conditions, coupling of <b>25</b>–<b>27</b> with TsOR using cesium carbonate in DMF gave deuterated <i>C</i>-aryl glycosides <b>36</b>–<b>40</b> and <b>42</b>–<b>43</b> in 68–75% yield.</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>29</b>–<b>33</b>, <b>5</b>, <b>13</b>, and <b>34</b>–<b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (j) 4.6 N aqueous NaOH, ROH, THF, −5 to 15 °C; (k) TsOR (<b>29</b>–<b>33</b>), Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40 °C.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The in vitro inhibition activities of newly synthesized compounds on SGLT2 and SGLT1 were evaluated in cell-based SGLT functional assays in which inhibition of the rate of glucose uptake was monitored with CHO-K1 cells expressing human SGLT1 (<i>h</i>SGLT1) and SGLT2 (<i>h</i>SGLT2). For the SGLT2 assay, 293.ETN cells expressing <i>h</i>SGLT2 were used, whereas COS-7 cells expressing <i>h</i>SGLT1 were used to measure SGLT1 inhibition. Sodium-dependent glucopyranoside uptake was measured by subtracting the values obtained with a sodium-free buffer from those obtained using a sodium-containing buffer, and triplicate determinations were made for each test compound. The IC<sub>50</sub> values of the test compounds against SGLT2 and SGLT1 were determined, and the selectivity for SGLT2 inhibition was assessed. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, when the hydrogens at the X, Y, or R sites were replaced partly or totally with deuteriums, the in vitro activities against SGLT2 of compounds <b>35</b>, <b>38</b>, <b>39</b>, <b>40</b>, and <b>43</b> showed about a 2-fold loss of activity compared to parent compound <b>5</b>, whereas other compounds exhibited the same or improved activity against SGLT2 compared to parent compound <b>5</b>. With the exception of compounds <b>13</b> and <b>41</b>–<b>42</b>, all other deuterated compounds showed the same or less potent activity against SGLT1 compared to compound <b>5</b>. For example, compounds <b>34</b> and <b>36</b> exhibited slightly improved SGLT2 inhibitory activities compared to <b>5</b>. With the exception of <b>38</b>, all five derivatives (<b>34</b>, <b>37</b>, <b>39</b>, and <b>40</b>) exhibited a slightly better selectivity than <b>5</b>. Compounds <b>41</b>–<b>43</b> also exhibited a slightly better selectivity than the parent compound <b>13</b>, indicating that deuterium substitution maintained SGLT2 inhibitory activity and improved the inhibitory selectivity for SGLT2 versus SGLT1.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro <i>h</i>SGLT Inhibitory Activity and Selectivity<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0015.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="."><i>h</i>SGLT2 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>h</i>SGLT1 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>h</i>SGLT1/<i>h</i>SGLT2 selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">3.2</td><td class="colsep0 rowsep0" align="left">3140</td><td class="colsep0 rowsep0" align="left">981</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CD<sub>2</sub>CD<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">2.5</td><td class="colsep0 rowsep0" align="left">3170</td><td class="colsep0 rowsep0" align="left">1268</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CD<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">7.5</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>1333</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">2.9</td><td class="colsep0 rowsep0" align="left">3060</td><td class="colsep0 rowsep0" align="left">1055</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">3.2</td><td class="colsep0 rowsep0" align="left">3988</td><td class="colsep0 rowsep0" align="left">1246</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">CD<sub>2</sub>CD<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">7.5</td><td class="colsep0 rowsep0" align="left">5040</td><td class="colsep0 rowsep0" align="left">672</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">6.5</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>1538</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">CD<sub>2</sub>CD<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">7.2</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>1388</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">1.9</td><td class="colsep0 rowsep0" align="left">540</td><td class="colsep0 rowsep0" align="left">284</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CD<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">2.5</td><td class="colsep0 rowsep0" align="left">900</td><td class="colsep0 rowsep0" align="left">360</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">CD<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">0.8</td><td class="colsep0 rowsep0" align="left">820</td><td class="colsep0 rowsep0" align="left">1025</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">CD<sub>3</sub></td><td class="colsep0 rowsep0" align="left" char=".">6.8</td><td class="colsep0 rowsep0" align="left">7000</td><td class="colsep0 rowsep0" align="left">1029</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values for SGLT1 and SGLT2 activities were obtained using eight-point dose-response curves constructed from triplicate measurements.</p></div></div></div><div class="NLM_p">The pharmacokinetic profiles of the deuterated analogues in male Sprague–Dawley (SD) rats were also assessed. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, deuterated compounds <b>34</b>–<b>35</b>, <b>37</b>, and <b>38</b> generally displayed better PK properties as compared to parent compound <b>5</b> at the 3 mg/kg dose. In particular, compound <b>34</b> exhibited an almost 2-fold increase in AUC<sub>0–∞</sub> (ng h/mL) (22 646 ± 1778) compared to <b>5</b> (11 658 ± 2918). Its <i>t</i><sub>1/2</sub> was also increased to 6.05 ± 0.85 h compared to that of <b>5</b> (4.52 ± 0.98 h). Similarly, deuterated compounds <b>41</b> and <b>42</b> also displayed slightly better PK properties than the parent compound <b>13</b>. The <i>t</i><sub>1/2</sub> of <b>41</b> and <b>42</b> (6.34 ± 2.79 and 5.66 ± 1.24 h, respectively) were found to be greater than that of <b>13</b> (3.55 ± 1.80 h) and were also greater than that of <b>5</b> (4.52 ± 0.98 h). Of note, <b>41</b> exhibited the longest <i>t</i><sub>1/2</sub> among all the test compounds.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Parameters after Oral Compound Administration to SD Rats<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">PK in rat</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>0–∞</sub> (ng h/mL)</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="char" char="±">0.88 ± 0.75</td><td class="colsep0 rowsep0" align="char" char="±">1603 ± 425</td><td class="colsep0 rowsep0" align="char" char="±">11 658 ± 2918</td><td class="colsep0 rowsep0" align="char" char="±">4.52 ± 0.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="char" char="±">1.38 ± 0.75</td><td class="colsep0 rowsep0" align="char" char="±">2285 ± 697</td><td class="colsep0 rowsep0" align="char" char="±">22 646 ± 1778</td><td class="colsep0 rowsep0" align="char" char="±">6.05 ± 0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="char" char="±">0.88 ± 0.75</td><td class="colsep0 rowsep0" align="char" char="±">2923 ± 393</td><td class="colsep0 rowsep0" align="char" char="±">20 885 ± 1837</td><td class="colsep0 rowsep0" align="char" char="±">4.56 ± 0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="char" char="±">1.69 ± 0.59</td><td class="colsep0 rowsep0" align="char" char="±">1830 ± 365</td><td class="colsep0 rowsep0" align="char" char="±">16 124 ± 2931</td><td class="colsep0 rowsep0" align="char" char="±">5.14 ± 1.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="char" char="±">1.00 ± 0.71</td><td class="colsep0 rowsep0" align="char" char="±">2683 ± 471</td><td class="colsep0 rowsep0" align="char" char="±">22 428 ± 4994</td><td class="colsep0 rowsep0" align="char" char="±">5.70 ± 0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="char" char="±">0.56 ± 0.31</td><td class="colsep0 rowsep0" align="char" char="±">1638 ± 326</td><td class="colsep0 rowsep0" align="char" char="±">5350 ± 709</td><td class="colsep0 rowsep0" align="char" char="±">3.55 ± 1.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char="±">1.75 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">165 ± 31</td><td class="colsep0 rowsep0" align="char" char="±">943 ± 74</td><td class="colsep0 rowsep0" align="char" char="±">3.23 ± 0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="char" char="±">1.19 ± 0.94</td><td class="colsep0 rowsep0" align="char" char="±">1494 ± 428</td><td class="colsep0 rowsep0" align="char" char="±">7005 ± 622</td><td class="colsep0 rowsep0" align="char" char="±">6.34 ± 2.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char="±">1.56 ± 0.88</td><td class="colsep0 rowsep0" align="char" char="±">257 ± 38</td><td class="colsep0 rowsep0" align="char" char="±">1016 ± 263</td><td class="colsep0 rowsep0" align="char" char="±">3.50 ± 0.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="char" char="±">0.75 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">1398 ± 212</td><td class="colsep0 rowsep0" align="char" char="±">5352 ± 411</td><td class="colsep0 rowsep0" align="char" char="±">5.66 ± 1.24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data are presented as the mean ± SD from four male Sprague–Dawley rats.</p></div></div></div><div class="NLM_p">To compare the pharmacokinetics profiles of deuterated compound <b>41</b> and parent nondeuterated compound <b>13</b> further, we assessed these two compounds in male Sprague–Dawley (SD) rats (<i>n</i> = 4 per group) at a dose other than 3 mg/kg (i.e., 1 mg/kg). As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the pharmacokinetics profiles of <b>41</b> and <b>13</b> in the rats orally dosed were poorer at the lower dose (i.e., 1 mg/kg) than at the higher dose (i.e., 3 mg/kg). Compounds <b>41</b> and <b>13</b> were administrated both orally (p.o.) and intravenously (i.v.). As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, the key findings from this experiment were that although <b>41</b> and <b>13</b> showed similar oral bioavailability (<i>F</i>%) (76.3 ± 19.7 and 77.0 ± 6.0, respectively), <b>41</b> showed a greater <i>C</i><sub>max</sub> (ng/mL, p.o.) than <b>13</b> (257 ± 38 and 165 ± 31, respectively). Moreover, <b>41</b> and <b>13</b> seemed to exhibit similar values for other PK parameters.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Parameters after Oral and IV Administration to SD Rats<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char="±">PK in rat (1 mg/kg dose)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>0–∞</sub> (ng h/mL)</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±">CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>F</i>%</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="center"><b>41</b></td><td class="colsep0 rowsep0" align="left">p.o.</td><td class="colsep0 rowsep0" align="char" char="±">1.56 ± 0.88</td><td class="colsep0 rowsep0" align="char" char="±">257 ± 38</td><td class="colsep0 rowsep0" align="char" char="±">1016 ± 263</td><td class="colsep0 rowsep0" align="char" char="±">3.50 ± 0.73</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">76.3 ± 19.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">1332 ± 195</td><td class="colsep0 rowsep0" align="char" char="±">2.69 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">0.76 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="center"><b>13</b></td><td class="colsep0 rowsep0" align="left">p.o.</td><td class="colsep0 rowsep0" align="char" char="±">1.75 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">165 ± 31</td><td class="colsep0 rowsep0" align="char" char="±">943 ± 74</td><td class="colsep0 rowsep0" align="char" char="±">3.23 ± 0.65</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">77.0 ± 6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">1225 ± 226</td><td class="colsep0 rowsep0" align="char" char="±">2.09 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">0.84 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data are presented as the mean ± SD from four male Sprague–Dawley rats.</p></div></div></div><div class="NLM_p">The effects of the deuterated analogues on urinary glucose excretion (UGE) in normal male Sprague–Dawley (SD) rats were also evaluated, and the results are reported as milligrams of glucose per 200 g of body weight in 24 h. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, compound <b>36</b> exhibited a higher UGE than <b>5</b> for three different time periods, and <b>34</b>, <b>35</b>, <b>37</b>, and <b>38</b> exhibited similar UGE activities to that of <b>5</b>. Similarly, compound <b>41</b> was also observed to exhibit a higher UGE in the 4–24 and 0–24 h time periods than <b>13</b>. Compound <b>41</b> was also observed to exhibit a higher UGE in the 0–4 h period and a slightly lower UGE in the 0–24 h period than <b>5</b>. Compounds <b>42</b> and <b>43</b> exhibited similar or better UGE activities than <b>13</b> but slightly lower UGE activities than <b>5</b> in the 0–24 h period. It was found that the derivatives of <b>5</b> or <b>13</b> deuterated at only one metabolite site, such as <b>36</b> (deuterated at the A site) and <b>41</b> (deuterated at the C site), exhibited better UGE activities in SD rats.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effects on Urinary Glucose Excretion in SD Rats<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">urinary glucose excretion in SD rats (mg) (% relative to ref <b><a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">5</a></b>) (mean ± SD)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">0–4 h</th><th class="colsep0 rowsep0" align="center">4–24 h</th><th class="colsep0 rowsep0" align="center">0–24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">191 ± 48 (100%)</td><td class="colsep0 rowsep0" align="left">2231 ± 353 (100%)</td><td class="colsep0 rowsep0" align="left">2422 ± 361 (100%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">145 ± 67 (76%)</td><td class="colsep0 rowsep0" align="left">2151 ± 548 (96%)</td><td class="colsep0 rowsep0" align="left">2297 ± 548 (95%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">119 ± 73 (82%)</td><td class="colsep0 rowsep0" align="left">2311 ± 774 (98%)</td><td class="colsep0 rowsep0" align="left">2431 ± 789 (97%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">193 ± 24 (101%)</td><td class="colsep0 rowsep0" align="left">2457 ± 369 (110%)</td><td class="colsep0 rowsep0" align="left">2650 ± 385 (109%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">168 ± 17 (88%)</td><td class="colsep0 rowsep0" align="left">2057 ± 835 (92%)</td><td class="colsep0 rowsep0" align="left">2225 ± 842 (92%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">137 ± 9 (92%)</td><td class="colsep0 rowsep0" align="left">1941 ± 396 (91%)</td><td class="colsep0 rowsep0" align="left">2078 ± 391 (91%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">233 ± 35 (122%)</td><td class="colsep0 rowsep0" align="left">1657 ± 354 (74%)</td><td class="colsep0 rowsep0" align="left">1889 ± 361 (78%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">251 ± 44 (131%)</td><td class="colsep0 rowsep0" align="left">1983 ± 167 (89%)</td><td class="colsep0 rowsep0" align="left">2234 ± 199 (92%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">101 ± 38 (70%)</td><td class="colsep0 rowsep0" align="left">1994 ± 303 (84%)</td><td class="colsep0 rowsep0" align="left">2096 ± 332 (83%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">166 ± 24 (111%)</td><td class="colsep0 rowsep0" align="left">1483 ± 254 (69%)</td><td class="colsep0 rowsep0" align="left">1649 ± 242 (72%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle control</td><td class="colsep0 rowsep0" align="left">1.82 ± 3.78 (0.07%)</td><td class="colsep0 rowsep0" align="left">5.04 ± 0.69 (0.23%)</td><td class="colsep0 rowsep0" align="left">5.17 ± 0.72 (0.21%)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Each test compound was dissolved in 30% poly(ethylene glycol) (PEG400, average molecular weight of 400) and administered orally to overnight-fasted Sprague–Dawley rats (<i>n</i> = 3 per group) by gavage at the 1 mg/kg dose level. Control rats were given 30% PEG400 only. One hour postdosing, a glucose solution (2 g/kg, 10 mL/kg) was administered by oral gavage. Each value represents the mean ± SD.</p></div></div></div><div class="NLM_p">Assessment of the UGE in dogs was also performed, and the results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Compared with <b>5</b>, all test compounds except <b>38</b> (i.e., <b>34</b>, <b>36</b>, <b>37</b>, <b>13</b>, and <b>41</b>) induced 58–75% more UGE at the 0–8 h period. Consistent with the results in SD rats, compound <b>36</b> (12 676 ± 2150 mg) and <b>41</b> (14 682 ± 4172 mg) exhibited slightly more UGE than <b>5</b> (11 610 ± 1677 mg) during the 0–24 h period after compound administration. Among all of the tested deuterated analogues, <b>41</b> exhibited the most significant effect on UGE (0–24 h) in dogs.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effects on Urinary Glucose Excretion in Beagle dogs<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">urinary glucose excretion in beagle dog (mg) (% relative to ref <a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">5</a>) (mean ± SD)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">0–8 h</th><th class="colsep0 rowsep0" align="center">8–24 h</th><th class="colsep0 rowsep0" align="center">0–24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">2155 ± 854 (100%)</td><td class="colsep0 rowsep0" align="left">9455 ± 2271 (100%)</td><td class="colsep0 rowsep0" align="left">11 610 ± 1677 (100%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">3472 ± 622 (161%)</td><td class="colsep0 rowsep0" align="left">8491 ± 1569 (90%)</td><td class="colsep0 rowsep0" align="left">11 964 ± 2190 (103%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">3765 ± 808 (175%)</td><td class="colsep0 rowsep0" align="left">8910 ± 1700 (94%)</td><td class="colsep0 rowsep0" align="left">12 676 ± 2150 (109%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">3396 ± 442 (158%)</td><td class="colsep0 rowsep0" align="left">6832 ± 2555 (72%)</td><td class="colsep0 rowsep0" align="left">10 228 ± 895 (88%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">4362 ± 818 (114%)</td><td class="colsep0 rowsep0" align="left">10 995 ± 1987 (95%)</td><td class="colsep0 rowsep0" align="left">15 357 ± 2514 (99%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">3620 ± 470 (168%)</td><td class="colsep0 rowsep0" align="left">10 876 ± 1303 (115%)</td><td class="colsep0 rowsep0" align="left">14 497 ± 1656 (125%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">3485 ± 596 (162%)</td><td class="colsep0 rowsep0" align="left">11 197 ± 3579 (118%)</td><td class="colsep0 rowsep0" align="left">14 682 ± 4172 (127%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle control</td><td class="colsep0 rowsep0" align="left">8.19 ± 3.04 (0.4%)</td><td class="colsep0 rowsep0" align="left">16.86 ± 4.59 (0.2%)</td><td class="colsep0 rowsep0" align="left">25.05 ± 6.81 (0.2%)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Each test compound was dissolved in 10% PEG400 and administered orally to overnight-fasted beagle dogs (<i>n</i> = 3 per group) by gavage at the 0.03 mg/kg dose level. Control dogs were given 10% PEG400 only. One hour postdosing, a glucose solution (2 g/kg, 5 mL/kg) was administered by oral gavage. Each value represents the mean ± SD.</p></div></div></div><div class="NLM_p">We further performed the UGE and oral glucose-tolerance tests on compound <b>41</b> in normal male SD Rats. Compound <b>41</b> was found to lower blood glucose levels after a 2 g/kg glucose challenge. The baseline-corrected blood glucose AUC values observed following administration of 0.1, 0.3, 1, 3, and 10 mg/kg of <b>41</b> were 18.6, 20.7, 26.7, 21.6, and 5.0% that of the control AUC, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). These results indicated that <b>41</b> could significantly lower the blood glucose level in rats and could blunt the normal physiological response to a high dietary glucose load. Compound <b>41</b> was also found to increase the UGE significantly in a dose-dependent manner for all of the doses tested (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). It should be pointed out that although an essentially linear dose–response curve was observed in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, a bell-curve was observed in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>. In our opinion, these observations could be explained as follows: the initial <b>41</b>-induced withdrawal of glucose from the bloodstream would likely stimulate a compensatory response in a rat to produce/secrete more glucose into the bloodstream (from liver) in an attempt to maintain the blood glucose concentration, especially during a long (2 h) period of time; however, the dramatic increase in <b>41</b> (to 10 mg/kg) would overcome this natural compensatory response, leading to the observed dramatic decline in the blood glucose concentration. However, this would not have a linear correspondence to the UGE response because of the presence of another layer of the control (i.e., filtration in kidney). Therefore, a bell-curve was observed in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, and an essentially linear dose–response curve was still observed in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compound <b>41</b> on blood glucose levels in glucose-loaded Sprague–Dawley rats (<i>n</i> = 5 per group). Rats were fasted overnight and treated with a single oral dose of compound (0.1–10 mg/kg of <b>41</b>) 1 h prior to receiving the glucose challenge (20%, 2 g/kg, p.o.). Blood samples were obtained at −60, 0, 30, 60, 90, and 120 min. Blood glucose levels were then measured using a glucometer. Values of AUC (0–2 h) stand for baseline-corrected values calculated using the trapezoidal rule. Values represent the mean ± SD. * <i>p</i> < 0.01 and ** <i>p</i> < 0.05 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Rat 24 h UGE following treatment with <b>41</b>. Male Sprague–Dawley rats (<i>n</i> = 5 per group) were randomized to receive one of five doses of compound <b>41</b> (0.1, 0.3, 1, 3, and 10 mg/kg) by oral gavage. The test compound was dissolved in 30% PEG400. Control rats were given 30% PEG400 only. One hour postdosing, a glucose solution (2 g/kg, 10 mL/kg) was administered by oral gavage. Following compound administration, urine was collected over 24 h for measurement of UGE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Comparative studies of the in vivo metabolism of deuterated compound <b>41</b> and nondeuterated compounds <b>13</b> and <b>5</b> were performed in rats. Compounds <b>41</b>, <b>13</b>, and <b>5</b> were dosed orally (50 mg/kg) to male Sprague–Dawley rats for five consecutive days, and all urine samples were collected and analyzed for metabolites. The HPLC-MS spectra and the proposed metabolites for <b>41</b> are shown in Figures <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, <a class="ref internalNav" href="#notes-1" aria-label="S1">S1</a>, and <a class="ref internalNav" href="#notes-1" aria-label="S2">S2</a>. Compound <b>11</b> was observed to be the major metabolite of <b>41</b> and <b>13</b>, but 87% of <b>41</b> remained unchanged, compared to 73% of <b>13</b> (0.84-fold that of <b>41</b>), indicating that deuterated compound <b>41</b> was more stable in vivo than <b>13</b>. We found that compound <b>5</b> not only had a de-ethylation metabolite (<b>11</b>, 41% by HPLC) but also had a hydroxylation metabolite (<b>12</b>, 16% by HPLC),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and unchanged <b>5</b> was observed during our HPLC analysis to constitute 43% of the parent plus metabolites (0.49-fold that of <b>41</b>). Compound <b>41</b> exhibited a low dealkylation (13%) compared to <b>5</b> (41%). Also, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, only one major metabolite was found for compound <b>41</b>, and the conversion rate of parent to metabolite (13%) in vivo for this compound was also the lowest compared to other compounds, which may lead to less concern over the formation of the methine-quinone metabolite from <b>41</b>.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Overlay of the HPLC chromatograms showing the metabolites of <b>41</b>, <b>13</b>, <b>5</b>, and <b>11</b>. Compound <b>11</b> was used as a reference.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0011.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Conversion of parent compounds into metabolites. 1, 2, and 3 on <i>x</i> axis refer to the parent compound, the hydroxylation metabolite (<b>12</b>), and the dealkylation metabolite (<b>11</b>), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have designed and synthesized one class of potent, selective, and long-acting SGLT2 inhibitors through deuteration at the potential metabolic hotspots of known SGLT2 inhibitors. Among the deuterated compounds studied, compounds <b>34</b>, <b>36</b>, <b>41</b>, and <b>42</b> exhibited slightly stronger in vitro inhibitory activity against <i>h</i>SGLT2 than nondeuterated compound <b>5</b>. The pharmacokinetics studies in SD rats revealed that the <i>t</i><sub>1/2</sub> of <b>41</b> was increased the most among all of the deuterated analogues compared to the nondeuterated compounds (<b>5</b> and <b>13</b>). It was observed that deuteration at only one metabolic site, exemplified by <b>36</b> (deuterated at A site) and <b>41</b> (deuterated at C site), might be enough to improve UGE activities in SD rats. Compound <b>41</b> also exhibited an increase in UGE in beagle dogs versus <b>5</b> in the 0–24 h period. Compound <b>41</b> caused a dose-dependent increase in UGE in SD rats for all of the doses tested. Analysis of the in vivo metabolite profiles revealed that <b>41</b> had the least metabolites and was devoid of the hydroxylation metabolite (<b>12</b>), confirming the hypothesis that deuteration would reduce oxidative metabolism. In summary, via the C–D for C–H replacement at the principal oxidative metabolic site, resulting deuterated compound <b>41</b> exhibited improved in vivo PK/ADME profiles, in vivo metabolite profiles, and in vivo efficacy in SD rats compared to nondeuterated compound <b>13</b>. As a potentially selective and long-acting SGLT2 inhibitor, compound <b>41</b> may warrant further assessment as an antidiabetic drug candidate.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div class="NLM_p last">Unless specified otherwise, starting materials were generally available from commercial sources. Commercial grade anhydrous solvents were purchased from SK Chemical. Silica gel (Qingdao Haiyang) was used for analytical TLC (F254 plates) and flash chromatography (200–300 mesh). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker 400 and 600 MHz instrument using CDCl<sub>3</sub>, CD<sub>3</sub>OD, or acetone-<i>d</i><sub>6</sub> as the solvent and TMS as the internal reference. Chemical shifts (δ) are expressed in parts per million (ppm) relative to the residual solvent peak (for chloroform-<i>d</i>, δ(<sup>1</sup>H) = 7.26 ppm and δ(<sup>13</sup>C) = 77.16 ppm; for methanol-<i>d</i><sub>4</sub>, δ(<sup>1</sup>H) = 3.31 ppm and δ(<sup>13</sup>C) = 49.00 ppm; and for acetone-<i>d</i><sub>6</sub>, δ(<sup>1</sup>H) = 2.05 ppm and δ(<sup>13</sup>C) = 29.84 ppm). Abbreviations used for signal patterns are as follows: s, singlet; d, doublet; dd, doublet of doublets; ddd, doublet of doublet of doublets; t, triplet; q, quadruplet; and m, multiplet. The high-pressure liquid chromatography–mass spectrometry (HPLC–MS) system employed a Waters ZQ2000 mass spectrometer interfaced with a Waters series 2695 liquid chromatograph and a Waters 2996 photodiode array detector. Electrospray ionization (ESI) was used as the ionization technique. MS analysis was performed in either positive or negative mode. Chromatographic separation was achieved using a Waters XTerra C18 column (3.5 μm, 50 × 2.1 mm column). The column temperature was 35 °C. The mobile phases A and B were 0.03% formic acid in acetonitrile and 0.05% formic acid in Milli-Q water, respectively. Gradient elution from 10 to 95% solvent A in 4.5 min at a flow rate of 0.8 mL/min and a final hold of 1.5 min at 95% A were employed. The total run time was 6 min. The photodiode array detector used wavelengths between 190 and 400 nm (or 225 nm). The preparative HPLC-MS system employed a Waters ZQ2000 mass spectrometer interfaced with a Waters series 2525 liquid chromatograph and a Waters 2487 UV absorbance detector. The mobile phases A and B were 100% acetonitrile and 0.1% formic acid in Milli-Q water, respectively. Chromatographic separation was achieved using a Waters XTerra Prep MS C18 OBD column (5 μm, 19 × 100 mm column). A gradient elution was performed from 33 to 95% A in 15 min followed by a 5 min isocratic step at 95% A at a flow rate of 17 mL/min. UV absorbance at 225 nm was used to monitor the chromatography. High-resolution mass spectrometry (HRMS) was performed with an Agilent model 6210 time-of-flight instrument. Where the intensity of single chlorine ions is described, the expected intensity ratio was observed (approximately 3:1 for <sup>35</sup>Cl/<sup>37</sup>Cl-containing ions), and the intensity of only the lower mass ion is given. GC was measured by a FULI 9790II gas chromatograph. The measurement conditions for GC were as follows: column, SE-54 (30 m × 0.32 mm × 0.25 μm); detector, flame ionization (hydrogen gas flame); detector temperature, 280 °C; split ratio, 10:1; inlet temperature, 250 °C; flow (N<sub>2</sub>), 3 mL/min; flow (H<sub>2</sub>), 30 mL/min; flow (air), 300 mL/min; and column temperature program, column oven was started from 220 °C, held for 2 min, and raised to 300 °C at a rate of 20 °C/min with a final hold of 10 min at 300 °C. Analytical HPLC was measured by a 2690/2996 from Waters. The measurement conditions for HPLC were as follows: (condition I) column, Waters Sunfire C18 4.6 mm × 250 mm, 5 μm; mobile phases A and B, 0.05% formic acid in acetonitrile and 0.05% formic acid in Milli-Q water, respectively; gradient elution from 25 to 45% solvent A in 5 min followed by 45 to 90% solvent A in 15 min at a flow rate of 1.0 mL/min and a final hold of 10 min at 90% A; total run time, 30 min; and column temperature, 30 °C. The photodiode array detector used a 225 nm wavelength. Condition II: column, Waters Sunfire C18 4.6 mm × 250 mm, 5 μm; mobile phases A and B, 0.05% formic acid in acetonitrile and 0.05% formic acid in Milli-Q water, respectively; gradient elution from 50 to 100% solvent A in 20 min at a flow rate of 1.0 mL/min and a hold of 19.5 min at 100% A followed by 50% A in 0.5 min; total run time,40 min; column temperature, 30 °C. The photodiode array detector used a 225 nm wavelength. All of the test compounds were determined to be >95% pure by HPLC.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>5</b>)</h3><div class="NLM_p last">To a stirred solution of <b>11</b> (100 mg, 0.263 mmol) and <b>29</b> (57.9 mg, 0.289 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (1.5 mL) was added cesium carbonate (257 mg, 0.789 mmol) followed by addition of tetrabutylammonium iodide (9.7 mg, 0.026 mmol). After stirring for 12 h at 40 °C under argon, the mixture was quenched by addition of ice water (10 mL). The mixture was extracted with ethyl acetate (2 × 20 mL). The combined organic layers were washed with water (20 mL) and brine (20 mL), dried over anhydrous sodium sulfate, and concentrated, and the residue was purified by preparative TLC (thin-layer chromatography) to give product <b>5</b> (80.6 mg, 75% yield, HPLC purity (condition I): 99.8%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.09 (d, <i>J</i> = 8.8 Hz, 2H), 6.79 (d, <i>J</i> = 8.8 Hz, 2H), 4.10–4.01 (m, 3H), 3.98 (q, <i>J</i> = 7.2 Hz, 2H), 3.87 (d, <i>J</i> = 11.2 Hz, 1H), 3.69 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.47–3.43 (m, 1H), 3.42–3.38 (m, 2H), 3.29–3.26 (m, 1H), 1.36 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 158.8, 140.0, 139.9, 134.4, 132.8, 131.9, 130.8, 130.1, 128.2, 115.4, 82.9, 82.2, 79.7, 76.4, 71.8, 64.4, 63.0, 39.2, 15.2. MS (ESI) <i>m</i>/<i>z</i> 431 (M + Na<sup>+</sup>, positive mode), 453 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>25</sub>ClNaO<sub>6</sub> (M + Na<sup>+</sup>), 431.1232; found, 431.1232.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>11</b>)</h3><div class="NLM_p last">To a solution of <b>23</b> (1.03 g, 2.50 mmol) in dichloromethane (10.0 mL) and acetonitrile (10.0 mL) at −30 °C under argon was added triethylsilane (1.6 mL, 10.0 mmol, 97 atom % D). Then, boron trifluoride etherate (0.95 mL, 7.50 mmol) was added while maintaining the reaction temperature below −15 °C, and the reaction mixture was stirred for another 2 h at −20 to −10 °C. The reaction was quenched by addition of 5% sodium bicarbonate until reaching pH 7.5. The organic phase was separated, and the aqueous phase was extracted with ethyl acetate (3 × 30 mL). The combined organic phases were washed with brine (2 × 50 mL) and dried over anhydrous sodium sulfate. The sample was concentrated under reduced pressure to provide a pale solid product, which was purified by the flash chromatography to give product <b>11</b> (571 mg, 60% yield, HPLC purity (condition I): 99.0%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.34 (d, <i>J</i> = 8.0 Hz, 1H), 7.31 (d, <i>J</i> = 1.6 Hz, 1H), 7.26 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 2H), 6.68 (d, <i>J</i> = 8.4 Hz, 2H), 4.08 (d, <i>J</i> = 9.6 Hz, 1H), 4.02 (d, <i>J</i> = 15.2 Hz, 1H), 3.96 (d, <i>J</i> = 15.2 Hz, 1H), 3.87 (d, <i>J</i> = 11.6 Hz, 1H), 3.69 (dd, <i>J</i> = 5.6, 11.6 Hz, 1H), 3.47–3.44 (m, 1H), 3.42–3.38 (m, 2H), 3.30–3.27 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 156.7, 140.1, 139.9, 134.4, 131.9, 131.7, 130.8, 130.1, 128.1, 116.1, 82.9, 82.2, 79.7, 76.4, 71.8, 63.1, 39.2. MS (ESI) <i>m</i>/<i>z</i> 403 (M + Na<sup>+</sup>, positive mode), 425 (M + HCO<sub>2</sub><sup>–</sup>, negative mode).</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-(4-methoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> (72.7 mg, 70% yield, HPLC purity (condition I): 99.9%) was prepared as a white solid from <b>11</b> (100 mg, 0.263 mmol) and <b>32</b> (53.8 mg, 0.289 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.34 (d, <i>J</i> = 8.4 Hz, 1H), 7.32 (d, <i>J</i> = 2.0 Hz, 1H), 7.27 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.10 (d, <i>J</i> = 8.8 Hz, 2H), 6.81 (d, <i>J</i> = 8.8 Hz, 2H), 4.07–3.98 (m, 3H), 3.87 (d, <i>J</i> = 11.6 Hz, 1H), 3.75 (s, 3H), 3.69 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.46–3.42 (m, 1H), 3.41–3.35 (m, 2H), 3.30–3.27 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 159.6, 140.0, 139.9, 134.4, 133.0, 131.9, 130.8, 130.1, 128.2, 114.8, 82.9, 82.2, 79.7, 76.4, 71.9, 63.1, 55.6, 39.2. MS (ESI) <i>m</i>/<i>z</i> 412 (M + NH<sub>4</sub><sup>+</sup>, positive mode), 439 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>23</sub>ClNaO<sub>6</sub> (M + Na<sup>+</sup>), 417.1075; found, 417.1079.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 5-Bromo-2-chlorobenzoyl chloride (<b>15</b>)</h3><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethylformamide (0.1 mL) was added to a suspension of 5-bromo-2-chlorobenzoic acid (23.6 g, 100 mmol) and oxalyl chloride (15.2 g, 120 mmol) in a 500 mL four-necked flask containing dichloromethane (118 mL) at room temperature. Once the vigorous evolution of gas ceased, the reaction was stirred for 10 h at room temperature. The reaction mixture was concentrated under vacuum to give product <b>15</b> (25.4 g, 100%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.19 (d, <i>J</i> = 2.4 Hz, 1H), 7.64 (dd, <i>J</i> = 2.4, 8.8 Hz, 1H), 7.38 (d, <i>J</i> = 8.8 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 164.1, 137.4, 135.8, 134.5, 132.9, 132.7, 120.6.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (5-Bromo-2-chlorophenyl)(4-methoxyphenyl)methanone (<b>16</b>)</h3><div class="NLM_p last">A 250 mL four-necked flask equipped with an internal thermometer was charged with anisole (5.68 g, 52.5 mmol) and dichloromethane (19 mL) under argon. The mixture was stirred for 10 min at room temperature and cooled to −5 to 0 °C. Aluminum(III) chloride (7.33 g, 55 mmol) was added portionwise to the above solution over 30 min while maintaining the internal temperature below 0 °C. After the addition was complete, the reaction mixture was stirred for another 30 min at −5 to 0 °C, and a solution of 5-bromo-2-chlorobenzoyl chloride (12.7 g, 50 mmol) in dichloromethane (19 mL) was added via an addition funnel over 30 min while keeping the reaction temperature below 0 °C. After the addition was completed, the reaction mixture was stirred for another 1.5 h at −5 to 0 °C under argon. The reaction was poured into ice water (150 g) with stirring, and dichloromethane (100 mL) and concentrated hydrochloric acid (5 mL) were added. The organic layer was separated, and the aqueous layer was extracted with dichloromethane (100 mL). The combined organic layers were washed with water (100 mL), saturated aqueous sodium bicarbonate (100 mL), and brine (100 mL), dried over sodium sulfate (10 g), and concentrated. The residue was recrystallized in absolute ethanol (75 mL) to give title compound <b>16</b> as a white solid (13.5 g, 83% yield, HPLC purity (condition II): 99.9%, GC purity: 99.7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.78 (d, <i>J</i> = 8.8 Hz, 2H), 7.53 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.32 (d, <i>J</i> = 8.8 Hz, 1H), 6.95 (d, <i>J</i> = 8.8 Hz, 2H), 3.89 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 192.2, 164.5, 140.8, 133.9, 132.7, 131.7, 131.6, 130.2, 128.9, 120.6, 114.2, 55.7. MS (ESI) <i>m</i>/<i>z</i> 325 (M + H<sup>+</sup>, positive mode).</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4-Bromo-1-chloro-2-(4-methoxybenzyl)benzene (<b>17</b>)</h3><div class="NLM_p last">To a stirred solution of (5-bromo-2-chlorophenyl)(4-methoxyphenyl)methanone (<b>16</b>) (6.51 g, 20 mmol) and sodium borohydride (757 mg, 20 mmol) in tetrahydrofuran (52 mL) was slowly added aluminum chloride (2.67 g, 20 mmol) over 1 h at 5 to 10 °C under argon. The reaction was warmed slowly to reflux for 5 h and cooled to 15 to 20 °C. Additional sodium borohydride (757 mg, 20 mmol) was added slowly over 1 h, and the reaction was refluxed for another 12 h. The reaction mixture was cooled to 15 to 20 °C, poured into ice water (100 mL), and then extracted with ethyl acetate (2 × 80 mL). The combined organic layers were washed with water (2 × 50 mL) and brine (50 mL) and concentrated under vacuum to give an off-white solid. This solid was dissolved in ethanol at 75 to 80 °C with stirring (6 mL), cooled to 0 to 5 °C, and stirred for 10 h. The mixture was filtered, and the filter cake was washed with precooled (−5 °C) ethanol (2 mL) and dried under vacuum to give product <b>17</b> (5.11 g, 82% yield, HPLC purity (condition I): 99.1%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.26 (dd, <i>J</i> = 2.4, 8.4 Hz, 1H), 7.24 −7.20 (m, 2H), 7.09 (d, <i>J</i> = 8.8 Hz, 2H), 6.84 (d, <i>J</i> = 8.8 Hz, 2H), 3.98 (s, 2H), 3.79 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 158.4, 141.4, 133.7, 133.2, 131.0, 130.7, 130.1, 120.6, 114.2, 55.4, 38.3.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 4-Bromo-1-chloro-2-((4-methoxyphenyl)methyl-<i>d</i><sub>2</sub>)benzene (<b>18</b>)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></h3><div class="NLM_p last">To a stirred solution of (5-bromo-2-chlorophenyl)(4-methoxyphenyl)methanone (<b>16</b>) (6.51 g, 20 mmol) and sodium borodeuteride (837 mg, 20 mmol) in tetrahydrofuran (52 mL) was slowly added aluminum chloride (2.67 g, 20 mmol) over 1 h at 5 to 10 °C under argon. The reaction was warmed slowly to reflux for 5 h and then cooled to 15 to 20 °C. Additional sodium borodeuteride (837 mg, 20 mmol) was added slowly over 1 h, and the reaction was refluxed for another 12 h. The reaction mixture was cooled to 15 to 20 °C, poured into ice water (100 mL), and then extracted with ethyl acetate (2 × 80 mL). The combined organic layers were washed with water (2 × 50 mL) and brine (50 mL) and concentrated under vacuum to give an off-white solid. The solid was dissolved in ethanol at 75 to 80 °C with stirring (6 mL), the mixture was cooled to 0 to 5 °C and stirred for 10 h. The mixture was filtered, and the filter cake was washed with precooled (−5 °C) ethanol (2 mL) and dried under vacuum to give product <b>18</b> (5.17 g, 83% yield, HPLC purity (condition II): 99.5%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.27–7.24 (m, 2H), 7.21 (d, <i>J</i> = 8.0 Hz, 1H), 7.09 (d, <i>J</i> = 8.4 Hz, 2H), 6.84 (d, <i>J</i> = 8.4 Hz, 2H), 3.78 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 158.4, 141.3, 133.6, 133.2, 131.0, 130.7, 130.6, 130.1, 120.6, 114.2, 55.4.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-(5-Bromo-2-chlorobenzyl)phenol (<b>19</b>)</h3><div class="NLM_p last">To a solution of <b>17</b> (4.67 g, 15 mmol) in dichloromethane (46.7 mL) at −20 °C was added boron tribromide (1.62 mL, 0.022 mol) over 10 min at a rate that maintained the reaction temperature below −10 °C under argon. After addition, the mixture was slowly warmed to 0 °C and stirred for 2 h. The reaction mixture was poured into 100 mL of ice water and extracted with dichloromethane (2 × 100 mL). The combined organic layers were washed with saturated bicarbonate (80 mL), water (80 mL), and brine (80 mL) and then dried over sodium sulfate. The sample was concentrated and purified by silica gel column chromatography to give product <b>19</b> (3.35 g, 75% yield, HPLC purity (condition II): 99.7%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.33 (dd, <i>J</i> = 2.4, 8.4 Hz, 1H), 7.29 −7.27 (m, 2H), 6.99 (d, <i>J</i> = 8.4 Hz, 2H), 6.72 (d, <i>J</i> = 8.4 Hz, 2H), 3.95 (s, 2H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 157.1, 143.2, 134.7, 134.2, 132.0, 131.7, 131.0, 130.8, 121.5, 116.4, 38.9. MS (ESI) <i>m</i>/<i>z</i> 295 (M – H<sup>+</sup>, negative mode), 341 (M + HCO<sub>2</sub><sup>–</sup>, negative mode).</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-((5-Bromo-2-chlorophenyl)methyl-<i>d</i><sub>2</sub>)phenol (<b>20</b>)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h3><div class="NLM_p last">To a solution of <b>18</b> (4.70 g, 15 mmol) in dichloromethane (46.7 mL) under argon at −20 °C was added boron tribromide (1.62 mL, 0.022 mol) over 10 min at a rate that maintained the reaction temperature below −10 °C. After addition, the mixture was slowly warmed to 0 °C and stirred for 2 h. The reaction mixture was poured into 100 mL of ice water and extracted with dichloromethane (2 × 100 mL). The combined organic layers were washed with saturated bicarbonate (80 mL), water (80 mL), and brine (80 mL) and then dried over anhydrous sodium sulfate. The sample was concentrated and purified by silica gel column chromatography to give product <b>20</b> (3.51 g, 78% yield, HPLC purity (condition II): 99.8%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.31 (dd, <i>J</i> = 2.4, 8.4 Hz, 1H), 7.29 (d, <i>J</i> = 2.4 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 6.99 (d, <i>J</i> = 8.4 Hz, 2H), 6.72 (d, <i>J</i> = 8.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 157.1, 143.1, 134.7, 134.1, 132.0, 131.7, 130.9, 130.6, 121.5, 116.4. MS (ESI) <i>m</i>/<i>z</i> 297 (M – H<sup>+</sup>, negative mode), 343 (M + HCO<sub>2</sub><sup>–</sup>, negative mode).</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (4-(5-Bromo-2-chlorobenzyl)phenoxy)(<i>tert</i>-butyl)dimethylsilane (<b>21</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>19</b> (3.0 g, 10.1 mmol) and <i>tert</i>-butylchlorodimethylsilane (1.82 g, 12.1 mol) in acetonitrile (30 mL) was added dropwise triethylamine (2.11 mL, 15.1 mmol) so that the reaction temperature did not exceed 5 °C. After the addition was completed, the reaction mixture was stirred for 2 h at 10 to 15 °C. This reaction mixture was filtered, and the filter cake was washed with petroleum ether (2 × 20 mL). The combined organic layers were evaporated under reduced pressure (30 °C), and the residue was dissolved in petroleum ether (30 mL). The solution was washed with water (2 × 30 mL) and evaporated, and the residue was dissolved in ethanol (9 mL) at 35 °C with stirring. This solution was cooled to 5 to 10 °C and kept for 4 h. The solids were filtered, and the filter cake was washed with precooled ethanol (0–5 °C, 3 mL) and then dried under vacuum at 20 to 25 °C for 16 h to give <b>21</b> (3.58 g, 86% yield, HPLC purity (condition II): 99.8%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.27 (dd, <i>J</i> = 2.4, 8.4 Hz, 1H), 7.23 −7.21 (m, 2H), 7.03 (d, <i>J</i> = 8.4 Hz, 2H), 6.78 (d, <i>J</i> = 8.4 Hz, 2H), 3.97 (s, 2H), 0.98 (s, 9H), 0.19 (s, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.4, 141.5, 133.7, 133.2, 131.3, 131.0, 130.6, 130.1, 120.6, 120.3, 38.4, 25.8, 18.3, −4.3.</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (4-((5-Bromo-2-chlorophenyl)methyl-<i>d</i><sub>2</sub>)phenoxy)(<i>tert</i>-butyl)dimethylsilane (<b>22</b>)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></h3><div class="NLM_p last">To a stirred suspension of <b>20</b> (3.0 g, 10 mmol) and <i>tert</i>-butylchlorodimethylsilane (1.80 g, 12.0 mol) in acetonitrile (30 mL) was added dropwise triethylamine (2.10 mL, 15.0 mmol) so that the reaction temperature did not exceed 5 °C. After the addition was completed, the reaction mixture was stirred for 2 h at 10 to 15 °C. This reaction mixture was filtered, and the filter cake was washed with petroleum ether (2 × 20 mL). The combined organic layers were evaporated under reduced pressure (30 °C), and the residue was dissolved in petroleum ether (30 mL). The solution was washed with water (2 × 30 mL) and evaporated, and the residue was dissolved in ethanol (9 mL) at 35 °C with stirring. The solution was cooled to 5 to 10 °C and kept for 4 h. The solids were filtered, and the filter cake was washed with precooled ethanol (0–5 °C, 3 mL) and then dried under vacuum at 20 to 25 °C for 16 h to give <b>22</b> (3.72 g, 90% yield, HPLC purity (condition II): 99.6%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.28–7.20 (m, 3H), 7.03 (d, <i>J</i> = 8.4 Hz, 2H), 6.78 (d, <i>J</i> = 8.8 Hz, 2H), 0.98 (s, 9H), 0.19 (s, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.4, 141.4, 133.7, 133.2, 131.2, 131.0, 130.7, 130.1, 120.6, 120.3, 25.8, 18.3, −4.3.</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (2<i>S</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>23</b>)</h3><div class="NLM_p last">To a solution of <b>21</b> (2.5 g, 6.1 mmol) in anhydrous toluene/tetrahydrofuran (15 mL, 2:1) at −65 °C was added dropwise <i>n</i>-BuLi (2.5 M in hexane, 2.92 mL), and the reaction was stirred for an additional 30 min at −65 °C under argon. A precooled (−30 °C) solution of (3<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-3,4,5-tris(trimethylsilyloxy)-6-((trimethylsilyloxy)methyl)tetrahydro-2<i>H</i>-pyran-2-one) (3.7 g, 7.9 mmol) in toluene (10 mL) was added slowly dropwise to the above reaction mixture and kept such that the reaction temperature did not exceed −60 °C. The mixture was stirred at −65 to −55 °C for 3 h. The reaction was quenched with hydrochloric acid (0.76 mL, 9.1 mmol) in methanol (10 mL), and the mixture was allowed to warm to 20 to 25 °C and stirred for 16 h. The reaction mixture was quenched by the addition of 5% aqueous sodium bicarbonate until the pH reached 7.5, and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (2 × 30 mL), and the combined organic phases were washed with saturated bicarbonate (50 mL), water (50 mL), and brine (50 mL) and dried over sodium sulfate. After removal of the volatiles, the residue was dried under vacuum to give product <b>23</b> (2.0 g; 80%), which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.53 (d, <i>J</i> = 2.0 Hz, 1H), 7.45 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.35 (d, <i>J</i> = 8.4 Hz, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 2H), 6.68 (d, <i>J</i> = 8.8 Hz, 2H), 4.06 (d, <i>J</i> = 15.2 Hz, 1H), 3.98–3.91 (m, 2H), 3.81 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.75 (t, <i>J</i> = 9.2 Hz, 1H), 3.58 (ddd, <i>J</i> = 2.0, 5.2, 7.6 Hz, 1H), 3.42 (t, <i>J</i> = 9.2 Hz, 1H), 3.09 (d, <i>J</i> = 9.2 Hz, 1H), 3.07 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 156.7, 139.8, 139.1, 134.9, 131.9, 130.8, 129.9, 128.2, 116.1, 102.4, 78.6, 76.0, 75.1, 71.7, 62.8, 39.3. MS (ESI) <i>m</i>/<i>z</i> 433 (M + Na<sup>+</sup>, positive mode), 455 (M + HCO<sub>2</sub><sup>–</sup>, negative mode).</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-((4-hydroxyphenyl)methyl-<i>d</i><sub>2</sub>)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>24</b>)<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a></h3><div class="NLM_p last">To a solution of <b>22</b> (2.48 g, 6.0 mmol) in anhydrous toluene/tetrahydrofuran (15 mL, 2:1) at −65 °C was added dropwise <i>n</i>-BuLi (2.5 M in hexane, 2.90 mL), and the reaction was stirred for an additional 30 min at −65 °C under argon. A precooled (−30 °C) solution of (3<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-3,4,5-tris(trimethylsilyloxy)-6-((trimethylsilyloxy)methyl)tetrahydro-2<i>H</i>-pyran-2-one) (3.64 g, 7.8 mmol) in toluene (10 mL) was added dropwise slowly to the above reaction mixture, and the reaction temperature was not allowed to exceed −60 °C. The mixture was stirred at −65 to −55 °C for 3 h. The reaction was quenched with hydrochloric acid (0.75 mL, 9.0 mmol) in methanol (10 mL), and the mixture was allowed to warm to 20 to 25 °C and stirred for 16 h. The reaction mixture was quenched by the addition of 5% aqueous sodium bicarbonate until the pH reached 7.5, and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (2 × 30 mL), and the combined organic phases were washed with saturated bicarbonate (50 mL), water (50 mL), and brine (50 mL) and dried over sodium sulfate. After removal of the volatiles, the residue was dried under vacuum to give product <b>24</b> (1.86 g, 75%), which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.53 (d, <i>J</i> = 2.0 Hz, 1H), 7.45 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.35 (d, <i>J</i> = 8.4 Hz, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 2H), 6.68 (d, <i>J</i> = 8.4 Hz, 2H), 3.93 (dd, <i>J</i> = 2.0, 12.0 Hz, 1H), 3.81 (dd, <i>J</i> = 5.6, 12.0 Hz, 1H), 3.75 (t, <i>J</i> = 9.2 Hz, 1H), 3.61 (ddd, <i>J</i> = 2.0, 5.2, 7.6 Hz, 1H), 3.42 (t, <i>J</i> = 9.6 Hz, 1H), 3.09 (d, <i>J</i> = 9.6 Hz, 1H), 3.07 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 156.7, 139.8, 139.1, 134.9, 131.8, 130.8, 129.9, 128.2, 116.1, 102.5, 78.6, 76.0, 75.1, 71.7, 62.8. MS (ESI) <i>m</i>/<i>z</i> 435 (M + Na<sup>+</sup>, positive mode), 457 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>21</sub>D<sub>2</sub>ClO<sub>7</sub> (M – H<sup>+</sup>), 411.1258; found, 411.1191.</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-(4-hydroxybenzyl)phenyl)-2-<i>d</i>-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>25</b>)</h3><div class="NLM_p last">To a solution of <b>23</b> (205.4 mg, 0.50 mmol) in dichloromethane (2.0 mL) and acetonitrile (2.0 mL) at −30 °C under argon was added triethylsilane-<i>d</i> (0.32 mL, 2.0 mmol, 97 atom % D). Then, boron trifluoride etherate (0.19 mL, 1.5 mmol) was added while maintaining the reaction temperature below −15 °C, and the reaction mixture was stirred for another 2 h at −20 to −10 °C. The reaction was quenched by addition of 5% sodium bicarbonate until reaching pH 7.5. The organic phase was separated, and the aqueous phase was extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed with brine (2 × 30 mL) and dried over anhydrous sodium sulfate. The sample was concentrated under reduced pressure to provide a pale solid product, which was purified by preparative HPLC to give product <b>25</b> as a white solid (125 mg, 65% yield, HPLC purity (condition I): 99.6%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.34 (d, <i>J</i> = 8.0 Hz, 1H), 7.31 (d, <i>J</i> = 1.6 Hz, 1H), 7.26 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 2H), 6.68 (d, <i>J</i> = 8.4 Hz, 2H), 4.02 (d, <i>J</i> = 15.2 Hz, 1H), 3.96 (d, <i>J</i> = 15.2 Hz, 1H), 3.87 (d, <i>J</i> = 12.0 Hz, 1H), 3.68 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.47–3.43 (m, 1H), 3.42–3.38 (m, 2H), 3.30–3.28 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 156.8, 140.1, 139.9, 134.4, 131.9, 131.7, 130.9, 130.1, 128.1, 116.1, 82.2, 79.7, 76.4, 71.9, 63.1, 39.2. MS (ESI) <i>m</i>/<i>z</i> 382 (M + H<sup>+</sup>, positive mode), 426 (M + HCO<sub>2</sub><sup>–</sup>, negative mode).</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-((4-hydroxyphenyl)methyl-<i>d</i><sub>2</sub>)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> (474 mg, 62% yield, HPLC purity (condition I): 99.0%) was prepared as a white solid from <b>24</b> (826 mg, 2.0 mmol) according to the method described for the synthesis of <b>11</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.34 (d, <i>J</i> = 8.4 Hz, 1H), 7.31 (d, <i>J</i> = 2.0 Hz, 1H), 7.26 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 2H), 6.68 (d, <i>J</i> = 8.4 Hz, 2H), 4.08 (d, <i>J</i> = 9.2 Hz, 1H), 3.87 (d, <i>J</i> = 11.2 Hz, 1H), 3.68 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.47–3.43 (m, 1H), 3.43–3.38 (m, 2H), 3.30–3.27 (m, 1H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD): δ 156.8, 140.1, 140.0, 134.4, 131.9, 131.7, 130.8, 130.1, 128.1, 116.2, 82.9, 82.2, 79.8, 76.5, 71.9, 63.1. MS (ESI) <i>m</i>/<i>z</i> 400 (M + NH<sub>4</sub><sup>+</sup>, positive mode), 427 (M + HCO<sub>2</sub><sup>–</sup>, negative mode).</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-((4-hydroxyphenyl)methyl-<i>d</i><sub>2</sub>)phenyl)-2-<i>d</i>-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>27</b>)<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a></h3><div class="NLM_p last">Compound <b>27</b> (461 mg, 60% yield, HPLC purity (condition I): 99.4%) was prepared as a white solid from <b>24</b> (826 mg, 2.0 mmol) according to the method described for the synthesis of <b>25</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.34 (d, <i>J</i> = 8.4 Hz, 1H), 7.31 (d, <i>J</i> = 2.0 Hz, 1H), 7.26 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 2H), 6.68 (d, <i>J</i> = 8.4 Hz, 2H), 3.87 (d, <i>J</i> = 11.2 Hz, 1H), 3.68 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.47–3.43 (m, 1H), 3.42–3.36 (m, 2H), 3.29–3.26 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 156.8, 140.1, 139.9, 134.4, 131.9, 131.7, 130.8, 130.1, 128.1, 116.1, 82.2, 79.7, 76.4, 71.9, 63.1. MS (ESI) <i>m/z</i>401 (M + NH<sub>4</sub><sup>+</sup>, positive mode), 428 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>18</sub>D<sub>3</sub>ClO<sub>6</sub> (M – H<sup>+</sup>), 382.1215; found, 382.1140.</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Ethyl 4-Methylbenzenesulfonate (<b>29</b>)</h3><div class="NLM_p last">To a stirred solution of ethanol (2.30 g, 50 mmol) in THF (11.5 mL) was added precooled (0–5 °C) aqueous sodium hydroxide (6 g NaOH in 32.6 mL of water). After stirring for 15 min and cooling to −5 °C, <i>p</i>-toluenesulfonyl chloride <b>28</b> (10.5 g, 55 mmol) was added portionwise while keeping the reaction temperature so that it did not exceed 0 °C. After the addition was completed, the reaction mixture was allowed to warm to 15 to 20 °C and stirred for another 10 h. The reaction mixture was quenched by addition of ice water (100 mL). The mixture was extracted with dichloromethane (2 × 80 mL), the combined organic layers were washed with saturated aqueous ammonium chloride (100 mL), water (100 mL), and brine (100 mL), dried over anhydrous sodium sulfate, and concentrated, and the residue was purified by flash silica gel column to give product <b>29</b> (6.61 g, 66%) as a whilte solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.48 (d, <i>J</i> = 8.4 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 2.46 (s, 3H), 1.24 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 145.7, 134.6, 130.8, 128.6, 67.8, 21.5, 14.9. MS (ESI) <i>m</i>/<i>z</i> 201 (M + H<sup>+</sup>, positive mode).</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Ethyl-<i>d</i><sub>5</sub> 4-Methylbenzenesulfonate (<b>30</b>)</h3><div class="NLM_p last">Compound <b>30</b> (6.68 g, 65%) was prepared as a white solid from ethanol-<i>d</i><sub>6</sub> (2.61 g, 50 mmol, 99.5 atom % D) according to the method described for the synthesis of <b>29</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.48 (d, <i>J</i> = 8.4 Hz, 2H), 2.45 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 145.7, 134.5, 130.8, 128.6, 21.5. MS (ESI) <i>m</i>/<i>z</i> 206 (M + H<sup>+</sup>, positive mode).</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Ethyl-1,1-<i>d</i><sub>2</sub> Alcohol 4-Methylbenzenesulfonate (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> (3.44 g, 68%) was prepared as a white solid from ethyl-1,1-<i>d</i><sub>2</sub> alcohol (1.20 g, 25 mmol, 98 atom % D) according to the method described for the synthesis of <b>29</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.48 (d, <i>J</i> = 8.0 Hz, 2H), 2.46 (s, 3H), 1.23 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 145.7, 134.6, 130.8, 128.6, 21.5, 14.7. MS (ESI) <i>m</i>/<i>z</i> 203 (M + H<sup>+</sup>, positive mode).</div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Methyl 4-Methylbenzenesulfonate (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> (12.7 g, 68%) was prepared as a white solid from methanol (3.2 g, 100 mmol) according to the method described for the synthesis of <b>29</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.50 (d, <i>J</i> = 8.4 Hz, 2H), 3.74 (s, 3H), 2.46 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 146.0, 133.5, 130.9, 128.8, 57.0, 21.5. MS (ESI) <i>m</i>/<i>z</i> 187 (M + H<sup>+</sup>, positive mode).</div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Methyl-<i>d</i><sub>3</sub> 4-Methylbenzenesulfonate (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> (12.8 g, 68%) was prepared as a white solid from methanol-<i>d</i><sub>4</sub> (3.61 g, 100 mmol, 99.5 atom % D) according to the method described for the synthesis of <b>29</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 7.80 (d, <i>J</i> = 8.0 Hz, 2H), 7.49 (d, <i>J</i> = 8.0 Hz, 2H), 2.46 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 145.9, 133.4, 130.9, 128.8, 21.5. MS (ESI) <i>m</i>/<i>z</i> 190 (M + H<sup>+</sup>, positive mode).</div></div><div id="sec6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-(4-(ethoxy-<i>d</i><sub>5</sub>)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> (82.7 mg, 76% yield, HPLC purity (condition I): 99.6%) was prepared as a white solid from <b>11</b> (100 mg, 0.263 mmol) and <b>30</b> (59.3 mg, 0.289 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (d, <i>J</i> = 8.4 Hz, 1H), 7.09 (d, <i>J</i> = 8.4 Hz, 2H), 6.79 (d, <i>J</i> = 8.4 Hz, 2H), 4.10–3.97 (m, 3H), 3.87 (d, <i>J</i> = 11.6 Hz, 1H), 3.69 (dd, <i>J</i> = 4.8, 11.6 Hz, 1H), 3.47–3.43 (m, 1H), 3.42–3.35 (m, 2H), 3.29–3.26 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 158.9, 140.0, 139.9, 134.4, 132.8, 131.9, 130.8, 130.1, 128.2, 115.4, 82.9, 82.2, 79.7, 76.5, 71.8, 63.1, 39.2. MS (ESI) <i>m</i>/<i>z</i> 431 (M + NH<sub>4</sub><sup>+</sup>, positive mode), 458 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>20</sub>D<sub>5</sub>Cl<sub>2</sub>O<sub>6</sub> (M + Cl<sup>–</sup>) 448.1348; found, 448.1362.</div></div><div id="sec6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-(ethoxy-1,1-<i>d</i><sub>2</sub>)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> (77.8 g, 72% yield, HPLC purity (condition I): 99.6%) was prepared as a white solid from <b>11</b> (100 mg, 0.263 mmol) and <b>31</b> (58.5 mg, 0.289 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (dd, <i>J</i> = 1.6, 8.0 Hz, 1H), 7.09 (d, <i>J</i> = 8.8 Hz, 2H), 6.79 (d, <i>J</i> = 8.8 Hz, 2H), 4.09 (d, <i>J</i> = 9.2 Hz, 1H), 4.05 (d, <i>J</i> = 15.2 Hz, 1H), 3.99 (d, <i>J</i> = 15.2 Hz, 1H), 3.87 (d, <i>J</i> = 12.0 Hz, 1H), 3.69 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.48–3.44 (m, 1H), 3.43–3.37 (m, 2H), 3.30–3.26 (m, 1H), 1.33 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 158.8, 140.0, 139.9, 134.4, 132.9, 131.9, 130.8, 130.1, 128.2, 115.4, 82.9, 82.2, 79.7, 76.4, 71.8, 63.1, 39.2, 14.9. MS (ESI) <i>m</i>/<i>z</i> 411 (M + H<sup>+</sup>, positive mode), 455 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>22</sub>D<sub>2</sub>ClO<sub>6</sub> (M – H<sup>+</sup>), 409.1393; found, 409.1406.</div></div><div id="sec6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-2-<i>d</i>-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> (80.5 mg, 75% yield, HPLC purity (condition I): 99.7%) was prepared as a white solid from <b>25</b> (100 mg, 0.262 mmol) and <b>29</b> (57.7 mg, 0.288 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (d, <i>J</i> = 8.4 Hz, 1H), 7.09 (d, <i>J</i> = 8.4 Hz, 2H), 6.79 (d, <i>J</i> = 8.4 Hz, 2H), 4.07–4.01 (m, 2H), 3.98 (q, <i>J</i> = 7.2 Hz, 2H), 3.87 (d, <i>J</i> = 12.0 Hz, 1H), 3.69 (dd, <i>J</i> = 4.8, 12.0 Hz, 1H), 3.48–3.43 (m, 1H), 3.42–3.35 (m, 2H), 3.29–3.26 (m, 1H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 158.8, 140.0, 139.9, 134.4, 132.9, 131.9, 130.8, 130.1, 128.2, 115.4, 82.2, 79.7, 76.4, 71.8, 64.4, 63.1, 39.2, 15.2. MS (ESI) <i>m</i>/<i>z</i> 410 (M + H<sup>+</sup>, positive mode), 454 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>24</sub>DCl<sub>2</sub>O<sub>6</sub> (M + Cl<sup>–</sup>), 444.1096; found, 444.1101.</div></div><div id="sec6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-((4-ethoxyphenyl)methyl-<i>d</i><sub>2</sub>)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> (75.1 mg, 70% yield, HPLC purity (condition I): 99.0%) was prepared as a white solid from <b>26</b> (100 mg, 0.261 mmol) and <b>29</b> (57.5 mg, 0.287 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (dd, <i>J</i> = 2.4, 8.4 Hz, 1H), 7.09 (d, <i>J</i> = 8.8 Hz, 2H), 6.79 (d, <i>J</i> = 8.8 Hz, 2H), 4.09 (d, <i>J</i> = 9.6 Hz, 1H), 3.99 (q, <i>J</i> = 7.2 Hz, 2H), 3.87 (d, <i>J</i> = 11.6 Hz, 1H), 3.69 (dd, <i>J</i> = 5.2, 11.6 Hz, 1H), 3.48–3.43 (m, 1H), 3.42–3.36 (m, 2H), 3.29–3.26 (m, 1H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 158.8, 140.0, 139.9, 134.4, 132.8, 131.9, 130.8, 130.1, 128.2, 115.4, 82.9, 82.2, 79.7, 76.4, 71.8, 64.4, 63.1, 15.2. MS (ESI) <i>m</i>/<i>z</i> 411 (M + H<sup>+</sup>, positive mode), 455 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>23</sub>D<sub>2</sub>Cl<sub>2</sub>O<sub>6</sub> (M + Cl<sup>–</sup>), 445.1159; found, 445.1168.</div></div><div id="sec6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-((4-(ethoxy-<i>d</i><sub>5</sub>)phenyl)methyl-<i>d</i><sub>2</sub>)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> (73.8 mg, 68% yield, HPLC purity (condition I): 98.8%) was prepared as a white solid from <b>26</b> (100 mg, 0.261 mmol) and <b>30</b> (58.9 mg, 0.287 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.09 (d, <i>J</i> = 8.4 Hz, 2H), 6.79 (d, <i>J</i> = 8.4 Hz, 2H), 3.87 (d, <i>J</i> = 12.0 Hz, 1H), 3.69 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.47–3.43 (m, 1H), 3.42–3.35 (m, 2H), 3.29–3.26 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 158.9, 140.0, 139.9, 134.4, 132.8, 131.9, 130.8, 130.1, 128.2, 115.4, 82.9, 82.2, 79.7, 76.5, 71.8, 63.1. MS (ESI) <i>m</i>/<i>z</i> 438 (M + Na<sup>+</sup>, positive mode), 460 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>18</sub>D<sub>7</sub>ClNaO<sub>6</sub> (M + Na<sup>+</sup>), 438.1671; found, 438.1676.</div></div><div id="sec6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-((4-ethoxyphenyl)methyl-<i>d</i><sub>2</sub>)phenyl)-2-<i>d</i>-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> (78.5 mg, 73% yield, HPLC purity (condition I): 99.1%) was prepared as a white solid from <b>27</b> (100 mg, 0.261 mmol) and <b>29</b> (57.5 mg, 0.287 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.09 (d, <i>J</i> = 8.8 Hz, 2H), 6.79 (d, <i>J</i> = 8.8 Hz, 2H), 4.09 (d, <i>J</i> = 9.6 Hz, 1H), 3.97 (q, <i>J</i> = 6.8 Hz, 2H), 3.87 (d, <i>J</i> = 12.0 Hz, 1H), 3.69 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.48–3.44 (m, 1H), 3.43–3.35 (m, 2H), 3.30–3.27 (m, 1H), 1.35 (t, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 158.9, 140.0, 139.9, 134.4, 132.9, 131.9, 130.8, 130.1, 128.2, 115.5, 82.2, 79.8, 76.4, 71.9, 64.5, 63.1, 15.2. MS (ESI) <i>m</i>/<i>z</i> 429 (M + NH<sub>4</sub><sup>+</sup>, positive mode), 456 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>21</sub>D<sub>3</sub>ClO<sub>6</sub> (M – H<sup>+</sup>), 410.1456; found, 410.1445.</div></div><div id="sec6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-((4-(ethoxy-<i>d</i><sub>5</sub>)phenyl)methyl-<i>d</i><sub>2</sub>)phenyl)-2-<i>d</i>-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>40</b>)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></h3><div class="NLM_p last">To a stirred solution of <b>27</b> (100 mg, 0.261 mmol) and <b>30</b> (58.9 mg, 0.287 mmol) in <i>N,N</i>-dimethylformamide (1.5 mL) was added cesium carbonate (258 mg, 0.79 mmol) followed by addition of tetrabutylammonium iodide (9.7 mg, 0.026 mmol). After stirring for 12 h at 40 °C under argon, the mixture was quenched by addition of ice water (10 mL). The mixture was extracted with ethyl acetate (2 × 20 mL). The combined organic layers were washed with water (20 mL) and brine (20 mL), dried over anhydrous sodium sulfate, and concentrated, and the residue was purified by preparative TLC to give product <b>40</b> (81.6 mg, 75% yield, HPLC purity (condition I): 99.9%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.09 (d, <i>J</i> = 8.4 Hz, 2H), 6.79 (d, <i>J</i> = 8.4 Hz, 2H), 4.09 (d, <i>J</i> = 9.6 Hz, 1H), 3.87 (d, <i>J</i> = 12.4 Hz, 1H), 3.69 (dd, <i>J</i> = 4.8, 11.6 Hz, 1H), 3.47–3.43 (m, 1H), 3.42–3.35 (m, 2H), 3.29–3.26 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 158.9, 140.0, 139.9, 134.4, 132.8, 131.9, 130.8, 130.1, 128.2, 115.4, 82.2, 79.8, 76.4, 71.9, 63.1. MS (ESI) <i>m</i>/<i>z</i> 417 (M + H<sup>+</sup>, positive mode), 461 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>17</sub>D<sub>8</sub>ClO<sub>6</sub> (M – H<sup>+</sup>), 415.1842; found, 415.1769.</div></div><div id="sec6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-(4-(methoxy-<i>d</i><sub>3</sub>)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>41</b>)</h3><div class="NLM_p last">Compound <b>41</b> (75.3 mg, 72% yield, HPLC purity (condition I): 99.1%) was prepared as a white solid from <b>11</b> (100 mg, 0.263 mmol) and <b>33</b> (54.8 mg, 0.289 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.34 (d, <i>J</i> = 8.0 Hz, 1H), 7.32 (d, <i>J</i> = 2.0 Hz, 1H), 7.27 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.10 (d, <i>J</i> = 8.8 Hz, 2H), 6.81 (d, <i>J</i> = 8.8 Hz, 2H), 4.10–3.98 (m, 3H), 3.87 (d, <i>J</i> = 11.6 Hz, 1H), 3.69 (dd, <i>J</i> = 5.2, 11.6 Hz, 1H), 3.48–3.43 (m, 1H), 3.42–3.35 (m, 2H), 3.30–3.27 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 159.6, 140.0, 139.9, 134.4, 132.9, 131.9, 130.8, 130.1, 128.2, 114.8, 82.9, 82.2, 79.7, 76.5, 71.8, 63.1, 39.2. MS (ESI) <i>m</i>/<i>z</i> 415 (M + NH<sub>4</sub><sup>+</sup>, positive mode), 442 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>20</sub>D<sub>3</sub>ClNaO<sub>6</sub> (M + Na<sup>+</sup>), 420.1264; found, 420.1264.</div></div><div id="sec6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-((4-(methoxy-<i>d</i><sub>3</sub>)phenyl)methyl-<i>d</i><sub>2</sub>)phenyl)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> (73.0 mg, 70% yield, HPLC purity (condition I): 99.6%) was prepared as a white solid from <b>26</b> (100 mg, 0.261 mmol) and <b>33</b> (54.3 mg, 0.287 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.10 (d, <i>J</i> = 8.8 Hz, 2H), 6.80 (d, <i>J</i> = 8.8 Hz, 2H), 4.09 (d, <i>J</i> = 9.6 Hz, 1H), 3.87 (d, <i>J</i> = 12.0 Hz, 1H), 3.69 (dd, <i>J</i> = 5.2, 12.0 Hz, 1H), 3.48–3.43 (m, 1H), 3.42–3.36 (m, 2H), 3.30–3.27 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 159.6, 140.0, 139.9, 134.4, 132.9, 131.9, 130.8, 130.1, 128.2, 114.8, 82.9, 82.2, 79.7, 76.4, 71.8, 63.1. MS (ESI) <i>m</i>/<i>z</i> 422 (M + Na<sup>+</sup>, positive mode), 444 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>D<sub>5</sub>ClNaO<sub>6</sub> (M + Na<sup>+</sup>), 422.1389; found, 422.1382.</div></div><div id="sec6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-Chloro-3-((4-(methoxy-<i>d</i><sub>3</sub>)phenyl)methyl-<i>d</i><sub>2</sub>)phenyl)-2-<i>d</i>-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> (75.3 mg, 72% yield, HPLC purity (condition I): 99.8%) was prepared as a white solid from <b>27</b> (100 mg, 0.261 mmol) and <b>33</b> (54.3 mg, 0.287 mmol) according to the method described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.32 (m, 2H), 7.27 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.11 (d, <i>J</i> = 8.4 Hz, 2H), 6.80 (d, <i>J</i> = 8.4 Hz, 2H), 3.87 (d, <i>J</i> = 11.6 Hz, 1H), 3.69 (dd, <i>J</i> = 5.2, 11.6 Hz, 1H), 3.48–3.43 (m, 1H), 3.42–3.35 (m, 2H), 3.30–3.27 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 159.6, 140.0, 139.9, 134.5, 132.9, 131.9, 130.8, 130.1, 128.2, 114.8, 82.2, 79.8, 76.4, 71.9, 63.1. MS (ESI) <i>m</i>/<i>z</i> 418 (M + NH<sub>4</sub><sup>+</sup>, positive mode), 444 (M + HCO<sub>2</sub><sup>–</sup>, negative mode). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>16</sub>D<sub>6</sub>ClO<sub>6</sub> (M – H<sup>+</sup>), 399.1488; found, 399.1475.</div></div><div id="sec6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Glucose Uptake Inhibition Assay</h3><div class="NLM_p last">A plasmid bearing the human full-length SGLT1 coding sequence in the pDream 2.1 mammalian expression vector was purchased from GenScript Corporation. Full-length human SGLT2 cDNA (GenScript Corporation) was cloned into the pEAK15 mammalian expression vector. Human SGLT1 expression plasmid DNA was transfected into COS-7 cells (American Type Culture Collection) using Lipofectamine 2000 (Invitrogen Corporation). Transfected cells were evaluated for SGLT1 activity in a methyl-α-<span class="smallcaps smallerCapital">d</span>-[U-<sup>14</sup>C]glucopyranoside (AMG) uptake assay and cryopreserved until use. The plasmid encoding human SGLT2 was linearized and stably transfected into 293.ETN cells. SGLT2-expressing clones were selected on the basis of resistance to puromycin (Invitrogen Corporation) and activity in the AMG uptake assay. CHO-K1 cells expressing SGLT1 or SGLT2 were seeded on 96-well ScintiPlates (PerkinElmer, Inc.) in DMEM containing 10% FBS (1 × 10<sup>5</sup> cells per well in 100 μL of medium) incubated at 37 °C under 5% CO<sub>2</sub> for 48 h prior to the assay. Cells were washed twice with 150 μL of either sodium buffer (137 mM NaCl, 5.4 mM KCl, 2.8 mM CaCl<sub>2</sub>, 1.2 mM MgCl<sub>2</sub>, 10 mM tris(hydroxymethyl)aminomethane/<i>N</i>-2-hydroxyethylpiperazine-<i>N</i>′-ethanesulfonic acid [Tris/Hepes], pH 7.2) or sodium-free buffer (137 mM <i>N</i>-methyl-glucamine, 5.4 mM KCl, 2.8 mM CaCl<sub>2</sub>, 1.2 mM MgCl<sub>2</sub>, 10 mM Tris/Hepes, pH 7.2). Test compound in 50 μL each of sodium or sodium-free buffer containing 40 μCi/mL methyl-α-<span class="smallcaps smallerCapital">d</span>-[U-<sup>14</sup>C]glucopyranoside (Amersham Biosciences/GE Healthcare) and 25% human plasma was added per well of a 96-well plate and incubated at 37 °C with shaking for either 2 (SGLT1 assay) or 1.5 h (SGLT2 assay). Cells were washed twice with 150 μL of wash buffer (137 mM <i>N</i>-methylglucamine, 10 mM Tris/Hepes, pH 7.2), and methyl-α-<span class="smallcaps smallerCapital">d</span>-[U-<sup>14</sup>C]glucopyranoside uptake was quantitated using a TopCount scintillation counter (PerkinElmer, Inc.). Compounds were initially screened at three different concentrations in triplicate measurements. Potent and selective SGLT2 inhibitors were further evaluated at eight concentrations in triplicate. Sodium-dependent glucopyranoside uptake was calculated by subtracting the values obtained with sodium-free buffer from those obtained using sodium buffer. In general, ratios of sodium-dependent to sodium-independent AMG uptake in SGLT1- and SGLT2-expressing cells were 10–15 and 15–20, respectively. Results of AMG uptake were analyzed using GraphPad Prism (Intuitive Software for Science). IC<sub>50</sub> calculations were performed using nonlinear regression with variable slope. As a reference standard, (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-(4-chloro-3-(4-ethylbenzyl)phenyl)-6-(hydroxymethyl) tetrahydro-2<i>H</i>-pyran-3,4,5-triol was routinely included in the assays. In 26-independent evaluations, the reference compound inhibited SGLT2 activity by 69.7 ± 9.6% at 10 nM and SGLT1 by 72.7 ± 6.7% at 10 μM.</div></div><div id="sec6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Pharmacokinetic Parameters in SD Rats</h3><div id="sec6_34_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Route of Administration:</h4><div class="NLM_p last">p.o. (IG) and i.v.</div></div><div id="sec6_34_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Collection Means</h4><div class="NLM_p last">Three-hundred microliters of blood was collected from the orbital plexus into tubes after the animal was temporarily anesthetized by ether inhalation. The tubes were filled full for about 12 h with a saline solution containing heparin (1000 units/mL), the saline was removed, and the tubes were dried at 105 °C before use. At the last data point, animals were sacrificed by ether inhalation after the blood was collected. Animals were disposed of without further analysis.</div></div><div id="sec6_34_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Blood Samples</h4><div class="NLM_p">Immediately after collection, blood collection tubes were gently inverted at least five times, ensuring complete mixing, and were then immediately placed on ice. The blood was centrifuged for 5 min at 5000 rpm and 4 °C to separate the plasma from the red blood cells. After separation, 200 μL disposable pipettes were used to take 100 μL aliquots from the top plasma layer into tubes, with each being labeled by the name of analysis unit. Plasma was frozen on dry ice and stored at −80 °C until removal for LC–MS/MS analysis for the test compound concentration.</div><div class="NLM_p last">Each test compound was dissolved in 30% poly(ethylene glycol) (average molecular weight of 400, PEG400) and administered orally to overnight-fasted Sprague–Dawley rats (<i>n</i> = 4 per group) by gavage at the dose level of 3 mg/kg (or 1 mg/kg). Control rats were given 30% PEG400 only. One hour postdosing, a glucose solution (2 g/kg, 10 mL/kg) was administered by oral gavage. Each test compound was evaluated in four Sprague–Dawley (SD) rats following a single oral administration of 3 mg/kg (or 1 mg/kg) of the compound. The plasma samples were collected from the orbital plexus at 0.083, 0.25, 0.50, 1.0, 2.0, 4.0, 6.0, 8.0, 10, 12, and 24 h postdose, and the drug concentrations in the samples were determined using an established LC–MS/MS system after deproteinization. LC–MS/MS analysis was performed using a Dionex Ultimate 3000 HPLC system and an Applied Biosystems 4000 Q-Trap mass spectrometer with an ESI source. Chromatographic separation was achieved using a Kromasil C18 column (2.1 mm ×150 mm, 5 μm) (EKA Chemicals Co., Sweden). The mobile phase consisted of acetonitrile/10 mM ammonium formate solution (4:6, v/v), and the flow rate was set at 0.3 mL/min. The injection cycle of each sample was set at 10 min. Noncompartmental pharmacokinetic parameters were calculated on the basis of the plasma concentration–time data using WinNonlin Professional 5.0 (Pharsight, Mountain View, CA). The cumulative drug amount excreted into urine was divided by the corresponding AUC to estimate renal clearance.</div></div></div><div id="sec6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Urinary Glucose Excretion in SD Rats</h3><div class="NLM_p last">Each test compound was dissolved in 30% PEG400 and administered orally to overnight-fasted Sprague–Dawley rats (<i>n</i> = 3 per group) by gavage at the dose level of 1 mg/kg. Control rats were given 30% PEG400 only. One hour postdosing, a glucose solution (2 g/kg, 10 mL/kg) was administered by oral gavage. Urine was collected within metabolic cages from 0 to 4 and 4 to 24 h postdosing for urine volume and glucose measurement. Food was removed 16 h before dosing and then provided 3 h after dosing. Water was supplied ad libitum. The concentration of urinary glucose was determined at 4 and 24 h postdose using a biochemistry analyzer. Results were recorded for the periods 0–4, 4–24, and 0–24 h and expressed as a percentage of the urinary glucose excretion (UGE) seen with reference <b>5</b>, which was run as a positive control in all experiments.</div></div><div id="sec6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Urinary Glucose Excretion in Beagle Dogs</h3><div class="NLM_p last">Each test compound was dissolved in 10% PEG400 and administered orally to overnight-fasted beagle dogs (<i>n</i> = 3 per group) by gavage at the dose level of 0.03 mg/kg. Control dogs were given 10% PEG400 only. One hour postdosing, a glucose solution (2 g/kg, 5 mL/kg) was administered by oral gavage. Urine was collected within metabolic cages from 0 to 8 and 8 to 24 h postdosing for urine volume and glucose measurement. Food was removed 16 h before dosing and then provided 3 h after dosing. Water was supplied ad libitum. The concentration of urinary glucose was determined at 8 and 24 h postdose using a biochemistry analyzer. Results were recorded for the periods 0–8, 8–24, and 0–24 h and expressed as a percentage of the urinary glucose excretion (UGE) seen with reference <b>5</b>, which was run as a positive control in all experiments.</div></div><div id="sec6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Urinary Glucose Excretion and Oral Glucose-Tolerance Test in SD Rats</h3><div class="NLM_p last">Compound <b>41</b> was administered orally to overnight-fasted Sprague–Dawley rats (<i>n</i> = 5 per group) by gavage at different doses (0.1, 0.3, 1, 3, and 10 mg/kg). Control rats were given the vehicle of 30% PEG400 only. One hour postdosing, a glucose solution (2 g/kg, 10 mL/kg) was administered by oral gavage. Blood glucose concentration was measured before dosing, before the glucose challenge, and 15, 30, 60, and 120 min after glucose challenge. Urine was collected from 0 to 4, 4 to 8, and 8 to 24 h postdosing for glucose measurement. Urine volumes and food and water consumption were also recorded. Blood glucose levels were determined using a glucometer (One Touch, LifeScan Inc.). The glucose concentration in urine was determined using a Hitachi 7080 automatic biochemistry analyzer.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55"><a href="/doi/suppl/10.1021/jm401780b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">HPLC-MS chromatographic metabolic monitoring for <b>41</b>, metabolic process confirmation for <b>41</b> and <b>5</b> by HPLC-MS chromatography, and <sup>1</sup>H and <sup>13</sup>C NMR spectra for all new compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401780b/suppl_file/jm401780b_si_001.pdf">jm401780b_si_001.pdf (2.81 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401780b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xun Sun</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, 826 Zhangheng Road, Pudong New Area, Shanghai 201203, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#592a2c37212c373f192a31342c773c3d2c773a37"><span class="__cf_email__" data-cfemail="562523382e23383016253e3b2378333223783538">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ge Xu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, 826 Zhangheng Road, Pudong New Area, Shanghai 201203, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Binhua Lv</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacques Y. Roberge</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Baihua Xu</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiyan Du</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiajia Dong</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuanwei Chen</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kun Peng</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lili Zhang</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinxing Tang</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Feng</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Xu</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Fu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, 826 Zhangheng Road, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenbin Zhang</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liangcheng Zhu</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongping Deng</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zelin Sheng</span> - <span class="hlFld-Affiliation affiliation">Egret
Pharma (Shanghai) Co., Ltd, 4F, 1118 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ajith Welihinda</span> - <span class="hlFld-Affiliation affiliation">Theracos
Inc., 550 Del Rey Avenue, Sunnyvale, California 94805-3528, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3330e6045-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support from the Shanghai Municipal Committee of Science and Technology (no. 10431903100) and the National Basic Research Program of China (973 Program, no. 2010CB912603) are acknowledged. We also thank the analytical group of Egret Pharma (Shanghai) Limited for providing analytical service.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> Abbreviations Used</h2><tr><td class="NLM_term">SGLT</td><td class="NLM_def"><p class="first last">sodium-dependent glucose cotransporter</p></td></tr><tr><td class="NLM_term">UGE</td><td class="NLM_def"><p class="first last">urinary glucose excretion</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr><tr><td class="NLM_term">DM2</td><td class="NLM_def"><p class="first last">type 2 diabetes mellitus</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">U.S. Food and Drug Administration</p></td></tr><tr><td class="NLM_term">EMA</td><td class="NLM_def"><p class="first last">European Medicines Agency</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the plasma concentration time curve</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TBDMS</td><td class="NLM_def"><p class="first last">tertbutyl-dimethylsilyl</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">PEG400</td><td class="NLM_def"><p class="first last">poly(ethylene glycol) (average molecular weight of 400)</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization diabetes fact sheet (no. 312).</span><a href="http://www.who.int/mediacentre/factsheets/fs312" class="extLink">http://www.who.int/mediacentre/factsheets/fs312</a> (accessed August<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization+diabetes+fact+sheet+%28no.+312%29.http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs312+%28accessed+August+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Facchini, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Insulin resistance as a predictor of age-related diseases</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">3574</span><span class="NLM_x">–</span> <span class="NLM_lpage">3578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1210%2Fjc.86.8.3574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=11502781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFektrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=3574-3578&author=F.+S.+Facchiniauthor=N.+Huaauthor=F.+Abbasiauthor=G.+M.+Reaven&title=Insulin+resistance+as+a+predictor+of+age-related+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin resistance as a predictor of age-related diseases</span></div><div class="casAuthors">Facchini, Francesco S.; Hua, Nancy; Abbasi, Fahim; Reaven, Gerald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3574-3578</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The current study was initiated to evaluate the ability of insulin resistance to predict a variety of age-related diseases.  Baseline measurements of insulin resistance and related variables were made between 1988-1995 in 208 apparently healthy, nonobese (body mass index < 30 kg/m2) individuals, who were then evaluated 4-11 yr later (mean ± SEM = 6.3 ± 0.2 yr) for the appearance of the following age-related diseases: hypertension, coronary heart disease, stroke, cancer, and type 2 diabetes.  The effect of insulin resistance on the development of clin. events was evaluated by dividing the study group into tertiles of insulin resistance at baseline and comparing the events in these 3 groups.  Clin. endpoints (n = 40) were identified in 37 individuals (18%) of those evaluated, including 12 with hypertension, 3 with hypertension + type 2 diabetes, 9 with cancer, 7 with coronary heart disease, 4 with stroke, and 2 with type 2 diabetes.  Twenty-eight out of the total 40 clin. events were seen in 25 individuals (36%) in the most insulin-resistant tertile, with the other 12 occurring in the group with an intermediate degree of insulin resistance.  Furthermore, insulin resistance was an independent predictor of all clin. events, using both multiple logistic regression and Cox's proportional hazards anal.  The fact that an age-related clin. event developed in approx. 1 out of 3 healthy individuals in the upper tertile of insulin resistance at baseline, followed for an av. of 6 yr, whereas no clin. events were obsd. in the most insulin-sensitive tertile, should serve as a strong stimulus to further efforts to define the role of insulin resistance in the genesis of age-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCdrUQGFn67Vg90H21EOLACvtfcHk0lgo9nhe7ubPUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFektrc%253D&md5=7ebe20852848a49ad461baa16a96d484</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1210%2Fjc.86.8.3574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.86.8.3574%26sid%3Dliteratum%253Aachs%26aulast%3DFacchini%26aufirst%3DF.%2BS.%26aulast%3DHua%26aufirst%3DN.%26aulast%3DAbbasi%26aufirst%3DF.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DInsulin%2520resistance%2520as%2520a%2520predictor%2520of%2520age-related%2520diseases%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2001%26volume%3D86%26spage%3D3574%26epage%3D3578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Stumvoll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Haeften, T. W.</span><span> </span><span class="NLM_article-title">Type 2 diabetes: Principles of pathogenesis and therapy</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2FS0140-6736%2805%2961032-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=15823385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtF2iu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=1333-1346&author=M.+Stumvollauthor=B.+J.+Goldsteinauthor=T.+W.+van+Haeften&title=Type+2+diabetes%3A+Principles+of+pathogenesis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Type 2 diabetes: principles of pathogenesis and therapy</span></div><div class="casAuthors">Stumvoll, Michael; Goldstein, Barry J.; van Haeften, Timon W.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">9467</span>),
    <span class="NLM_cas:pages">1333-1346</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Type 2 diabetes mellitus has become an epidemic, and virtually no physician is without patients who have the disease.  Whereas insulin insensitivity is an early phenomenon partly related to obesity, pancreas β-cell function declines gradually over time already before the onset of clin. hyperglycemia.  Several mechanisms have been proposed, including increased non-esterified fatty acids, inflammatory cytokines, adipokines, and mitochondrial dysfunction for insulin resistance, and glucotoxicity, lipotoxicity, and amyloid formation for β-cell dysfunction.  Moreover, the disease has a strong genetic component, but only a handful of genes have been identified so far: genes for calpain 10, potassium inward-rectifier 6·2, peroxisome proliferator-activated receptor γ, insulin receptor substrate-1, and others.  Management includes not only diet and exercise, but also combinations of anti-hyperglycemic drug treatment with lipid-lowering, antihypertensive, and anti platelet therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIpI_NflPwPbVg90H21EOLACvtfcHk0ljuOZC0n1TsHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtF2iu7g%253D&md5=ed0ca5b0572e2c2aabd2caf05eb53254</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2961032-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252961032-X%26sid%3Dliteratum%253Aachs%26aulast%3DStumvoll%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DB.%2BJ.%26aulast%3Dvan%2BHaeften%26aufirst%3DT.%2BW.%26atitle%3DType%25202%2520diabetes%253A%2520Principles%2520of%2520pathogenesis%2520and%2520therapy%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D1333%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Davidson, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, A. L.</span><span> </span><span class="NLM_article-title">An overview of metformin in the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2FS0002-9343%2896%2900353-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=9209206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaK2sXhtleltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1997&pages=99-110&author=M.+B.+Davidsonauthor=A.+L.+Peters&title=An+overview+of+metformin+in+the+treatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of metformin in the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Davidson, Mayer B.; Peters, Anne L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-110</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica</span>)
        </div><div class="casAbstract">A review with 87 refs.  Type 2 diabetes mellitus results from impaired insulin secretion and reduced peripheral insulin sensitivity.  Treatment options include diet, oral antihyperglycemic agents, and insulin.  Metformin, an oral biguanide, ameliorates hyperglycemia by improving peripheral sensitivity to insulin, and reducing gastrointestinal glucose absorption and hepatic glucose prodn.  Unlike sulfonylureas, it does not stimulate insulin secretion, aggravate hyperinsulinemia, or cause hypoglycemia or wt. gain (wt. stabilizes or decreases).  It also has beneficial effects on serum lipid profiles.  In lean or overweight type 2 diabetic patients uncontrolled by diet, metformin monotherapy significantly improves glycemic control, compared with placebo, and to similar extents as sulfonylurea monotherapy.  In secondary sulfonylurea failure, combination metformin-sulfonylurea treatment significantly improves glycemic control beyond that achieved with either agent alone.  Metformin-sulfonylurea also appears to be as effective as insulin or insulin plus sulfonylurea, suggesting that such combination therapy may obviate or substantially delay insulin therapy.  Limited data suggest that metformin-insulin therapy may improve glycemic control, possibly reducing insulin requirements, in type 2 diabetic patients uncontrolled by insulin alone following secondary sulfonylurea failure.  Gastrointestinal side effects are common, but usually tolerated.  Lactic acidosis risk is minimal, provided that contraindications, particularly renal impairment, and prescribing guidelines are respected.  Aside from elevated plasma metformin levels with cimetidine and synergistic hypoglycemia with sulfonylureas, few interactions occur.  Thus, metformin is safe and effective both as monotherapy or in combination with other antihyperglycemic agents in type 2 diabetic patients requiring addnl. glycemic control, and may be advantageous when wt. control is desirable and/or hyperlipidemia exists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptjLpFKfhhbrVg90H21EOLACvtfcHk0ljuOZC0n1TsHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtleltr8%253D&md5=a1d71c37a53efaa908ec5d996cb18215</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0002-9343%2896%2900353-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9343%252896%252900353-1%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DM.%2BB.%26aulast%3DPeters%26aufirst%3DA.%2BL.%26atitle%3DAn%2520overview%2520of%2520metformin%2520in%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DAm.%2520J.%2520Med.%26date%3D1997%26volume%3D102%26spage%3D99%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Horii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kameda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, K.</span><span> </span><span class="NLM_article-title">Synthesis and R-<span class="smallcaps smallerCapital">d</span>-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00156a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=1038-1046&author=S.+Horiiauthor=H.+Fukaseauthor=T.+Matsuoauthor=Y.+Kamedaauthor=N.+Asanoauthor=K.+Matsui&title=Synthesis+and+R-d-glucosidase+inhibitory+activity+of+N-substituted+valiolamine+derivatives+as+potential+oral+antidiabetic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm00156a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00156a023%26sid%3Dliteratum%253Aachs%26aulast%3DHorii%26aufirst%3DS.%26aulast%3DFukase%26aufirst%3DH.%26aulast%3DMatsuo%26aufirst%3DT.%26aulast%3DKameda%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DN.%26aulast%3DMatsui%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520R-d-glucosidase%2520inhibitory%2520activity%2520of%2520N-substituted%2520valiolamine%2520derivatives%2520as%2520potential%2520oral%2520antidiabetic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D1038%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Davis, S. N.</span><span> </span><span class="NLM_article-title">The role of glimepiride in the effective management of type 2 diabetes</span> <span class="citation_source-journal">J. Diabetes Complications</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2Fj.jdiacomp.2004.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A280%3ADC%252BD2crlvFaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=367-376&author=S.+N.+Davis&title=The+role+of+glimepiride+in+the+effective+management+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of glimepiride in the effective management of Type 2 diabetes</span></div><div class="casAuthors">Davis Stephen N</div><div class="citationInfo"><span class="NLM_cas:title">Journal of diabetes and its complications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">367-76</span>
        ISSN:<span class="NLM_cas:issn">1056-8727</span>.
    </div><div class="casAbstract">Type 2 diabetes mellitus, a disorder of impaired insulin secretion and insulin resistance, has reached epidemic proportions.  The effective management of Type 2 diabetes is of vital concern to clinicians.  The identification of high-risk individuals and lifestyle management can help control diabetes; however, most patients require pharmacologic intervention.  The goals of pharmacologic therapy are to achieve adequate glycemic control while avoiding hypoglycemia and weight gain and to minimize the risk of future micro- and macrovascular complications.  There are a number of available glucose-lowering agents from which to choose.  This review focuses on the sulfonylureas, the first oral agents introduced for the management of Type 2 diabetes, which are effective, well-tolerated, and well-established drugs, Second-generation sulfonylureas are now widely used in the management of Type 2 diabetes.  The most recent addition, glimepiride, can be used in combination with metformin, the thiazolidinediones, alpha-glucosidase inhibitors, and insulin.  The unique properties of glimepiride may provide advantages over other currently available insulin secretagogues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRvH-kEH8I5Bcr74wzj5o5fW6udTcc2ebUqrp8TzWfdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crlvFaktg%253D%253D&md5=771d37140741af70b01d9ca62a3ec111</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jdiacomp.2004.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdiacomp.2004.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DS.%2BN.%26atitle%3DThe%2520role%2520of%2520glimepiride%2520in%2520the%2520effective%2520management%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Diabetes%2520Complications%26date%3D2004%26volume%3D18%26spage%3D367%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torsten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urs, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoph, R.</span><span> </span><span class="NLM_article-title">Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor γ activity: A combined virtual screening and biological assay approach</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=398-406&author=S.+Marcoauthor=P.+Michaelauthor=R.+Adrianauthor=H.+Hubertauthor=K.+Sanderauthor=A.+Hugoauthor=S.+Torstenauthor=A.+M.+Ursauthor=R.+Christoph&title=Sulfonylureas+and+glinides+exhibit+peroxisome+proliferator-activated+receptor+%CE%B3+activity%3A+A+combined+virtual+screening+and+biological+assay+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DS.%26aulast%3DMichael%26aufirst%3DP.%26aulast%3DAdrian%26aufirst%3DR.%26aulast%3DHubert%26aufirst%3DH.%26aulast%3DSander%26aufirst%3DK.%26aulast%3DHugo%26aufirst%3DA.%26aulast%3DTorsten%26aufirst%3DS.%26aulast%3DUrs%26aufirst%3DA.%2BM.%26aulast%3DChristoph%26aufirst%3DR.%26atitle%3DSulfonylureas%2520and%2520glinides%2520exhibit%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520activity%253A%2520A%2520combined%2520virtual%2520screening%2520and%2520biological%2520assay%2520approach%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D398%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ajjan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, P. J.</span><span> </span><span class="NLM_article-title">The cardiovascular safety of rosiglitazone</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1517%2F14740338.7.4.367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Cgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=367-376&author=R.+A.+Ajjanauthor=P.+J.+Grant&title=The+cardiovascular+safety+of+rosiglitazone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The cardiovascular safety of rosiglitazone</span></div><div class="casAuthors">Ajjan, Ramzi A.; Grant, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">367-376</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Thiazolidinediones (rosiglitazone, pioglitazone) influence insulin sensitivity and are used for the treatment of Type 2 diabetes.  Rosiglitazone achieves sustained improvements in glycemic control, while having pleiotropic effects on cardiovascular risk factors.  However, anal. of cardiovascular outcomes has been controversial.  Review the cardiovascular safety of rosiglitazone by conducting a literature search.  We conducted a PubMed search and critically reviewed published work on cardiovascular outcome of rosiglitazone, including clin. studies and meta-analyses.  The meta-anal. by Nissen and Wolski suggested increased cardiovascular risk in users of rosiglitazone, but this was not supported by an interim anal. of the RECORD trial designed to evaluate this, and several other reports failed to shed conclusive light on this issue.  The cardiovascular benefits of pioglitazone have also been in doubt due to the failure of the PROactive trial to reach the primary cardiovascular end points, although this study reported a significant redn. in secondary end points.  All of this has left diabetes care in some disarray, with weak evidence for adverse cardiovascular effects driving the reduced use of rosiglitazone, an agent that has important sustained effects on glycemic control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xDKtFqnMgbVg90H21EOLACvtfcHk0lin6iWo5Fu8OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Cgs78%253D&md5=cecc4f9a6fc57e8c36df921c0787ccd6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F14740338.7.4.367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.7.4.367%26sid%3Dliteratum%253Aachs%26aulast%3DAjjan%26aufirst%3DR.%2BA.%26aulast%3DGrant%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520cardiovascular%2520safety%2520of%2520rosiglitazone%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2008%26volume%3D7%26spage%3D367%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Momose, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoda, T.</span><span> </span><span class="NLM_article-title">Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=1440-1445&author=Y.+Momoseauthor=K.+Meguroauthor=H.+Ikedaauthor=C.+Hatanakaauthor=S.+Oiauthor=T.+Shoda&title=Studies+on+antidiabetic+agents.+X.+Synthesis+and+biological+activities+of+pioglitazone+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMomose%26aufirst%3DY.%26aulast%3DMeguro%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DHatanaka%26aufirst%3DC.%26aulast%3DOi%26aufirst%3DS.%26aulast%3DShoda%26aufirst%3DT.%26atitle%3DStudies%2520on%2520antidiabetic%2520agents.%2520X.%2520Synthesis%2520and%2520biological%2520activities%2520of%2520pioglitazone%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D1440%26epage%3D1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-R]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonsauthor=F.+Marsilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+S.+Royauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifluoromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-R%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluorophenyl%29butan-2-amine%3A+A+potent%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifluoromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-R%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluorophenyl%2529butan-2-amine%253A%2520A%2520potent%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dicker, D.</span><span> </span><span class="NLM_article-title">DPP-4 inhibitors. Impact on glycemic control and cardiovascular risk factors</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">S276</span><span class="NLM_x">–</span> <span class="NLM_lpage">S278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=S276-S278&author=D.+Dicker&title=DPP-4+inhibitors.+Impact+on+glycemic+control+and+cardiovascular+risk+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDicker%26aufirst%3DD.%26atitle%3DDPP-4%2520inhibitors.%2520Impact%2520on%2520glycemic%2520control%2520and%2520cardiovascular%2520risk%2520factors%26jtitle%3DDiabetes%2520Care%26date%3D2011%26volume%3D34%26spage%3DS276%26epage%3DS278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Vallon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koepsell, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieg, T.</span><span> </span><span class="NLM_article-title">SGLT2 mediates glucose reabsorption in the early proximal tubule</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1681%2FASN.2010030246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVChsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=104-112&author=V.+Vallonauthor=K.+A.+Plattauthor=R.+Cunardauthor=J.+Schrothauthor=J.+Whaleyauthor=S.+C.+Thomsonauthor=H.+Koepsellauthor=T.+Rieg&title=SGLT2+mediates+glucose+reabsorption+in+the+early+proximal+tubule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">SGLT2 mediates glucose reabsorption in the early proximal tubule</span></div><div class="casAuthors">Vallon, Volker; Platt, Kenneth A.; Cunard, Robyn; Schroth, Jana; Whaley, Jean; Thomson, Scott C.; Koepsell, Hermann; Rieg, Timo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-112</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Mutations in the gene encoding for the Na+-glucose co-transporter SGLT2 (SLC5A2) assoc. with familial renal glucosuria, but the role of SGLT2 in the kidney is incompletely understood.  Here, we detd. the localization of SGLT2 in the mouse kidney and generated and characterized SGLT2-deficient mice.  In wild-type (WT) mice, immunohistochem. localized SGLT2 to the brush border membrane of the early proximal tubule.  Sglt2-/- mice had glucosuria, polyuria, and increased food and fluid intake without differences in plasma glucose concns., GFR, or urinary excretion of other proximal tubular substrates (including amino acids) compared with WT mice.  SGLT2 deficiency did not assoc. with vol. depletion, suggested by similar body wt., BP, and hematocrit; however, plasma renin concns. were modestly higher and plasma aldosterone levels were lower in Sglt2-/- mice.  Whole-kidney clearance studies showed that fractional glucose reabsorption was significantly lower in Sglt2-/- mice compared with WT mice and varied in Sglt2-/- mice between 10 and 60%, inversely with the amt. of filtered glucose.  Free-flow micropuncture revealed that for early proximal collections, 78 ± 6% of the filtered glucose was reabsorbed in WT mice compared with no reabsorption in Sglt2-/- mice.  For late proximal collections, fractional glucose reabsorption was 93 ± 1% in WT and 21 ± 6% in Sglt2-/- mice, resp.  These results demonstrate that SGLT2 mediates glucose reabsorption in the early proximal tubule and most of the glucose reabsorption by the kidney, overall.  This mouse model mimics and explains the glucosuric phenotype of individuals carrying SLC5A2 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0glw1C3NSKLVg90H21EOLACvtfcHk0lhU60sSz-EtUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVChsrY%253D&md5=dbc09afbe725f7d7eea6244231fa2fe5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1681%2FASN.2010030246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2010030246%26sid%3Dliteratum%253Aachs%26aulast%3DVallon%26aufirst%3DV.%26aulast%3DPlatt%26aufirst%3DK.%2BA.%26aulast%3DCunard%26aufirst%3DR.%26aulast%3DSchroth%26aufirst%3DJ.%26aulast%3DWhaley%26aufirst%3DJ.%26aulast%3DThomson%26aufirst%3DS.%2BC.%26aulast%3DKoepsell%26aufirst%3DH.%26aulast%3DRieg%26aufirst%3DT.%26atitle%3DSGLT2%2520mediates%2520glucose%2520reabsorption%2520in%2520the%2520early%2520proximal%2520tubule%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2011%26volume%3D22%26spage%3D104%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hediger, M. A.</span><span> </span><span class="NLM_article-title">The human kidney low affinity Na<sup>+</sup>/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for <span class="smallcaps smallerCapital">d</span>-glucose</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1994&pages=397-404&author=Y.+Kanaiauthor=W.-S.+Leeauthor=G.+Youauthor=D.+Brownauthor=M.+A.+Hediger&title=The+human+kidney+low+affinity+Na%2B%2Fglucose+cotransporter+SGLT2.+Delineation+of+the+major+renal+reabsorptive+mechanism+for+d-glucose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DW.-S.%26aulast%3DYou%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DHediger%26aufirst%3DM.%2BA.%26atitle%3DThe%2520human%2520kidney%2520low%2520affinity%2520Na%252B%252Fglucose%2520cotransporter%2520SGLT2.%2520Delineation%2520of%2520the%2520major%2520renal%2520reabsorptive%2520mechanism%2520for%2520d-glucose%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1994%26volume%3D93%26spage%3D397%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Powell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaCosta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doree, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeter-Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mseeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhring, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brommage, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shadoan, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambrowicz, B.</span><span> </span><span class="NLM_article-title">Improved glycemic control in mice lacking Sglt1 and Sglt2</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">E117</span><span class="NLM_x">–</span> <span class="NLM_lpage">E130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2013&pages=E117-E130&author=D.+R.+Powellauthor=C.+M.+DaCostaauthor=J.+Gayauthor=Z.+M.+Dingauthor=M.+Smithauthor=J.+Greerauthor=D.+Doreeauthor=S.+Jeter-Jonesauthor=F.+Mseehauthor=L.+A.+Rodriguezauthor=A.+Harrisauthor=L.+Buhringauthor=K.+A.+Plattauthor=P.+Vogelauthor=R.+Brommageauthor=M.+K.+Shadoanauthor=A.+T.+Sandsauthor=B.+Zambrowicz&title=Improved+glycemic+control+in+mice+lacking+Sglt1+and+Sglt2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DDaCosta%26aufirst%3DC.%2BM.%26aulast%3DGay%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DZ.%2BM.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DGreer%26aufirst%3DJ.%26aulast%3DDoree%26aufirst%3DD.%26aulast%3DJeter-Jones%26aufirst%3DS.%26aulast%3DMseeh%26aufirst%3DF.%26aulast%3DRodriguez%26aufirst%3DL.%2BA.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DBuhring%26aufirst%3DL.%26aulast%3DPlatt%26aufirst%3DK.%2BA.%26aulast%3DVogel%26aufirst%3DP.%26aulast%3DBrommage%26aufirst%3DR.%26aulast%3DShadoan%26aufirst%3DM.%2BK.%26aulast%3DSands%26aufirst%3DA.%2BT.%26aulast%3DZambrowicz%26aufirst%3DB.%26atitle%3DImproved%2520glycemic%2520control%2520in%2520mice%2520lacking%2520Sglt1%2520and%2520Sglt2%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2013%26volume%3D304%26spage%3DE117%26epage%3DE130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chao, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">SGLT2 inhibition–a novel strategy for diabetes treatment</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=551-559&author=E.+C.+Chaoauthor=R.+R.+Henry&title=SGLT2+inhibition%E2%80%93a+novel+strategy+for+diabetes+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DE.%2BC.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DSGLT2%2520inhibition%25E2%2580%2593a%2520novel%2520strategy%2520for%2520diabetes%2520treatment%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D551%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Toggenburger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G.</span><span> </span><span class="NLM_article-title">Phlorizin as a probe of the small-intestinal Na<sup>+</sup>, <span class="smallcaps smallerCapital">d</span>-glucose cotransporter. A model</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">688</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=688&publication_year=1982&pages=557-571&author=G.+Toggenburgerauthor=M.+Kesslerauthor=G.+Semenza&title=Phlorizin+as+a+probe+of+the+small-intestinal+Na%2B%2C+d-glucose+cotransporter.+A+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToggenburger%26aufirst%3DG.%26aulast%3DKessler%26aufirst%3DM.%26aulast%3DSemenza%26aufirst%3DG.%26atitle%3DPhlorizin%2520as%2520a%2520probe%2520of%2520the%2520small-intestinal%2520Na%252B%252C%2520d-glucose%2520cotransporter.%2520A%2520model%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1982%26volume%3D688%26spage%3D557%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ehrenkranz, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J.</span><span> </span><span class="NLM_article-title">Phlorizin: A review</span> <span class="citation_source-journal">Diabetes/Metab. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1002%2Fdmrr.532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=15624123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs12gs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=31-38&author=J.+R.+Ehrenkranzauthor=N.+G.+Lewisauthor=C.+R.+Kahnauthor=J.+Roth&title=Phlorizin%3A+A+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phlorizin: a review</span></div><div class="casAuthors">Ehrenkranz, Joel R. L.; Lewis, Norman G.; Kahn, C. Ronald; Roth, Jesse</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/Metabolism Research and Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-38</span>CODEN:
                <span class="NLM_cas:coden">DMRRFM</span>;
        ISSN:<span class="NLM_cas:issn">1520-7552</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The dihydrochalcone phlorizin is a natural product and dietary constituent found in a no. of fruit trees.  It has been used as a pharmaceutical and tool for physiol. research for over 150 years.  Phlorizin's principal pharmacol. action is to produce renal glycosuria and block intestinal glucose absorption through inhibition of the sodium-glucose symporters located in the proximal renal tubule and mucosa of the small intestine.  This review covers the role phlorizin has played in the history of diabetes mellitus and its use as an agent to understand fundamental concepts in renal physiol. as well as summarizes the physiol. of cellular glucose transport and the pathophysiol. of renal glycosuria.  It reviews the biol. and pathobiol. of glucose transporters and discusses the medical botany of phlorizin and the potential effects of plant flavonoids, such as phlorizin, on human metab.  Lastly, it describes the clin. pharmacol. and toxicol. of phlorizin, including investigational uses of phlorizin and phlorizin analogs in the treatment of diabetes, obesity, and stress hyperglycemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpOKzj4-WFbVg90H21EOLACvtfcHk0ljer2rbJ6Azvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs12gs7c%253D&md5=03f04faab4da2f9ac1e5383036f98649</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.532%26sid%3Dliteratum%253Aachs%26aulast%3DEhrenkranz%26aufirst%3DJ.%2BR.%26aulast%3DLewis%26aufirst%3DN.%2BG.%26aulast%3DKahn%26aufirst%3DC.%2BR.%26aulast%3DRoth%26aufirst%3DJ.%26atitle%3DPhlorizin%253A%2520A%2520review%26jtitle%3DDiabetes%252FMetab.%2520Res.%2520Rev.%26date%3D2005%26volume%3D21%26spage%3D31%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Oku, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuronuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endou, H.</span><span> </span><span class="NLM_article-title">T-1095, an inhibitor of renal Na<sup>+</sup>-glucose cotransporters, may provide a novel approach to treating diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1794</span><span class="NLM_x">–</span> <span class="NLM_lpage">1800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=1794-1800&author=A.+Okuauthor=K.+Uetaauthor=K.+Arakawaauthor=T.+Ishiharaauthor=M.+Nawanoauthor=Y.+Kuronumaauthor=M.+Matsumotoauthor=A.+Saitoauthor=K.+Tsujiharaauthor=M.+Anaiauthor=T.+Asanoauthor=Y.+Kanaiauthor=H.+Endou&title=T-1095%2C+an+inhibitor+of+renal+Na%2B-glucose+cotransporters%2C+may+provide+a+novel+approach+to+treating+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOku%26aufirst%3DA.%26aulast%3DUeta%26aufirst%3DK.%26aulast%3DArakawa%26aufirst%3DK.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DNawano%26aufirst%3DM.%26aulast%3DKuronuma%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DA.%26aulast%3DTsujihara%26aufirst%3DK.%26aulast%3DAnai%26aufirst%3DM.%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DEndou%26aufirst%3DH.%26atitle%3DT-1095%252C%2520an%2520inhibitor%2520of%2520renal%2520Na%252B-glucose%2520cotransporters%252C%2520may%2520provide%2520a%2520novel%2520approach%2520to%2520treating%2520diabetes%26jtitle%3DDiabetes%26date%3D1999%26volume%3D48%26spage%3D1794%26epage%3D1800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Tsujihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oku, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, A.</span><span> </span><span class="NLM_article-title">Na<sup>+</sup>-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4′-dehydroxyphlorizin derivatives substituted on the B ring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5311</span><span class="NLM_x">–</span> <span class="NLM_lpage">5324</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990175n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5311-5324&author=K.+Tsujiharaauthor=M.+Honguauthor=K.+Saitoauthor=H.+Kawanishiauthor=K.+Kuriyamaauthor=M.+Matsumotoauthor=A.+Okuauthor=K.+Uetaauthor=M.+Tsudaauthor=A.+Saito&title=Na%2B-glucose+cotransporter+%28SGLT%29+inhibitors+as+antidiabetic+agents.+4.+Synthesis+and+pharmacological+properties+of+4%E2%80%B2-dehydroxyphlorizin+derivatives+substituted+on+the+B+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm990175n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990175n%26sid%3Dliteratum%253Aachs%26aulast%3DTsujihara%26aufirst%3DK.%26aulast%3DHongu%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DKawanishi%26aufirst%3DH.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DOku%26aufirst%3DA.%26aulast%3DUeta%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DA.%26atitle%3DNa%252B-glucose%2520cotransporter%2520%2528SGLT%2529%2520inhibitors%2520as%2520antidiabetic%2520agents.%25204.%2520Synthesis%2520and%2520pharmacological%2520properties%2520of%25204%25E2%2580%25B2-dehydroxyphlorizin%2520derivatives%2520substituted%2520on%2520the%2520B%2520ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5311%26epage%3D5324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Katsuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1124%2Fjpet.106.110296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=17050778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFCiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=323-330&author=K.+Katsunoauthor=Y.+Fujimoriauthor=Y.+Takemuraauthor=M.+Hiratochiauthor=F.+Itohauthor=Y.+Komatsuauthor=H.+Fujikuraauthor=M.+Isaji&title=Sergliflozin%2C+a+novel+selective+inhibitor+of+low-affinity+sodium+glucose+cotransporter+%28SGLT2%29%2C+validates+the+critical+role+of+SGLT2+in+renal+glucose+reabsorption+and+modulates+plasma+glucose+level"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level</span></div><div class="casAuthors">Katsuno, Kenji; Fujimori, Yoshikazu; Takemura, Yukiko; Hiratochi, Masahiro; Itoh, Fumiaki; Komatsu, Yoshimitsu; Fujikura, Hideki; Isaji, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-330</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The low-affinity sodium glucose cotransporter (SGLT2), which is expressed specifically in the kidney, plays a major role in renal glucose resorption in the proximal tubule.  We have discovered sergliflozin, a prodrug of a novel selective SGLT2 inhibitor, based on benzylphenol glucoside.  In structure, it belongs to a new category of SGLT2 inhibitors and its skeleton differs from that of phlorizin, a nonselective SGLT inhibitor.  We investigated its pharmacol. properties and potencies in vitro and in vivo.  By examg. a Chinese hamster ovary-K1 cell line stably expressing either human SGLT2 or human high-affinity sodium glucose cotransporter (SGLT1), we found sergliflozin-A (active form) to be a highly selective and potent inhibitor of human SGLT2.  At pharmacol. doses, sergliflozin, sergliflozin-A, and its aglycon had no effects on facilitative glucose transporter 1 activity, which was inhibited by phloretin (the aglycon of phlorizin).  The transport max. for glucose in the kidney was reduced by sergliflozin-A in normal rats.  As a result of this effect, orally administered sergliflozin increased urinary glucose excretion in mice, rats, and dogs in a dose-dependent manner.  In an oral glucose tolerance test in diabetic rats, sergliflozin exhibited glucose-lowering effects independently of insulin secretion.  Any glucose excretion induced by sergliflozin did not affect normoglycemia or electrolyte balance.  These data indicate that selective inhibition of SGLT2 increases urinary glucose excretion by inhibiting renal glucose resorption.  As a representative of a new category of antidiabetic drugs, sergliflozin may provide a new and unique approach to the treatment of diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpROCQYQ6yzj7Vg90H21EOLACvtfcHk0ljer2rbJ6Azvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFCiug%253D%253D&md5=d56b754818c4ef783c2b764b066b7fdd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.110296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.110296%26sid%3Dliteratum%253Aachs%26aulast%3DKatsuno%26aufirst%3DK.%26aulast%3DFujimori%26aufirst%3DY.%26aulast%3DTakemura%26aufirst%3DY.%26aulast%3DHiratochi%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DFujikura%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DSergliflozin%252C%2520a%2520novel%2520selective%2520inhibitor%2520of%2520low-affinity%2520sodium%2520glucose%2520cotransporter%2520%2528SGLT2%2529%252C%2520validates%2520the%2520critical%2520role%2520of%2520SGLT2%2520in%2520renal%2520glucose%2520reabsorption%2520and%2520modulates%2520plasma%2520glucose%2520level%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D323%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Fujimori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa-Takemura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1124%2Fjpet.108.140210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=18583547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1amsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=268-276&author=Y.+Fujimoriauthor=K.+Katsunoauthor=I.+Nakashimaauthor=Y.+Ishikawa-Takemuraauthor=H.+Fujikuraauthor=M.+Isaji&title=Remogliflozin+etabonate%2C+in+a+novel+category+of+selective+low-affinity+sodium+glucose+cotransporter+%28SGLT2%29+inhibitors%2C+exhibits+antidiabetic+efficacy+in+rodent+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models</span></div><div class="casAuthors">Fujimori, Yoshikazu; Katsuno, Kenji; Nakashima, Ikumi; Ishikawa-Takemura, Yukiko; Fujikura, Hideki; Isaji, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">268-276</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The low-affinity sodium glucose cotransporter (SGLT2) plays an important role in renal glucose reabsorption and is a remarkable transporter as a mol. target for the treatment of diabetes.  We have discovered remogliflozin etabonate, which is a novel category of selective SGLT2 inhibitors.  Remogliflozin etabonate is a prodrug based on benzylpyrazole glucoside and is metabolized to its active form, remogliflozin, in the body.  We identified remogliflozin to be a potent and highly selective SGLT2 inhibitor by examg. COS-7 cells transiently expressing either high-affinity sodium glucose cotransporter (SGLT1) or SGLT2.  Orally administered remogliflozin etabonate increased urinary glucose excretion in a dose-dependent manner in both mice and rats.  By increasing urinary glucose excretion, remogliflozin etabonate inhibited the increase in plasma glucose after glucose loading without stimulating insulin secretion in normal rats.  Remogliflozin etabonate also showed antihyperglycemic effects in both streptozotocin-induced diabetic rats in oral glucose tolerance and in db/db mice in the fed condition.  Chronic treatment with remogliflozin etabonate reduced the levels of fasting plasma glucose and glycated Hb, and it ameliorated glucosuria in db/db mice.  In high-fat diet-fed Goto-Kakizaki rats, remogliflozin etabonate improved hyperglycemia, hyperinsulinemia, hypertriglyceridemia, and insulin resistance.  This study demonstrates that treatment with remogliflozin etabonate exhibits antidiabetic efficacy in several rodent models and suggests that remogliflozin etabonate may be a new and useful drug for the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNsPxNw9fLtrVg90H21EOLACvtfcHk0liS8gLEjg4xyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1amsLfL&md5=04b95fbb060ff066f943a96e7308ca2c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.140210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.140210%26sid%3Dliteratum%253Aachs%26aulast%3DFujimori%26aufirst%3DY.%26aulast%3DKatsuno%26aufirst%3DK.%26aulast%3DNakashima%26aufirst%3DI.%26aulast%3DIshikawa-Takemura%26aufirst%3DY.%26aulast%3DFujikura%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DRemogliflozin%2520etabonate%252C%2520in%2520a%2520novel%2520category%2520of%2520selective%2520low-affinity%2520sodium%2520glucose%2520cotransporter%2520%2528SGLT2%2529%2520inhibitors%252C%2520exhibits%2520antidiabetic%2520efficacy%2520in%2520rodent%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D268%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girotra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshpande, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullockaran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obermeier, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discenza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterau, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janovitz, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flint, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, W. N.</span><span> </span><span class="NLM_article-title">Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701272q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFWgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1145-1149&author=W.+Mengauthor=B.+A.+Ellsworthauthor=A.+A.+Nirschlauthor=P.+J.+McCannauthor=M.+Patelauthor=R.+N.+Girotraauthor=G.+Wuauthor=P.+M.+Sherauthor=E.+P.+Morrisonauthor=S.+A.+Billerauthor=R.+Zahlerauthor=P.+P.+Deshpandeauthor=A.+Pullockaranauthor=D.+L.+Haganauthor=N.+Morganauthor=J.+R.+Taylorauthor=M.+T.+Obermeierauthor=W.+G.+Humphreysauthor=A.+Khannaauthor=L.+Discenzaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=S.+Hanauthor=J.+R.+Wetterauauthor=E.+B.+Janovitzauthor=O.+P.+Flintauthor=J.+M.+Whaleyauthor=W.+N.+Washburn&title=Discovery+of+dapagliflozin%3A+A+potent%2C+selective+renal+sodium-dependent+glucose+cotransporter+2+%28SGLT2%29+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Meng, Wei; Ellsworth, Bruce A.; Nirschl, Alexandra A.; McCann, Peggy J.; Patel, Manorama; Girotra, Ravindar N.; Wu, Gang; Sher, Philip M.; Morrison, Eamonn P.; Biller, Scott A.; Zahler, Robert; Deshpande, Prashant P.; Pullockaran, Annie; Hagan, Deborah L.; Morgan, Nathan; Taylor, Joseph R.; Obermeier, Mary T.; Humphreys, William G.; Khanna, Ashish; Discenza, Lorell; Robertson, James G.; Wang, Aiying; Han, Songping; Wetterau, John R.; Janovitz, Evan B.; Flint, Oliver P.; Whaley, Jean M.; Washburn, William N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1145-1149</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The C-aryl glucoside 6 (dapagliflozin) was identified as a potent and selective hSGLT2 inhibitor which reduced blood glucose levels in a dose-dependent manner by as much as 55% in hyperglycemic streptozotocin (STZ) rats.  These findings, combined with a favorable ADME profile, have prompted clin. evaluation of dapagliflozin for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDq_QPSZ3cf7Vg90H21EOLACvtfcHk0liS8gLEjg4xyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFWgtrY%253D&md5=8b31ec17acef23a7507ce6a7d9184eb9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm701272q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701272q%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26aulast%3DNirschl%26aufirst%3DA.%2BA.%26aulast%3DMcCann%26aufirst%3DP.%2BJ.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DGirotra%26aufirst%3DR.%2BN.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DSher%26aufirst%3DP.%2BM.%26aulast%3DMorrison%26aufirst%3DE.%2BP.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DDeshpande%26aufirst%3DP.%2BP.%26aulast%3DPullockaran%26aufirst%3DA.%26aulast%3DHagan%26aufirst%3DD.%2BL.%26aulast%3DMorgan%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DJ.%2BR.%26aulast%3DObermeier%26aufirst%3DM.%2BT.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DDiscenza%26aufirst%3DL.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DWetterau%26aufirst%3DJ.%2BR.%26aulast%3DJanovitz%26aufirst%3DE.%2BB.%26aulast%3DFlint%26aufirst%3DO.%2BP.%26aulast%3DWhaley%26aufirst%3DJ.%2BM.%26aulast%3DWashburn%26aufirst%3DW.%2BN.%26atitle%3DDiscovery%2520of%2520dapagliflozin%253A%2520A%2520potent%252C%2520selective%2520renal%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520%2528SGLT2%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1145%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Nomura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda-Tsukimoto, M.</span><span> </span><span class="NLM_article-title">Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6355</span><span class="NLM_x">–</span> <span class="NLM_lpage">6360</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100332n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVartbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6355-6360&author=S.+Nomuraauthor=S.+Sakamakiauthor=M.+Honguauthor=E.+Kawanishiauthor=Y.+Kogaauthor=T.+Sakamotoauthor=Y.+Yamamotoauthor=K.+Uetaauthor=H.+Kimataauthor=K.+Nakayamaauthor=M.+Tsuda-Tsukimoto&title=Discovery+of+canagliflozin%2C+a+novel+C-glucoside+with+thiophene+ring%2C+as+sodium-dependent+glucose+cotransporter+2+inhibitor+for+the+treatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Canagliflozin, a Novel C-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Co-transporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus</span></div><div class="casAuthors">Nomura, Sumihiro; Sakamaki, Shigeki; Hongu, Mitsuya; Kawanishi, Eiji; Koga, Yuichi; Sakamoto, Toshiaki; Yamamoto, Yasuo; Ueta, Kiichiro; Kimata, Hirotaka; Nakayama, Keiko; Tsuda-Tsukimoto, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6355-6360</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We discovered that aryl C-glucosides, e.g. I, bearing a heteroarom. ring formed metabolically more stable inhibitors for sodium-dependent glucose co-transporter 2 (SGLT2).  Thiophene I (canagliflozin) was a highly potent and selective SGLT2 inhibitor and showed pronounced anti-hyperglycemic effects in high-fat diet fed KK (HF-KK) mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLQqM2z47sI7Vg90H21EOLACvtfcHk0lgtDNmnjcu8ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVartbk%253D&md5=33c3a6bce5ae74799d051b6f8c06da7e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm100332n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100332n%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DS.%26aulast%3DSakamaki%26aufirst%3DS.%26aulast%3DHongu%26aufirst%3DM.%26aulast%3DKawanishi%26aufirst%3DE.%26aulast%3DKoga%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DUeta%26aufirst%3DK.%26aulast%3DKimata%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DTsuda-Tsukimoto%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520canagliflozin%252C%2520a%2520novel%2520C-glucoside%2520with%2520thiophene%2520ring%252C%2520as%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6355%26epage%3D6360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Imamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosakai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Discovery of ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3263</span><span class="NLM_x">–</span> <span class="NLM_lpage">3279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2Fj.bmc.2012.03.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=22507206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFCqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3263-3279&author=M.+Imamuraauthor=K.+Nakanishiauthor=T.+Suzukiauthor=K.+Ikegaiauthor=R.+Shirakiauthor=T.+Ogiyamaauthor=T.+Murakamiauthor=E.+Kurosakiauthor=A.+Nodaauthor=Y.+Kobayashiauthor=M.+Yokotaauthor=T.+Koideauthor=K.+Kosakaiauthor=Y.+Ohkuraauthor=M.+Takeuchiauthor=H.+Tomiyamaauthor=M.+Ohta&title=Discovery+of+ipragliflozin+%28ASP1941%29%3A+A+novel+C-glucoside+with+benzothiophene+structure+as+a+potent+and+selective+sodium+glucose+co-transporter+2+%28SGLT2%29+inhibitor+for+the+treatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Imamura, Masakazu; Nakanishi, Keita; Suzuki, Takayuki; Ikegai, Kazuhiro; Shiraki, Ryota; Ogiyama, Takashi; Murakami, Takeshi; Kurosaki, Eiji; Noda, Atsushi; Kobayashi, Yoshinori; Yokota, Masayuki; Koide, Tomokazu; Kosakai, Kazuhiro; Ohkura, Yasufumi; Takeuchi, Makoto; Tomiyama, Hiroshi; Ohta, Mitsuaki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3263-3279</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of C-glucosides with various heteroaroms. has been synthesized and its inhibitory activity toward SGLTs was evaluated.  Upon screening several compds., the benzothiophene deriv. I (R =H) was found to have potent inhibitory activity against SGLT2 and good selectivity vs. SGLT1.  Through further optimization of 14a, a novel benzothiophene deriv. I (R = F) (ipragliflozin, ASP1941) was discovered as a highly potent and selective SGLT2 inhibitor that reduced blood glucose levels in a dose-dependent manner in diabetic models KK-Ay mice and STZ rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFrm7CoAIzfbVg90H21EOLACvtfcHk0lgtDNmnjcu8ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFCqtLs%253D&md5=3552a64a85d0f769a10e1ad8e1dd8736</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.051%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIkegai%26aufirst%3DK.%26aulast%3DShiraki%26aufirst%3DR.%26aulast%3DOgiyama%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DKurosaki%26aufirst%3DE.%26aulast%3DNoda%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DYokota%26aufirst%3DM.%26aulast%3DKoide%26aufirst%3DT.%26aulast%3DKosakai%26aufirst%3DK.%26aulast%3DOhkura%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DTomiyama%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520ipragliflozin%2520%2528ASP1941%2529%253A%2520A%2520novel%2520C-glucoside%2520with%2520benzothiophene%2520structure%2520as%2520a%2520potent%2520and%2520selective%2520sodium%2520glucose%2520co-transporter%25202%2520%2528SGLT2%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3263%26epage%3D3279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Goodwin, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shadoan, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almstead, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhring, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaCosta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenhagen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mseeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nouraldeen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span> </span><span class="NLM_article-title">Novel <span class="smallcaps smallerCapital">l</span>-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6201</span><span class="NLM_x">–</span> <span class="NLM_lpage">6204</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900951n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6201-6204&author=N.+C.+Goodwinauthor=R.+Mabonauthor=B.+A.+Harrisonauthor=M.+K.+Shadoanauthor=Z.+Y.+Almsteadauthor=Y.+Xieauthor=J.+Healyauthor=L.+M.+Buhringauthor=C.+M.+DaCostaauthor=J.+Bardenhagenauthor=F.+Mseehauthor=Q.+Liuauthor=A.+Nouraldeenauthor=A.+G.+E.+Wilsonauthor=S.+D.+Kimballauthor=D.+R.+Powellauthor=D.+B.+Rawlins&title=Novel+l-xylose+derivatives+as+selective+sodium-dependent+glucose+cotransporter+2+%28SGLT2%29+inhibitors+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel L-Xylose Derivatives as Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Goodwin, Nicole C.; Mabon, Ross; Harrison, Bryce A.; Shadoan, Melanie K.; Almstead, Zheng Y.; Xie, Yiling; Healy, Jason; Buhring, Lindsey M.; DaCosta, Christopher M.; Bardenhagen, Jennifer; Mseeh, Faika; Liu, Qingyun; Nouraldeen, Amr; Wilson, Alan G. E.; Kimball, S. David; Powell, David R.; Rawlins, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6201-6204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prevalence of diabetes throughout the world continues to increase and has become a major health issue.  Recently there have been several reports of inhibitors directed toward the sodium-dependent glucose cotransporter 2 (SGLT2) as a method of maintaining glucose homeostasis in diabetic patients.  Herein we report the discovery of the novel O-xyloside 7c (I) that inhibits SGLT2 in vitro and urinary glucose reabsorption in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCyi0ZZIAswLVg90H21EOLACvtfcHk0lirG4TXtIJ7PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltb3O&md5=120dfc29a33db5857cb6876b35b9edf4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm900951n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900951n%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DN.%2BC.%26aulast%3DMabon%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DShadoan%26aufirst%3DM.%2BK.%26aulast%3DAlmstead%26aufirst%3DZ.%2BY.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHealy%26aufirst%3DJ.%26aulast%3DBuhring%26aufirst%3DL.%2BM.%26aulast%3DDaCosta%26aufirst%3DC.%2BM.%26aulast%3DBardenhagen%26aufirst%3DJ.%26aulast%3DMseeh%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DNouraldeen%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DA.%2BG.%2BE.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26atitle%3DNovel%2520l-xylose%2520derivatives%2520as%2520selective%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520%2528SGLT2%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6201%26epage%3D6204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boustany-Kari, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klenotic, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leininger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masterson, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Préville, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobol, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steppan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuma, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugnait, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span> </span><span class="NLM_article-title">Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2952</span><span class="NLM_x">–</span> <span class="NLM_lpage">2960</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200049r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2952-2960&author=V.+Mascittiauthor=T.+S.+Maurerauthor=R.+P.+Robinsonauthor=J.+Bianauthor=C.+M.+Boustany-Kariauthor=T.+Brandtauthor=B.+M.+Collmanauthor=A.+S.+Kalgutkarauthor=M.+K.+Klenoticauthor=M.+T.+Leiningerauthor=A.+Loweauthor=R.+J.+Maguireauthor=V.+M.+Mastersonauthor=Z.+Miaoauthor=E.+Mukaiyamaauthor=J.+D.+Patelauthor=J.+C.+Pettersenauthor=C.+Pr%C3%A9villeauthor=B.+Samasauthor=L.+Sheauthor=Z.+Sobolauthor=C.+M.+Steppanauthor=B.+D.+Stevensauthor=B.+A.+Thumaauthor=M.+Tugnaitauthor=D.+Zengauthor=T.+Zhu&title=Discovery+of+a+clinical+candidate+from+the+structurally+unique+dioxa-bicyclo%5B3.2.1%5Doctane+class+of+sodium-dependent+glucose+cotransporter+2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm200049r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200049r%26sid%3Dliteratum%253Aachs%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DBoustany-Kari%26aufirst%3DC.%2BM.%26aulast%3DBrandt%26aufirst%3DT.%26aulast%3DCollman%26aufirst%3DB.%2BM.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKlenotic%26aufirst%3DM.%2BK.%26aulast%3DLeininger%26aufirst%3DM.%2BT.%26aulast%3DLowe%26aufirst%3DA.%26aulast%3DMaguire%26aufirst%3DR.%2BJ.%26aulast%3DMasterson%26aufirst%3DV.%2BM.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DMukaiyama%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DJ.%2BD.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DPr%25C3%25A9ville%26aufirst%3DC.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DShe%26aufirst%3DL.%26aulast%3DSobol%26aufirst%3DZ.%26aulast%3DSteppan%26aufirst%3DC.%2BM.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DTugnait%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520clinical%2520candidate%2520from%2520the%2520structurally%2520unique%2520dioxa-bicyclo%255B3.2.1%255Doctane%2520class%2520of%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2952%26epage%3D2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welihinda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechanic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2Fj.phrs.2011.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Wltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=284-293&author=W.+Zhangauthor=A.+Welihindaauthor=J.+Mechanicauthor=H.+Dingauthor=L.+Zhuauthor=Y.+Luauthor=Z.+Dengauthor=Z.+Shengauthor=B.+Lvauthor=Y.+Chenauthor=J.+Y.+Robergeauthor=B.+Seedauthor=Y.+Wang&title=EGT1442%2C+a+potent+and+selective+SGLT2+inhibitor%2C+attenuates+blood+glucose+and+HbA1c+levels+in+db%2Fdb+mice+and+prolongs+the+survival+of+stroke-prone+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats</span></div><div class="casAuthors">Zhang, Wenbin; Welihinda, Ajith; Mechanic, Jordan; Ding, Haifeng; Zhu, Liangcheng; Lu, Yuan; Deng, Zhongping; Sheng, Zelin; Lv, Binhua; Chen, Yuanwei; Roberge, Jacques Y.; Seed, Brian; Wang, Yong-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sodium glucose co-transporter 2 (SGLT2) is a renal type III integral membrane protein that co-transports sodium and glucose from filtrate to epithelium in the proximal tubule.  Human subjects with homozygous or compd. heterozygous mutations in SLC5A2 exhibit glucosuria without hypoglycemia or other obvious morbidity, suggesting that blockade of SGLT2 has the potential to promote normalization of blood glucose without hypoglycemia in the setting of type 2 diabetes.  This report presents the in vitro and in vivo pharmacol. activities of EGT1442, a recently discovered SGLT2 inhibitor in the C-aryl glucoside class.  The inhibitory effects of EGT1442 for human SGLT1 and SGLT2 were evaluated in an AMG uptake assay and the in vivo efficacy of treatment with EGT1442 was investigated in rats and dogs after a single dose and in db/db mice after chronic administration.  The effect of EGT1442 on median survival of SHRSP rats was also evaluated.  The IC50 values for EGT1442 against human SGLT1 and SGLT2 are 5.6 μM and 2 nM, resp.  In normal rats and dogs a saturable urinary glucose excretion was produced with an ED50 of 0.38 and 0.09 mg/kg, resp.  Following chronic administration to db/db mice, EGT1442 dose-dependently reduced HbA1c and blood glucose concn. without affecting body mass or insulin level.  Addnl., EGT1442 significantly prolonged the median survival of SHRSP rats.  EGT1442 showed favorable properties both in vitro and in vivo and could be beneficial to the management of type 2 diabetic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwfZffvAqMWLVg90H21EOLACvtfcHk0lhAInsxSUVENA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Wltb8%253D&md5=f89fa5f6bb03598d318ba6287bece6aa</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2011.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2011.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWelihinda%26aufirst%3DA.%26aulast%3DMechanic%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DLv%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DSeed%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DEGT1442%252C%2520a%2520potent%2520and%2520selective%2520SGLT2%2520inhibitor%252C%2520attenuates%2520blood%2520glucose%2520and%2520HbA1c%2520levels%2520in%2520db%252Fdb%2520mice%2520and%2520prolongs%2520the%2520survival%2520of%2520stroke-prone%2520rats%26jtitle%3DPharmacol.%2520Res.%26date%3D2011%26volume%3D63%26spage%3D284%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Cai, M.; Liu, Q.; Xu, G.; Lv, B.; Seed, B.; Roberge, J. Y.</span><span> </span><span class="NLM_article-title">Crystalline form of benzylbenzene SGLT2 inhibitor</span>. PCT Int. Appl. WO2011153953, 2011.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cai%2C+M.%3B+Liu%2C+Q.%3B+Xu%2C+G.%3B+Lv%2C+B.%3B+Seed%2C+B.%3B+Roberge%2C+J.+Y.+Crystalline+form+of+benzylbenzene+SGLT2+inhibitor.+PCT+Int.+Appl.+WO2011153953%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DM.%26atitle%3DCrystalline%2520form%2520of%2520benzylbenzene%2520SGLT2%2520inhibitor" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Mayer, P.</span><span> </span><span class="NLM_article-title">Chances and risks of SGLT2 inhibitors</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1-4&author=P.+Mayer&title=Chances+and+risks+of+SGLT2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DP.%26atitle%3DChances%2520and%2520risks%2520of%2520SGLT2%2520inhibitors%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2011%26spage%3D1%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Dahl, S. G.</span><span> </span><span class="NLM_article-title">Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects</span> <span class="citation_source-journal">Ther. Drug Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1097%2F00007691-198204000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=6122292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaL38Xks1GktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1982&pages=33-40&author=S.+G.+Dahl&title=Active+metabolites+of+neuroleptic+drugs%3A+possible+contribution+to+therapeutic+and+toxic+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Active metabolites of neuroleptic drugs:  possible contribution to therapeutic and toxic effects</span></div><div class="casAuthors">Dahl, Svein G.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Drug Monitoring</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">TDMODV</span>;
        ISSN:<span class="NLM_cas:issn">0163-4356</span>.
    </div><div class="casAbstract">A review and discussion with 43 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogZx9aJ1HshLVg90H21EOLACvtfcHk0li2xXZ2a4z3JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xks1GktLk%253D&md5=96c8b59bcdfd3ffc373cac297bf63698</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1097%2F00007691-198204000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007691-198204000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%26aufirst%3DS.%2BG.%26atitle%3DActive%2520metabolites%2520of%2520neuroleptic%2520drugs%253A%2520possible%2520contribution%2520to%2520therapeutic%2520and%2520toxic%2520effects%26jtitle%3DTher.%2520Drug%2520Monit.%26date%3D1982%26volume%3D4%26spage%3D33%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Rogan, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badawi, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devanesan, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meza, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higginbotham, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalieri, E. L.</span><span> </span><span class="NLM_article-title">Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: Potential biomarkers of susceptibility to cancer</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=697-702&author=E.+G.+Roganauthor=A.+F.+Badawiauthor=P.+D.+Devanesanauthor=J.+L.+Mezaauthor=J.+A.+Edneyauthor=W.+W.+Westauthor=S.+M.+Higginbothamauthor=E.+L.+Cavalieri&title=Relative+imbalances+in+estrogen+metabolism+and+conjugation+in+breast+tissue+of+women+with+carcinoma%3A+Potential+biomarkers+of+susceptibility+to+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRogan%26aufirst%3DE.%2BG.%26aulast%3DBadawi%26aufirst%3DA.%2BF.%26aulast%3DDevanesan%26aufirst%3DP.%2BD.%26aulast%3DMeza%26aufirst%3DJ.%2BL.%26aulast%3DEdney%26aufirst%3DJ.%2BA.%26aulast%3DWest%26aufirst%3DW.%2BW.%26aulast%3DHigginbotham%26aufirst%3DS.%2BM.%26aulast%3DCavalieri%26aufirst%3DE.%2BL.%26atitle%3DRelative%2520imbalances%2520in%2520estrogen%2520metabolism%2520and%2520conjugation%2520in%2520breast%2520tissue%2520of%2520women%2520with%2520carcinoma%253A%2520Potential%2520biomarkers%2520of%2520susceptibility%2520to%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2003%26volume%3D24%26spage%3D697%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworetzky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivarao, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tertyshnikova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoeckler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M. W.</span><span> </span><span class="NLM_article-title">Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: Identification of (S)-N-[1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl]-3-(4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3778</span><span class="NLM_x">–</span> <span class="NLM_lpage">3781</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034111v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3778-3781&author=Y.+Wuauthor=C.+D.+Davisauthor=S.+Dworetzkyauthor=W.+C.+Fitzpatrickauthor=D.+Hardenauthor=H.+Heauthor=R.+J.+Knoxauthor=A.+E.+Newtonauthor=T.+Philipauthor=C.+Polsonauthor=D.+V.+Sivaraoauthor=L.+Sunauthor=S.+Tertyshnikovaauthor=D.+Weaverauthor=S.+Yeolaauthor=M.+Zoecklerauthor=M.+W.+Sinz&title=Fluorine+substitution+can+block+CYP3A4+metabolism-dependent+inhibition%3A+Identification+of+%28S%29-N-%5B1-%284-fluoro-3-morpholin-4-ylphenyl%29ethyl%5D-3-%284-fluorophenyl%29acrylamide+as+an+orally+bioavailable+KCNQ2+opener+devoid+of+CYP3A4+metabolism-dependent+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm034111v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034111v%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDavis%26aufirst%3DC.%2BD.%26aulast%3DDworetzky%26aufirst%3DS.%26aulast%3DFitzpatrick%26aufirst%3DW.%2BC.%26aulast%3DHarden%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DNewton%26aufirst%3DA.%2BE.%26aulast%3DPhilip%26aufirst%3DT.%26aulast%3DPolson%26aufirst%3DC.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTertyshnikova%26aufirst%3DS.%26aulast%3DWeaver%26aufirst%3DD.%26aulast%3DYeola%26aufirst%3DS.%26aulast%3DZoeckler%26aufirst%3DM.%26aulast%3DSinz%26aufirst%3DM.%2BW.%26atitle%3DFluorine%2520substitution%2520can%2520block%2520CYP3A4%2520metabolism-dependent%2520inhibition%253A%2520Identification%2520of%2520%2528S%2529-N-%255B1-%25284-fluoro-3-morpholin-4-ylphenyl%2529ethyl%255D-3-%25284-fluorophenyl%2529acrylamide%2520as%2520an%2520orally%2520bioavailable%2520KCNQ2%2520opener%2520devoid%2520of%2520CYP3A4%2520metabolism-dependent%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3778%26epage%3D3781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Benz, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsriku, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, G. K.</span><span> </span><span class="NLM_article-title">Novel pathways associated with quinone-induced stress in breast cancer cells</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1080%2F03602530600959391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=17145690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCnur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=601-613&author=C.+C.+Benzauthor=C.+Atsrikuauthor=C.+Yauauthor=D.+Brittonauthor=B.+Schillingauthor=B.+W.+Gibsonauthor=M.+A.+Baldwinauthor=G.+K.+Scott&title=Novel+pathways+associated+with+quinone-induced+stress+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel pathways associated with quinone-induced stress in breast cancer cells</span></div><div class="casAuthors">Benz, Christopher C.; Atsriku, Christian; Yau, Christina; Britton, David; Schilling, Birgit; Gibson, Bradford W.; Baldwin, Michael A.; Scott, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-613</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Hormone-dependent breast cancers that overexpress the ligand-binding nuclear transcription factor, estrogen receptor (ER), represent the most common form of breast epithelial malignancy.  Exposure of breast epithelial cells to a redox-cycling and arylating quinone induces mitogen-activated protein kinase phosphorylation of the cytoskeletal filament protein, cytokeratin-8, along with thiol arylation of H3 nuclear histones.  Exogenous or endogenous quinones can also induce ligand-independent nuclear translocation and phosphorylation of ER; with excess exposure, these quinones can arylate ER zinc fingers, impairing ER DNA-binding and altering ER-inducible gene expression.  Immunoaffinity enrichment for low abundance proteins such as ER, coupled with modern mass spectrometry techniques, promises to improve understanding of the protein-modifications produced by endogenous and exogenous quinone exposure and their role in the development or progression of epithelial malignancies such as breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHRQrQ26pwCLVg90H21EOLACvtfcHk0li961EDrWqpqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCnur7O&md5=833ab1c5127c9598e94adfd5db8e5386</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F03602530600959391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03602530600959391%26sid%3Dliteratum%253Aachs%26aulast%3DBenz%26aufirst%3DC.%2BC.%26aulast%3DAtsriku%26aufirst%3DC.%26aulast%3DYau%26aufirst%3DC.%26aulast%3DBritton%26aufirst%3DD.%26aulast%3DSchilling%26aufirst%3DB.%26aulast%3DGibson%26aufirst%3DB.%2BW.%26aulast%3DBaldwin%26aufirst%3DM.%2BA.%26aulast%3DScott%26aufirst%3DG.%2BK.%26atitle%3DNovel%2520pathways%2520associated%2520with%2520quinone-induced%2520stress%2520in%2520breast%2520cancer%2520cells%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2006%26volume%3D38%26spage%3D601%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Yao, M.; Cao, K.; Zhang, D.; Rodrigues, D.; Humphreys, W. G.; Zhu, M.</span><span> </span><span class="NLM_article-title">Identification of the human UDP-glucuronosyltransferase enzymes involved in glucuronidation of dapagliflozin</span>. <span class="NLM_conf-name">American Association of Pharmaceutical Scientists Annual Meeting</span>, <span class="NLM_conf-loc">Los Angeles, CA</span>, <span class="NLM_conf-date">November 8–12</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span> <span class="NLM_fpage">T3130</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=T3130&conference=American+Association+of+Pharmaceutical+Scientists+Annual+Meeting&author=M.+Yao&author=K.+Cao&author=D.+Zhang&author=D.+Rodrigues&author=W.+G.+Humphreys&author=M.+Zhu&title=Identification+of+the+human+UDP-glucuronosyltransferase+enzymes+involved+in+glucuronidation+of+dapagliflozin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520the%2520human%2520UDP-glucuronosyltransferase%2520enzymes%2520involved%2520in%2520glucuronidation%2520of%2520dapagliflozin%26date%3D2009%26spage%3DT3130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Obermeier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koplowitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komoroski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasichayanula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discenza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span> </span><span class="NLM_article-title">In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II (SGLT2) inhibitor, in animals and humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=405-414&author=M.+Obermeierauthor=M.+Yaoauthor=A.+Khannaauthor=B.+Koplowitzauthor=M.+Zhuauthor=W.+Liauthor=B.+Komoroskiauthor=S.+Kasichayanulaauthor=L.+Discenzaauthor=W.+Washburnauthor=W.+Mengauthor=B.+A.+Ellsworthauthor=J.+M.+Whaleyauthor=W.+G.+Humphreys&title=In+vitro+characterization+and+pharmacokinetics+of+dapagliflozin+%28BMS-512148%29%2C+a+potent+sodium-glucose+cotransporter+type+II+%28SGLT2%29+inhibitor%2C+in+animals+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermeier%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DM.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DKoplowitz%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKomoroski%26aufirst%3DB.%26aulast%3DKasichayanula%26aufirst%3DS.%26aulast%3DDiscenza%26aufirst%3DL.%26aulast%3DWashburn%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26aulast%3DWhaley%26aufirst%3DJ.%2BM.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26atitle%3DIn%2520vitro%2520characterization%2520and%2520pharmacokinetics%2520of%2520dapagliflozin%2520%2528BMS-512148%2529%252C%2520a%2520potent%2520sodium-glucose%2520cotransporter%2520type%2520II%2520%2528SGLT2%2529%2520inhibitor%252C%2520in%2520animals%2520and%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D405%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0li961EDrWqpqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Maltais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanoury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shawgo, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Town, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brummel, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazhanisamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span> </span><span class="NLM_article-title">In vitro and in vivo isotope effects with hepatitis C protease inhibitors: Enhanced plasma exposure of deuterated telaprevir versus telaprevir in rats</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">8001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=4993-8001&author=F.+Maltaisauthor=Y.+C.+Jungauthor=M.+Chenauthor=J.+Tanouryauthor=R.+B.+Perniauthor=N.+Maniauthor=L.+Laitinenauthor=H.+Huangauthor=S.+Liaoauthor=H.+Gaoauthor=H.+Tsaoauthor=E.+Blockauthor=C.+Maauthor=R.+S.+Shawgoauthor=C.+Townauthor=C.+L.+Brummelauthor=D.+Howeauthor=S.+Pazhanisamyauthor=S.+Raybuckauthor=M.+Namchukauthor=Y.+L.+Bennani&title=In+vitro+and+in+vivo+isotope+effects+with+hepatitis+C+protease+inhibitors%3A+Enhanced+plasma+exposure+of+deuterated+telaprevir+versus+telaprevir+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DJung%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DLaitinen%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DTsao%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DE.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DShawgo%26aufirst%3DR.%2BS.%26aulast%3DTown%26aufirst%3DC.%26aulast%3DBrummel%26aufirst%3DC.%2BL.%26aulast%3DHowe%26aufirst%3DD.%26aulast%3DPazhanisamy%26aufirst%3DS.%26aulast%3DRaybuck%26aufirst%3DS.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520isotope%2520effects%2520with%2520hepatitis%2520C%2520protease%2520inhibitors%253A%2520Enhanced%2520plasma%2520exposure%2520of%2520deuterated%2520telaprevir%2520versus%2520telaprevir%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D52%26spage%3D4993%26epage%3D8001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Sanderson, K.</span><span> </span><span class="NLM_article-title">Big interest in heavy drugs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1038%2F458269a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=19295573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlynsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=269&author=K.+Sanderson&title=Big+interest+in+heavy+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Big interest in heavy drugs</span></div><div class="casAuthors">Sanderson, Katharine</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7236</span>),
    <span class="NLM_cas:pages">269</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA-NMuykVs_7Vg90H21EOLACvtfcHk0lg4wAMewvsrDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlynsbg%253D&md5=da6280b542e188604884ca4b43e925c6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2F458269a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F458269a%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DK.%26atitle%3DBig%2520interest%2520in%2520heavy%2520drugs%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Yarnell, A. T.</span><span> </span><span class="NLM_article-title">Heavy-hydrogen drugs turn heads, again. Firms seek to improve drug candidates by selective deuterium substitution</span> <span class="citation_source-journal">Chem. Eng. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/doi/10.1021/cen-v087n025.p036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=36-39&author=A.+T.+Yarnell&title=Heavy-hydrogen+drugs+turn+heads%2C+again.+Firms+seek+to+improve+drug+candidates+by+selective+deuterium+substitution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcen-v087n025.p036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcen-v087n025.p036%26sid%3Dliteratum%253Aachs%26aulast%3DYarnell%26aufirst%3DA.%2BT.%26atitle%3DHeavy-hydrogen%2520drugs%2520turn%2520heads%252C%2520again.%2520Firms%2520seek%2520to%2520improve%2520drug%2520candidates%2520by%2520selective%2520deuterium%2520substitution%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2009%26volume%3D87%26spage%3D36%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Schneider, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillgenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koytchev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alken, R.-G.</span><span> </span><span class="NLM_article-title">Enhanced plasma concentration by selective deuteration of rofecoxib in rats</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=16724516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD28XltF2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2006&pages=295-300&author=F.+Schneiderauthor=M.+Hillgenbergauthor=R.+Koytchevauthor=R.-G.+Alken&title=Enhanced+plasma+concentration+by+selective+deuteration+of+rofecoxib+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced plasma concentration by selective deuteration of rofecoxib in rats</span></div><div class="casAuthors">Schneider, Frank; Hillgenberg, Moritz; Koytchev, Rossen; Alken, Rudolf-Giesbert</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel Forschung</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-300</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">The plasma concns. of BDD-11602 (4-[4-(methanesulfonyl)phenyl]-3-(pentadeuterophenyl)-5H-furan-2-one), a rofecoxib deriv. in which the positions 2', 3', 4', 5' and 6' of the Ph ring were deuterated, and rofecoxib (4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one, CAS 162011-90-7) were compared in order to explore the effects of selective deuteration on the systemic bioavailability.  The COX-2 selectivity in vitro was also compared.  Following oral gavage administration of 0.1, 1 or 10 mg/kg BDD-11602 to Sprague Dawley rats, AUCo-t (area under the curve) and Cmax (max. concn.) values were statistically significant higher than those of rofecoxib at the same doses.  The overall increase in AUCo-t and Cmax for BDD-11602 over rofecoxib was 1.53-fold and 1.60-fold, resp.  BDD-11602 and rofecoxib inhibited COX-2-derived PGE(2) synthesis with IC50 values of 173 nmol/1 and 169 nmol/1, resp.  IC50 values for inhibition of human platelet COX-1 were estd. to be above 1 μmol/l for both compds.  The substitution of hydrogen by deuterium on the positions 2', 3', 4', 5' and 6' in BDD-11602 leads to superior oral availability compared to the non-deuterated compd., whereas the COX-2 selectivity is not affected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLsIVPsmwYBrVg90H21EOLACvtfcHk0lg4wAMewvsrDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltF2hurY%253D&md5=55f8165f69f41ed6113c6761297a1fd1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DHillgenberg%26aufirst%3DM.%26aulast%3DKoytchev%26aufirst%3DR.%26aulast%3DAlken%26aufirst%3DR.-G.%26atitle%3DEnhanced%2520plasma%2520concentration%2520by%2520selective%2520deuteration%2520of%2520rofecoxib%2520in%2520rats%26jtitle%3DArzneim.%2520Forsch.%26date%3D2006%26volume%3D56%26spage%3D295%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Buteau, K. C.</span><span> </span><span class="NLM_article-title">Deuterated drugs: Unexpectedly nonobvious?</span> <span class="citation_source-journal">J. High Tech. Law</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=22-74&author=K.+C.+Buteau&title=Deuterated+drugs%3A+Unexpectedly+nonobvious%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButeau%26aufirst%3DK.%2BC.%26atitle%3DDeuterated%2520drugs%253A%2520Unexpectedly%2520nonobvious%253F%26jtitle%3DJ.%2520High%2520Tech.%2520Law%26date%3D2009%26spage%3D22%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Seed, B.; Lv, B.; Roberge, J. Y.; Chen, Y.; Peng, K.; Dong, J.; Xu, B.; Du, J.; Zhang, L.; Tang, X.; Xu, G.; Feng, Y.; Xu, M.</span><span> </span><span class="NLM_article-title">Deuterated benzylbenzene derivatives and methods of use</span>. PCT Int. Appl. WO2010009243,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Seed&author=B.+Lv&author=J.+Y.+Roberge&author=Y.+Chen&author=K.+Peng&author=J.+Dong&author=B.+Xu&author=J.+Du&author=L.+Zhang&author=X.+Tang&author=G.+Xu&author=Y.+Feng&author=M.+Xu&title=Deuterated+benzylbenzene+derivatives+and+methods+of+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSeed%26aufirst%3DB.%26atitle%3DDeuterated%2520benzylbenzene%2520derivatives%2520and%2520methods%2520of%2520use%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Smonou, I.</span><span> </span><span class="NLM_article-title">One step reduction of diaryl ketones to hydrocarbons by etherated boron trifluoride-triethylsilane system</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1080%2F00397919408010207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaK2cXltVyjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=1999-2002&author=I.+Smonou&title=One+step+reduction+of+diaryl+ketones+to+hydrocarbons+by+etherated+boron+trifluoride-triethylsilane+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">One step reduction of diaryl ketones to hydrocarbons by etherated boron trifluoride-triethylsilane system</span></div><div class="casAuthors">Smonou, Ioulia</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1999-2002</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">A convenient one-step redn. of diaryl ketones to hydrocarbons using etherated B trifluoride-triethylsilane is described.  This method also works with aryl ketones bearing strongly electron-withdrawing substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMfYLQpY0JYrVg90H21EOLACvtfcHk0liwJMnHbOYPkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVyjtLY%253D&md5=c3fc47455dd030a5dea219f1ea0c2685</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1080%2F00397919408010207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919408010207%26sid%3Dliteratum%253Aachs%26aulast%3DSmonou%26aufirst%3DI.%26atitle%3DOne%2520step%2520reduction%2520of%2520diaryl%2520ketones%2520to%2520hydrocarbons%2520by%2520etherated%2520boron%2520trifluoride-triethylsilane%2520system%26jtitle%3DSynth.%2520Commun.%26date%3D1994%26volume%3D24%26spage%3D1999%26epage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Nordlander, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balk, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laikos, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwanath, V. M.</span><span> </span><span class="NLM_article-title">Friedel–Crafts acylation with N-(trifluoroacetyl)-Cu-amino acid chlorides. Application to the preparation of β-arylalkylamines and 3-substituted 1,2,3,4-tetrahydroisoquinolines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4107</span><span class="NLM_x">–</span> <span class="NLM_lpage">4111</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00196a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=4107-4111&author=J.+E.+Nordlanderauthor=M.+J.+Payneauthor=F.+Njorogeauthor=M.+A.+Balkauthor=G.+D.+Laikosauthor=V.+M.+Vishwanath&title=Friedel%E2%80%93Crafts+acylation+with+N-%28trifluoroacetyl%29-Cu-amino+acid+chlorides.+Application+to+the+preparation+of+%CE%B2-arylalkylamines+and+3-substituted+1%2C2%2C3%2C4-tetrahydroisoquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo00196a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00196a001%26sid%3Dliteratum%253Aachs%26aulast%3DNordlander%26aufirst%3DJ.%2BE.%26aulast%3DPayne%26aufirst%3DM.%2BJ.%26aulast%3DNjoroge%26aufirst%3DF.%26aulast%3DBalk%26aufirst%3DM.%2BA.%26aulast%3DLaikos%26aufirst%3DG.%2BD.%26aulast%3DVishwanath%26aufirst%3DV.%2BM.%26atitle%3DFriedel%25E2%2580%2593Crafts%2520acylation%2520with%2520N-%2528trifluoroacetyl%2529-Cu-amino%2520acid%2520chlorides.%2520Application%2520to%2520the%2520preparation%2520of%2520%25CE%25B2-arylalkylamines%2520and%25203-substituted%25201%252C2%252C3%252C4-tetrahydroisoquinolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D4107%26epage%3D4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Davis, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of the AB ring segments of daunomycin and 4-demethoxydaunomycin</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00084a042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=1184-1190&author=F.+A.+Davisauthor=C.+Clarkauthor=A.+Kumarauthor=B.-C.+Chen&title=Asymmetric+synthesis+of+the+AB+ring+segments+of+daunomycin+and+4-demethoxydaunomycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjo00084a042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00084a042%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DF.%2BA.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DB.-C.%26atitle%3DAsymmetric%2520synthesis%2520of%2520the%2520AB%2520ring%2520segments%2520of%2520daunomycin%2520and%25204-demethoxydaunomycin%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D1184%26epage%3D1190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Sandanayaka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krohn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyvan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enache, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onua, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldorsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigthorsdottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorlaksdottir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigthorsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinnsdottir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembower, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andresson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselyov, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900838g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=573-585&author=V.+Sandanayakaauthor=B.+Mamatauthor=R.+K.+Mishraauthor=J.+Wingerauthor=M.+Krohnauthor=L.+Zhouauthor=M.+Keyvanauthor=L.+Enacheauthor=D.+Sullinsauthor=E.+Onuaauthor=J.+Zhangauthor=G.+Halldorsdottirauthor=H.+Sigthorsdottirauthor=A.+Thorlaksdottirauthor=G.+Sigthorssonauthor=M.+Thorsteinnsdottirauthor=D.+R.+Daviesauthor=L.+J.+Stewartauthor=D.+E.+Zembowerauthor=T.+Andressonauthor=A.+S.+Kiselyovauthor=J.+Singhauthor=M.+E.+Gurney&title=Discovery+of+4-%5B%282S%29-2-%7B%5B4-%284-chlorophenoxy%29phenoxy%5Dmethyl%7D-1-pyrrolidinyl%5Dbutanoic+acid+%28DG-051%29+as+a+novel+leukotriene+A4+hydrolase+inhibitor+of+leukotriene+B4+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm900838g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900838g%26sid%3Dliteratum%253Aachs%26aulast%3DSandanayaka%26aufirst%3DV.%26aulast%3DMamat%26aufirst%3DB.%26aulast%3DMishra%26aufirst%3DR.%2BK.%26aulast%3DWinger%26aufirst%3DJ.%26aulast%3DKrohn%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DKeyvan%26aufirst%3DM.%26aulast%3DEnache%26aufirst%3DL.%26aulast%3DSullins%26aufirst%3DD.%26aulast%3DOnua%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHalldorsdottir%26aufirst%3DG.%26aulast%3DSigthorsdottir%26aufirst%3DH.%26aulast%3DThorlaksdottir%26aufirst%3DA.%26aulast%3DSigthorsson%26aufirst%3DG.%26aulast%3DThorsteinnsdottir%26aufirst%3DM.%26aulast%3DDavies%26aufirst%3DD.%2BR.%26aulast%3DStewart%26aufirst%3DL.%2BJ.%26aulast%3DZembower%26aufirst%3DD.%2BE.%26aulast%3DAndresson%26aufirst%3DT.%26aulast%3DKiselyov%26aufirst%3DA.%2BS.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%25204-%255B%25282S%2529-2-%257B%255B4-%25284-chlorophenoxy%2529phenoxy%255Dmethyl%257D-1-pyrrolidinyl%255Dbutanoic%2520acid%2520%2528DG-051%2529%2520as%2520a%2520novel%2520leukotriene%2520A4%2520hydrolase%2520inhibitor%2520of%2520leukotriene%2520B4%2520biosynthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D573%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Guthikonda, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cama, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzmann, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, B. G.</span><span> </span><span class="NLM_article-title">Structure–activity relationships in the 2-arylcarbapenem series: Synthesis of 1-methyl-2-arylcarbapenems</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00388a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=871-880&author=R.+N.+Guthikondaauthor=L.+D.+Camaauthor=M.+Quesadaauthor=M.+F.+Woodsauthor=T.+N.+Salzmannauthor=B.+G.+Christensen&title=Structure%E2%80%93activity+relationships+in+the+2-arylcarbapenem+series%3A+Synthesis+of+1-methyl-2-arylcarbapenems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm00388a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00388a022%26sid%3Dliteratum%253Aachs%26aulast%3DGuthikonda%26aufirst%3DR.%2BN.%26aulast%3DCama%26aufirst%3DL.%2BD.%26aulast%3DQuesada%26aufirst%3DM.%26aulast%3DWoods%26aufirst%3DM.%2BF.%26aulast%3DSalzmann%26aufirst%3DT.%2BN.%26aulast%3DChristensen%26aufirst%3DB.%2BG.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520in%2520the%25202-arylcarbapenem%2520series%253A%2520Synthesis%2520of%25201-methyl-2-arylcarbapenems%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D871%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Horton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priebe, W.</span><span> </span><span class="NLM_article-title">Synthetic routes to higher-carbon sugars. Reaction of lactones with 2-lithio-1,3-dithiane</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2FS0008-6215%2800%2985593-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaL3MXmtVCgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1981&pages=27-41&author=D.+Hortonauthor=W.+Priebe&title=Synthetic+routes+to+higher-carbon+sugars.+Reaction+of+lactones+with+2-lithio-1%2C3-dithiane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic routes to higher-carbon sugars.  Reaction of lactones with 2-lithio-1,3-dithiane</span></div><div class="casAuthors">Horton, Derek; Priebe, Waldemar</div><div class="citationInfo"><span class="NLM_cas:title">Carbohydrate Research</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-41</span>CODEN:
                <span class="NLM_cas:coden">CRBRAT</span>;
        ISSN:<span class="NLM_cas:issn">0008-6215</span>.
    </div><div class="casAbstract">The per(trimethylsilyl) ether of D-glucono-1,5-lactone reacted with 2-lithio-1,3-dithiane to give, after removal of protecting groups 62% dithianylglucopyranose (I) as a single tautomer; this product is formally a deriv. of a 7-carbon, 1,2-dicarbonyl sugar.  The cryst. 2,3,4,6-tetraacetate (II) of I was readily obtained, again as a single tautomer, and forcing conditions of acetylation led to the acyclic, enol hexaacetate in admixt. with the cyclic pentaacetate (III) of I.  Desulfurization of II with Raney nickel gave 1-deoxy-D-gluco-heptulose as its α-pyranose 3,4,5,7-tetraacetate, whereas similar desulfurization of III was accompanied by removal of the tertiary acetoxy group, providing stereospecific access to the C-β-D-glucosyl compd. 2,6-anhydro-1-deoxy-D-glycero-D-gulo-heptitol as its 3,4,5,7-tetraacetate.  To explore the effects of chain substituents on the tautomeric behavior of the lactone-derived adducts, the simple lactones 5-pentanolide, 4-butanolide, and 4-pentanolide were treated with 2-lithio-1,3-dithiane, and the tautomeric compns. of the products were examd. before and after aceylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozQhppJY48brVg90H21EOLACvtfcHk0lh2x8Tvr_8wtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmtVCgsrg%253D&md5=9d7fd4236865922ae73e144d75fa72b6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0008-6215%2800%2985593-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6215%252800%252985593-7%26sid%3Dliteratum%253Aachs%26aulast%3DHorton%26aufirst%3DD.%26aulast%3DPriebe%26aufirst%3DW.%26atitle%3DSynthetic%2520routes%2520to%2520higher-carbon%2520sugars.%2520Reaction%2520of%2520lactones%2520with%25202-lithio-1%252C3-dithiane%26jtitle%3DCarbohydr.%2520Res.%26date%3D1981%26volume%3D94%26spage%3D27%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Czernecki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ville, G.</span><span> </span><span class="NLM_article-title">C-glycosides. 7. Stereospecific C-glycosylation of aromatic and heterocyclic rings</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00264a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=610-612&author=S.+Czerneckiauthor=G.+Ville&title=C-glycosides.+7.+Stereospecific+C-glycosylation+of+aromatic+and+heterocyclic+rings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo00264a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00264a020%26sid%3Dliteratum%253Aachs%26aulast%3DCzernecki%26aufirst%3DS.%26aulast%3DVille%26aufirst%3DG.%26atitle%3DC-glycosides.%25207.%2520Stereospecific%2520C-glycosylation%2520of%2520aromatic%2520and%2520heterocyclic%2520rings%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D610%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kraus, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, M. T.</span><span> </span><span class="NLM_article-title">A direct synthesis of C-glycosyl compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00239a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaL1cXpsVyntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=752-753&author=G.+A.+Krausauthor=M.+T.+Molina&title=A+direct+synthesis+of+C-glycosyl+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A direct synthesis of c-glycosyl compounds</span></div><div class="casAuthors">Kraus, George A.; Molina, Maria Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">752-3</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">C-Glycosides I (R = Ph, 2-pyridyl, CH2:CH, p-MeOC6H4, p-MeC6H4, m-MeOC6H4) were prepd. in 60-95% yields by treating the lactone II with organometallic reagents in THF followed by redn. with Et3SiH and BF3.Et2O in CH2Cl2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAuoINT8Nwl7Vg90H21EOLACvtfcHk0ljE7O3Yw4oZaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXpsVyntA%253D%253D&md5=0da20fb6b1b53eb49c8f8bb11d643c3b</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo00239a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00239a009%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%2BA.%26aulast%3DMolina%26aufirst%3DM.%2BT.%26atitle%3DA%2520direct%2520synthesis%2520of%2520C-glycosyl%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D752%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, G.</span><span> </span><span class="NLM_article-title">Convergent C-glycolipid synthesis via the Ramberg-Bäcklund reaction: Active antiproliferative glycolipids</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">2149</span><span class="NLM_x">–</span> <span class="NLM_lpage">2151</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol991211f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=2149-2151&author=G.+Yangauthor=R.+W.+Franckauthor=H.-S.+Byunauthor=R.+Bittmanauthor=P.+Samadderauthor=G.+Arthur&title=Convergent+C-glycolipid+synthesis+via+the+Ramberg-B%C3%A4cklund+reaction%3A+Active+antiproliferative+glycolipids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol991211f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol991211f%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DFranck%26aufirst%3DR.%2BW.%26aulast%3DByun%26aufirst%3DH.-S.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DSamadder%26aufirst%3DP.%26aulast%3DArthur%26aufirst%3DG.%26atitle%3DConvergent%2520C-glycolipid%2520synthesis%2520via%2520the%2520Ramberg-B%25C3%25A4cklund%2520reaction%253A%2520Active%2520antiproliferative%2520glycolipids%26jtitle%3DOrg.%2520Lett.%26date%3D1999%26volume%3D1%26spage%3D2149%26epage%3D2151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Oikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, A.</span><span> </span><span class="NLM_article-title">Involvement of Diels–Alder reactions in the biosynthesis of secondary natural products: The late stage of the biosynthesis of the phytotoxins solanapyrones</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1225-1232&author=H.+Oikawaauthor=Y.+Suzukiauthor=K.+Katayamaauthor=A.+Nayaauthor=C.+Sakanoauthor=A.+Ichihara&title=Involvement+of+Diels%E2%80%93Alder+reactions+in+the+biosynthesis+of+secondary+natural+products%3A+The+late+stage+of+the+biosynthesis+of+the+phytotoxins+solanapyrones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOikawa%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DKatayama%26aufirst%3DK.%26aulast%3DNaya%26aufirst%3DA.%26aulast%3DSakano%26aufirst%3DC.%26aulast%3DIchihara%26aufirst%3DA.%26atitle%3DInvolvement%2520of%2520Diels%25E2%2580%2593Alder%2520reactions%2520in%2520the%2520biosynthesis%2520of%2520secondary%2520natural%2520products%253A%2520The%2520late%2520stage%2520of%2520the%2520biosynthesis%2520of%2520the%2520phytotoxins%2520solanapyrones%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1999%26spage%3D1225%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Synthesis of a novel triptycene-based molecular tweezer and its complexation with paraquat derivatives</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol070017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=895-898&author=X.+Pengauthor=H.+Luauthor=T.+Hanauthor=C.+Chen&title=Synthesis+of+a+novel+triptycene-based+molecular+tweezer+and+its+complexation+with+paraquat+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fol070017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol070017n%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520triptycene-based%2520molecular%2520tweezer%2520and%2520its%2520complexation%2520with%2520paraquat%2520derivatives%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D895%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="note"><p class="first last">The published in vitro data for dapagliflozin <b>5</b> give an EC<sub>50</sub> value of 1.1 nM for SGLT2 and a selectivity (<i>h</i>SGLT1/<i>h</i>SGLT2) of 1200-fold (ref <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">22</a>). However, in our assays, we observed a 3.2 nM IC<sub>50</sub> value and 981-fold selectivity for <i>h</i>SGLT2.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 39 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mengnan Lai, Karwan Abdulmajed Othman, Hui Yao, Qiuyuan Wang, Yongkui Feng, Nianyu Huang, Mingguo Liu, <span class="NLM_string-name hlFld-ContribAuthor">Kun Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Open-Air Stereoselective Construction of C-Aryl Glycosides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (3)
                                     , 1144-1148. <a href="https://doi.org/10.1021/acs.orglett.9b04665" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b04665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b04665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b04665%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOpen-Air%252BStereoselective%252BConstruction%252Bof%252BC-Aryl%252BGlycosides%26aulast%3DLai%26aufirst%3DMengnan%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29122019%26date%3D23012020%26volume%3D22%26issue%3D3%26spage%3D1144%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qianwen Gao, Yong Shang, Fuzhen Song, Jinxiang Ye, Ze-Shui Liu, Lisha Li, Hong-Gang Cheng, <span class="NLM_string-name hlFld-ContribAuthor">Qianghui Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Modular Dual-Tasked C–H Methylation via the Catellani Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (40)
                                     , 15986-15993. <a href="https://doi.org/10.1021/jacs.9b07857" title="DOI URL">https://doi.org/10.1021/jacs.9b07857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b07857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b07857%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DModular%252BDual-Tasked%252BC%2525E2%252580%252593H%252BMethylation%252Bvia%252Bthe%252BCatellani%252BStrategy%26aulast%3DGao%26aufirst%3DQianwen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23072019%26date%3D25092019%26date%3D12092019%26volume%3D141%26issue%3D40%26spage%3D15986%26epage%3D15993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tracey Pirali, Marta Serafini, Sarah Cargnin, <span class="NLM_string-name hlFld-ContribAuthor">Armando A. Genazzani</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of Deuterium in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (11)
                                     , 5276-5297. <a href="https://doi.org/10.1021/acs.jmedchem.8b01808" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01808</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01808%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplications%252Bof%252BDeuterium%252Bin%252BMedicinal%252BChemistry%26aulast%3DPirali%26aufirst%3DTracey%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D19112018%26date%3D25012019%26date%3D14012019%26volume%3D62%26issue%3D11%26spage%3D5276%26epage%3D5297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huiling Wen, Chunmei Chen, Weiguang Sun, Yi Zang, Qin Li, Wenxuan Wang, Fanrong Zeng, Junjun Liu, Yuan Zhou, Qun Zhou, Jianping Wang, Zengwei Luo, Hucheng Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Yonghui Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Phenolic C-Glycosides and Aglycones from Marine-Derived Aspergillus sp. and Their Anti-Inflammatory Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2019,</strong> <em>82 </em>
                                    (5)
                                     , 1098-1106. <a href="https://doi.org/10.1021/acs.jnatprod.8b00744" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.8b00744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.8b00744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.8b00744%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DPhenolic%252BC-Glycosides%252Band%252BAglycones%252Bfrom%252BMarine-Derived%252BAspergillus%252Bsp.%252Band%252BTheir%252BAnti-Inflammatory%252BActivities%26aulast%3DWen%26aufirst%3DHuiling%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D01092018%26date%3D23042019%26volume%3D82%26issue%3D5%26spage%3D1098%26epage%3D1106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seth D.  Axen</span>, <span class="hlFld-ContribAuthor ">Xi-Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Elena L.  Cáceres</span>, <span class="hlFld-ContribAuthor ">Leo  Gendelev</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Michael J.  Keiser</span>  . </span><span class="cited-content_cbyCitation_article-title">A Simple Representation of Three-Dimensional Molecular Structure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7393-7409. <a href="https://doi.org/10.1021/acs.jmedchem.7b00696" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BSimple%252BRepresentation%252Bof%252BThree-Dimensional%252BMolecular%252BStructure%26aulast%3DAxen%26aufirst%3DSeth%2BD.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12052017%26date%3D08082017%26date%3D14092017%26date%3D21072017%26volume%3D60%26issue%3D17%26spage%3D7393%26epage%3D7409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Éva  Bokor</span>, <span class="hlFld-ContribAuthor ">Sándor  Kun</span>, <span class="hlFld-ContribAuthor ">David  Goyard</span>, <span class="hlFld-ContribAuthor ">Marietta  Tóth</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Praly</span>, <span class="hlFld-ContribAuthor ">Sébastien  Vidal</span>, and <span class="hlFld-ContribAuthor ">László  Somsák</span>  . </span><span class="cited-content_cbyCitation_article-title">C-Glycopyranosyl Arenes and Hetarenes: Synthetic Methods and Bioactivity Focused on Antidiabetic Potential. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2017,</strong> <em>117 </em>
                                    (3)
                                     , 1687-1764. <a href="https://doi.org/10.1021/acs.chemrev.6b00475" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00475%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DC-Glycopyranosyl%252BArenes%252Band%252BHetarenes%25253A%252BSynthetic%252BMethods%252Band%252BBioactivity%252BFocused%252Bon%252BAntidiabetic%252BPotential%26aulast%3DBokor%26aufirst%3D%25C3%2589va%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D21072016%26date%3D25012017%26date%3D08022017%26volume%3D117%26issue%3D3%26spage%3D1687%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yen-Bo  Chen</span>, <span class="hlFld-ContribAuthor ">Shi-Hao  Liu</span>, <span class="hlFld-ContribAuthor ">Min-Tsang  Hsieh</span>, <span class="hlFld-ContribAuthor ">Chih-Shiang  Chang</span>, <span class="hlFld-ContribAuthor ">Chun-Hung  Lin</span>, <span class="hlFld-ContribAuthor ">Chen-Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Po-Yen  Chen</span>, and <span class="hlFld-ContribAuthor ">Hui-Chang  Lin</span>  . </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of Spiro Bis-C,C-α-arylglycosides by Tandem Heck Type C-Glycosylation and Friedel–Crafts Cyclization. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (7)
                                     , 3007-3016. <a href="https://doi.org/10.1021/acs.joc.5b02891" title="DOI URL">https://doi.org/10.1021/acs.joc.5b02891</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b02891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b02891%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoselective%252BSynthesis%252Bof%252BSpiro%252BBis-C%25252CC-%2525CE%2525B1-arylglycosides%252Bby%252BTandem%252BHeck%252BType%252BC-Glycosylation%252Band%252BFriedel%2525E2%252580%252593Crafts%252BCyclization%26aulast%3DChen%26aufirst%3DYen-Bo%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D30122015%26date%3D22032016%26date%3D01042016%26date%3D17032016%26volume%3D81%26issue%3D7%26spage%3D3007%26epage%3D3016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Wagschal</span>, <span class="hlFld-ContribAuthor ">Johan  Guilbaud</span>, <span class="hlFld-ContribAuthor ">Pauline  Rabet</span>, <span class="hlFld-ContribAuthor ">Vittorio  Farina</span>, and <span class="hlFld-ContribAuthor ">Sébastien  Lemaire</span>  . </span><span class="cited-content_cbyCitation_article-title">α-C-Glycosides via syn Opening of 1,2-Anhydro Sugars with Organozinc Compounds in Toluene/n-Dibutyl Ether. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (18)
                                     , 9328-9335. <a href="https://doi.org/10.1021/acs.joc.5b01472" title="DOI URL">https://doi.org/10.1021/acs.joc.5b01472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b01472%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D%2525CE%2525B1-C-Glycosides%252Bvia%252Bsyn%252BOpening%252Bof%252B1%25252C2-Anhydro%252BSugars%252Bwith%252BOrganozinc%252BCompounds%252Bin%252BToluene%25252Fn-Dibutyl%252BEther%26aulast%3DWagschal%26aufirst%3DSimon%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D29062015%26date%3D08092015%26date%3D18092015%26date%3D18082015%26volume%3D80%26issue%3D18%26spage%3D9328%26epage%3D9335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-jun  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Denis  Byrne</span>, <span class="hlFld-ContribAuthor ">Larry  Nummy</span>, <span class="hlFld-ContribAuthor ">Dirk  Weber</span>, <span class="hlFld-ContribAuthor ">Dhileep  Krishnamurthy</span>, <span class="hlFld-ContribAuthor ">Nathan  Yee</span>, and <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Empagliflozin, an Inhibitor of SGLT-2, Utilizing an AlCl3-Promoted Silane Reduction of a β-Glycopyranoside. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (16)
                                     , 4090-4093. <a href="https://doi.org/10.1021/ol501755h" title="DOI URL">https://doi.org/10.1021/ol501755h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol501755h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol501755h%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEfficient%252BSynthesis%252Bof%252BEmpagliflozin%25252C%252Ban%252BInhibitor%252Bof%252BSGLT-2%25252C%252BUtilizing%252Ban%252BAlCl3-Promoted%252BSilane%252BReduction%252Bof%252Ba%252B%2525CE%2525B2-Glycopyranoside%26aulast%3DWang%26aufirst%3DXiao-jun%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17062014%26date%3D25072014%26date%3D15082014%26volume%3D16%26issue%3D16%26spage%3D4090%26epage%3D4093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunting  Xin</span>, <span class="hlFld-ContribAuthor ">Shuhao  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Wang</span>, <span class="hlFld-ContribAuthor ">Baichun  Hu</span>, <span class="hlFld-ContribAuthor ">Zhigang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Tiemin  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive structure–activity relationship (SAR) investigation of
              C
              -aryl glycoside derivatives for the development of SGLT1/SGLT2 dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>24 </em><a href="https://doi.org/10.1039/D1NJ02510D" title="DOI URL">https://doi.org/10.1039/D1NJ02510D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1NJ02510D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1NJ02510D%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DComprehensive%252Bstructure%2525E2%252580%252593activity%252Brelationship%252B%252528SAR%252529%252Binvestigation%252Bof%252BC%252B-aryl%252Bglycoside%252Bderivatives%252Bfor%252Bthe%252Bdevelopment%252Bof%252BSGLT1%25252FSGLT2%252Bdual%252Binhibitors%26aulast%3DXin%26aufirst%3DYunting%26date%3D2021%26date%3D2021%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiling  Wen</span>, <span class="hlFld-ContribAuthor ">Yi  Zang</span>, <span class="hlFld-ContribAuthor ">Qianheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Sheng  Ouyang</span>, <span class="hlFld-ContribAuthor ">Juanjuan  Luo</span>, <span class="hlFld-ContribAuthor ">Nianhua  Luo</span>, <span class="hlFld-ContribAuthor ">Hucheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Yonghui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Two new phenolic glucosides from marine-derived fungus
              Aspergillus
              sp.. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Research</span><span> <strong>2020,</strong> <em>11 </em>, 1-7. <a href="https://doi.org/10.1080/14786419.2020.1851226" title="DOI URL">https://doi.org/10.1080/14786419.2020.1851226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14786419.2020.1851226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14786419.2020.1851226%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Research%26atitle%3DTwo%252Bnew%252Bphenolic%252Bglucosides%252Bfrom%252Bmarine-derived%252Bfungus%252BAspergillus%252Bsp.%26aulast%3DWen%26aufirst%3DHuiling%26date%3D2020%26date%3D2020%26volume%3D11%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Siyu  Wang</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Huazhou  Ying</span>, <span class="hlFld-ContribAuthor ">Hao  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jinxin  Che</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Gang  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Pharmacokinetic Study of Deuterated Ticagrelor Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (35)
                                     , 10924-10927. <a href="https://doi.org/10.1002/slct.202002605" title="DOI URL">https://doi.org/10.1002/slct.202002605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002605%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BPharmacokinetic%252BStudy%252Bof%252BDeuterated%252BTicagrelor%252BDerivatives%26aulast%3DChen%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D35%26spage%3D10924%26epage%3D10927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayanta  Dowarah</span>, <span class="hlFld-ContribAuthor ">Ved Prakash  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-diabetic drugs recent approaches and advancements. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (5)
                                     , 115263. <a href="https://doi.org/10.1016/j.bmc.2019.115263" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115263%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAnti-diabetic%252Bdrugs%252Brecent%252Bapproaches%252Band%252Badvancements%26aulast%3DDowarah%26aufirst%3DJayanta%26date%3D2020%26volume%3D28%26issue%3D5%26spage%3D115263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan-Fei  Sui</span>. </span><span class="cited-content_cbyCitation_article-title">Supermolecules as Medicinal Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1587-1633. <a href="https://doi.org/10.1007/978-981-15-2686-2_66" title="DOI URL">https://doi.org/10.1007/978-981-15-2686-2_66</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-2686-2_66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-2686-2_66%26sid%3Dliteratum%253Aachs%26atitle%3DSupermolecules%252Bas%252BMedicinal%252BDrugs%26aulast%3DZhou%26aufirst%3DCheng-He%26date%3D2020%26date%3D2020%26spage%3D1587%26epage%3D1633%26pub%3DSpringer%2520Singapore%26atitle%3DHandbook%252Bof%252BMacrocyclic%252BSupramolecular%252BAssembly%26aulast%3DLiu%26aufirst%3DYu%26date%3D2020%26volume%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingxu  Ma</span>, <span class="hlFld-ContribAuthor ">Zhongpeng  Ding</span>, <span class="hlFld-ContribAuthor ">Shixiao  Wang</span>, <span class="hlFld-ContribAuthor ">Lingling  Ma</span>, <span class="hlFld-ContribAuthor ">Yuxi  Wang</span>, <span class="hlFld-ContribAuthor ">Lili  Zhong</span>, <span class="hlFld-ContribAuthor ">Zhongping  Li</span>, <span class="hlFld-ContribAuthor ">Jinliang  Yang</span>, <span class="hlFld-ContribAuthor ">Wenbao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Polymorphs, co-crystal structure and pharmacodynamics study of MBRI-001, a deuterium-substituted plinabulin derivative as a tubulin polymerization inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (9)
                                     , 1836-1844. <a href="https://doi.org/10.1016/j.bmc.2019.03.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPolymorphs%25252C%252Bco-crystal%252Bstructure%252Band%252Bpharmacodynamics%252Bstudy%252Bof%252BMBRI-001%25252C%252Ba%252Bdeuterium-substituted%252Bplinabulin%252Bderivative%252Bas%252Ba%252Btubulin%252Bpolymerization%252Binhibitor%26aulast%3DMa%26aufirst%3DMingxu%26date%3D2019%26volume%3D27%26issue%3D9%26spage%3D1836%26epage%3D1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samridhi  Thakral</span>, <span class="hlFld-ContribAuthor ">Vikramjeet  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2019,</strong> <em>15 </em>
                                    (2)
                                     , 186-195. <a href="https://doi.org/10.2174/1573406414666180924164327" title="DOI URL">https://doi.org/10.2174/1573406414666180924164327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406414666180924164327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406414666180924164327%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3D2%25252C4-Dichloro-5-%25255B%252528N-aryl%25252Falkyl%252529sulfamoyl%25255Dbenzoic%252BAcid%252BDerivatives%25253A%252BIn%252BVitro%252BAntidiabetic%252BActivity%25252C%252BMolecular%252BModeling%252Band%252BIn%252Bsilico%252BADMET%252BScreening%26aulast%3DThakral%26aufirst%3DSamridhi%26date%3D2019%26volume%3D15%26issue%3D2%26spage%3D186%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan-Fei  Sui</span>. </span><span class="cited-content_cbyCitation_article-title">Supermolecules as Medicinal Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-48. <a href="https://doi.org/10.1007/978-981-13-1744-6_66-1" title="DOI URL">https://doi.org/10.1007/978-981-13-1744-6_66-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-1744-6_66-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-1744-6_66-1%26sid%3Dliteratum%253Aachs%26atitle%3DSupermolecules%252Bas%252BMedicinal%252BDrugs%26aulast%3DZhou%26aufirst%3DCheng-He%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D48%26pub%3DSpringer%2520Singapore%26atitle%3DHandbook%252Bof%252BMacrocyclic%252BSupramolecular%252BAssembly%26aulast%3DLiu%26aufirst%3DYu%26date%3D2019%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangying  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxia  Jiang</span>, <span class="hlFld-ContribAuthor ">Yufang  Deng</span>, <span class="hlFld-ContribAuthor ">Jiang  Yu</span>, <span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of deuterated Vismodegib for improving pharmacokinetic properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (14)
                                     , 2399-2402. <a href="https://doi.org/10.1016/j.bmcl.2018.06.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bdeuterated%252BVismodegib%252Bfor%252Bimproving%252Bpharmacokinetic%252Bproperties%26aulast%3DWang%26aufirst%3DFangying%26date%3D2018%26volume%3D28%26issue%3D14%26spage%3D2399%26epage%3D2402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagaraju  Kerru</span>, <span class="hlFld-ContribAuthor ">Ashona  Singh-Pillay</span>, <span class="hlFld-ContribAuthor ">Paul  Awolade</span>, <span class="hlFld-ContribAuthor ">Parvesh  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Current anti-diabetic agents and their molecular targets: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>152 </em>, 436-488. <a href="https://doi.org/10.1016/j.ejmech.2018.04.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252Banti-diabetic%252Bagents%252Band%252Btheir%252Bmolecular%252Btargets%25253A%252BA%252Breview%26aulast%3DKerru%26aufirst%3DNagaraju%26date%3D2018%26volume%3D152%26spage%3D436%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingliang  Wang</span>, <span class="hlFld-ContribAuthor ">Jilai  Han</span>, <span class="hlFld-ContribAuthor ">Xiaojia  Si</span>, <span class="hlFld-ContribAuthor ">Yimin  Hu</span>, <span class="hlFld-ContribAuthor ">Jidong  Zhu</span>, <span class="hlFld-ContribAuthor ">Xun  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Effective approach to ureas through organocatalyzed one-pot process. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (17)
                                     , 1614-1618. <a href="https://doi.org/10.1016/j.tetlet.2017.11.030" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.11.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.11.030%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DEffective%252Bapproach%252Bto%252Bureas%252Bthrough%252Borganocatalyzed%252Bone-pot%252Bprocess%26aulast%3DWang%26aufirst%3DMingliang%26date%3D2018%26volume%3D59%26issue%3D17%26spage%3D1614%26epage%3D1618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens  Atzrodt</span>, <span class="hlFld-ContribAuthor ">Volker  Derdau</span>, <span class="hlFld-ContribAuthor ">William J.  Kerr</span>, <span class="hlFld-ContribAuthor ">Marc  Reid</span>. </span><span class="cited-content_cbyCitation_article-title">Deuterium- und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (7)
                                     , 1774-1802. <a href="https://doi.org/10.1002/ange.201704146" title="DOI URL">https://doi.org/10.1002/ange.201704146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201704146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201704146%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDeuterium-%252Bund%252Btritiummarkierte%252BVerbindungen%25253A%252BAnwendungen%252Bin%252Bden%252Bmodernen%252BBiowissenschaften%26aulast%3DAtzrodt%26aufirst%3DJens%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D7%26spage%3D1774%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens  Atzrodt</span>, <span class="hlFld-ContribAuthor ">Volker  Derdau</span>, <span class="hlFld-ContribAuthor ">William J.  Kerr</span>, <span class="hlFld-ContribAuthor ">Marc  Reid</span>. </span><span class="cited-content_cbyCitation_article-title">Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (7)
                                     , 1758-1784. <a href="https://doi.org/10.1002/anie.201704146" title="DOI URL">https://doi.org/10.1002/anie.201704146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201704146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201704146%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDeuterium-%252Band%252BTritium-Labelled%252BCompounds%25253A%252BApplications%252Bin%252Bthe%252BLife%252BSciences%26aulast%3DAtzrodt%26aufirst%3DJens%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D7%26spage%3D1758%26epage%3D1784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongze  Liao</span>, <span class="hlFld-ContribAuthor ">Jimei  Ma</span>, <span class="hlFld-ContribAuthor ">Hui  Yao</span>, <span class="hlFld-ContribAuthor ">Xue-Wei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress of
              C
              -glycosylation methods in the total synthesis of natural products and pharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (11)
                                     , 1791-1806. <a href="https://doi.org/10.1039/C8OB00032H" title="DOI URL">https://doi.org/10.1039/C8OB00032H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB00032H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB00032H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bof%252BC%252B-glycosylation%252Bmethods%252Bin%252Bthe%252Btotal%252Bsynthesis%252Bof%252Bnatural%252Bproducts%252Band%252Bpharmaceuticals%26aulast%3DLiao%26aufirst%3DHongze%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D11%26spage%3D1791%26epage%3D1806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuewei  Liang</span>, <span class="hlFld-ContribAuthor ">Simon  Duttwyler</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Brønsted-Acid-Catalyzed Deuteration of Arenes and Their Transformation to Functionalized Deuterated Products. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>6 </em>
                                    (8)
                                     , 1063-1071. <a href="https://doi.org/10.1002/ajoc.201700218" title="DOI URL">https://doi.org/10.1002/ajoc.201700218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201700218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201700218%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEfficient%252BBr%2525C3%2525B8nsted-Acid-Catalyzed%252BDeuteration%252Bof%252BArenes%252Band%252BTheir%252BTransformation%252Bto%252BFunctionalized%252BDeuterated%252BProducts%26aulast%3DLiang%26aufirst%3DXuewei%26date%3D2017%26date%3D2017%26volume%3D6%26issue%3D8%26spage%3D1063%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuehai  Pang</span>, <span class="hlFld-ContribAuthor ">Lingling  Peng</span>, <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of
              N
              -methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 401-409. <a href="https://doi.org/10.1002/jlcr.3516" title="DOI URL">https://doi.org/10.1002/jlcr.3516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3516%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DEffect%252Bof%252BN%252B-methyl%252Bdeuteration%252Bon%252Bpharmacokinetics%252Band%252Bpharmacodynamics%252Bof%252Benzalutamide%26aulast%3DPang%26aufirst%3DXuehai%26date%3D2017%26date%3D2017%26volume%3D60%26issue%3D9%26spage%3D401%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianchun  Zhao</span>, <span class="hlFld-ContribAuthor ">Hejuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Tianwen  Sun</span>, <span class="hlFld-ContribAuthor ">Shixiao  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongpeng  Ding</span>, <span class="hlFld-ContribAuthor ">Guifang  Dou</span>, <span class="hlFld-ContribAuthor ">Zhiyun  Meng</span>, <span class="hlFld-ContribAuthor ">Huashi  Guan</span>, <span class="hlFld-ContribAuthor ">Wenbao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacokinetic property improvement of deuterated plinabulin 9. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ocean University of China</span><span> <strong>2017,</strong> <em>16 </em>
                                    (2)
                                     , 305-310. <a href="https://doi.org/10.1007/s11802-017-3177-z" title="DOI URL">https://doi.org/10.1007/s11802-017-3177-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11802-017-3177-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11802-017-3177-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ocean%2520University%2520of%2520China%26atitle%3DSynthesis%252Band%252Bpharmacokinetic%252Bproperty%252Bimprovement%252Bof%252Bdeuterated%252Bplinabulin%252B9%26aulast%3DZhao%26aufirst%3DJianchun%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D2%26spage%3D305%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoxin  Du</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Li  Feng</span>, <span class="hlFld-ContribAuthor ">Zhuo  Yang</span>, <span class="hlFld-ContribAuthor ">Jiye  Shi</span>, <span class="hlFld-ContribAuthor ">Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Bo  Li</span>, <span class="hlFld-ContribAuthor ">Fujiang  Guo</span>, <span class="hlFld-ContribAuthor ">Weiliang  Zhu</span>, <span class="hlFld-ContribAuthor ">Yiming  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structure-Activity Relationships of Bavachinin Analogues as Peroxisome Proliferator-Activated Receptor γ Agonists. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (2)
                                     , 183-193. <a href="https://doi.org/10.1002/cmdc.201600554" title="DOI URL">https://doi.org/10.1002/cmdc.201600554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600554%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructure-Activity%252BRelationships%252Bof%252BBavachinin%252BAnalogues%252Bas%252BPeroxisome%252BProliferator-Activated%252BReceptor%2525E2%252580%252585%2525CE%2525B3%252BAgonists%26aulast%3DDu%26aufirst%3DGuoxin%26date%3D2017%26date%3D2016%26volume%3D12%26issue%3D2%26spage%3D183%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Mishra</span>, <span class="hlFld-ContribAuthor ">A.S.  Singh</span>, <span class="hlFld-ContribAuthor ">N.  Mishra</span>, <span class="hlFld-ContribAuthor ">H.  Pandey</span>, <span class="hlFld-ContribAuthor ">V.K.  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">Carbohydrate-Based Antidiabetic Agents From Nature∗∗This chapter is dedicated to Dr R P Tripathi, Senior Scientist at Central Drug Research Institute, Lucknow on the occasion of his 60th birthday celebration.. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 147-183. <a href="https://doi.org/10.1016/B978-0-12-809450-1.00005-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-809450-1.00005-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-809450-1.00005-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-809450-1.00005-3%26sid%3Dliteratum%253Aachs%26atitle%3DCarbohydrate-Based%252BAntidiabetic%252BAgents%252BFrom%252BNature%2525E2%252588%252597%2525E2%252588%252597This%252Bchapter%252Bis%252Bdedicated%252Bto%252BDr%252BR%252BP%252BTripathi%25252C%252BSenior%252BScientist%252Bat%252BCentral%252BDrug%252BResearch%252BInstitute%25252C%252BLucknow%252Bon%252Bthe%252Boccasion%252Bof%252Bhis%252B60th%252Bbirthday%252Bcelebration.%26aulast%3DMishra%26aufirst%3DS.%26date%3D2017%26spage%3D147%26epage%3D183%26pub%3DElsevier%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BAntidiabetic%252BAgents%252Bfrom%252BNatural%252BProducts%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ge  Xu</span>, <span class="hlFld-ContribAuthor ">Baihua  Xu</span>, <span class="hlFld-ContribAuthor ">Yanli  Song</span>, <span class="hlFld-ContribAuthor ">Xun  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient method for synthesis of bexagliflozin and its carbon-13 labeled analogue. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (42)
                                     , 4684-4687. <a href="https://doi.org/10.1016/j.tetlet.2016.09.003" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Bmethod%252Bfor%252Bsynthesis%252Bof%252Bbexagliflozin%252Band%252Bits%252Bcarbon-13%252Blabeled%252Banalogue%26aulast%3DXu%26aufirst%3DGe%26date%3D2016%26volume%3D57%26issue%3D42%26spage%3D4684%26epage%3D4687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Souful  Bhatia</span>, <span class="hlFld-ContribAuthor ">Greg  Spahlinger</span>, <span class="hlFld-ContribAuthor ">Nehal  Boukhumseen</span>, <span class="hlFld-ContribAuthor ">Quentin  Boll</span>, <span class="hlFld-ContribAuthor ">Zhenglong  Li</span>, <span class="hlFld-ContribAuthor ">James E.  Jackson</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoretentive H/D Exchange via an Electroactivated Heterogeneous Catalyst at sp
              3
              C-H Sites Bearing Amines or Alcohols. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (24)
                                     , 4230-4235. <a href="https://doi.org/10.1002/ejoc.201600719" title="DOI URL">https://doi.org/10.1002/ejoc.201600719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600719%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoretentive%252BH%25252FD%252BExchange%252Bvia%252Ban%252BElectroactivated%252BHeterogeneous%252BCatalyst%252Bat%252Bsp%252B3%252BC-H%252BSites%252BBearing%252BAmines%252Bor%252BAlcohols%26aulast%3DBhatia%26aufirst%3DSouful%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D24%26spage%3D4230%26epage%3D4235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana  Pazos</span>, <span class="hlFld-ContribAuthor ">Sebastián  Martínez</span>, <span class="hlFld-ContribAuthor ">María Agustina  Vila</span>, <span class="hlFld-ContribAuthor ">Paola  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Nicolás  Veiga</span>, <span class="hlFld-ContribAuthor ">Gustavo  Seoane</span>, <span class="hlFld-ContribAuthor ">Ignacio  Carrera</span>. </span><span class="cited-content_cbyCitation_article-title">Aza and oxo Diels–Alder reactions using cis-cyclohexadienediols of microbial origin: chemoenzymatic preparation of synthetically valuable heterocyclic scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron: Asymmetry</span><span> <strong>2015,</strong> <em>26 </em>
                                    (24)
                                     , 1436-1447. <a href="https://doi.org/10.1016/j.tetasy.2015.10.015" title="DOI URL">https://doi.org/10.1016/j.tetasy.2015.10.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetasy.2015.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetasy.2015.10.015%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%253A%2520Asymmetry%26atitle%3DAza%252Band%252Boxo%252BDiels%2525E2%252580%252593Alder%252Breactions%252Busing%252Bcis-cyclohexadienediols%252Bof%252Bmicrobial%252Borigin%25253A%252Bchemoenzymatic%252Bpreparation%252Bof%252Bsynthetically%252Bvaluable%252Bheterocyclic%252Bscaffolds%26aulast%3DPazos%26aufirst%3DMariana%26date%3D2015%26volume%3D26%26issue%3D24%26spage%3D1436%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Xuekun  Wang</span>, <span class="hlFld-ContribAuthor ">Xue  Xu</span>, <span class="hlFld-ContribAuthor ">Qianqian  Qiu</span>, <span class="hlFld-ContribAuthor ">Lei  Jiao</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and
              in vivo
              Evaluation of Novel
              C
              -Aryl Glucosides as Potent Sodium-Dependent Glucose Cotransporters Inhibitors for the Treatment of Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (4)
                                     , 764-775. <a href="https://doi.org/10.1111/cbdd.12547" title="DOI URL">https://doi.org/10.1111/cbdd.12547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12547%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252BSynthesis%252Band%252Bin%2525C2%2525A0vivo%252BEvaluation%252Bof%252BNovel%252BC%252B-Aryl%252BGlucosides%252Bas%252BPotent%252BSodium-Dependent%252BGlucose%252BCotransporters%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BDiabetes%26aulast%3DLi%26aufirst%3DZheng%26date%3D2015%26date%3D2015%26volume%3D86%26issue%3D4%26spage%3D764%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuyang  Ding</span>, <span class="hlFld-ContribAuthor ">Liufeng  Mao</span>, <span class="hlFld-ContribAuthor ">Dengfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Hui  Xie</span>, <span class="hlFld-ContribAuthor ">Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Hongjiang  Xu</span>, <span class="hlFld-ContribAuthor ">Wenjun  Geng</span>, <span class="hlFld-ContribAuthor ">Yong  Gao</span>, <span class="hlFld-ContribAuthor ">Chunguang  Xia</span>, <span class="hlFld-ContribAuthor ">Xiquan  Zhang</span>, <span class="hlFld-ContribAuthor ">Qingyi  Meng</span>, <span class="hlFld-ContribAuthor ">Donghai  Wu</span>, <span class="hlFld-ContribAuthor ">Junling  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenhui  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">C-Aryl glucoside SGLT2 inhibitors containing a biphenyl motif as potential anti-diabetic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (14)
                                     , 2744-2748. <a href="https://doi.org/10.1016/j.bmcl.2015.05.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.05.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.05.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DC-Aryl%252Bglucoside%252BSGLT2%252Binhibitors%252Bcontaining%252Ba%252Bbiphenyl%252Bmotif%252Bas%252Bpotential%252Banti-diabetic%252Bagents%26aulast%3DDing%26aufirst%3DYuyang%26date%3D2015%26volume%3D25%26issue%3D14%26spage%3D2744%26epage%3D2748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruixue  Xu</span>, <span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Lingling  Peng</span>, <span class="hlFld-ContribAuthor ">Xuehai  Pang</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongxia  Jiang</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of deuterated nintedanib for improving pharmacokinetic properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2015,</strong> <em>58 </em>
                                    (7)
                                     , 308-312. <a href="https://doi.org/10.1002/jlcr.3299" title="DOI URL">https://doi.org/10.1002/jlcr.3299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3299%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bdeuterated%252Bnintedanib%252Bfor%252Bimproving%252Bpharmacokinetic%252Bproperties%26aulast%3DXu%26aufirst%3DRuixue%26date%3D2015%26date%3D2015%26volume%3D58%26issue%3D7%26spage%3D308%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiwei  Guo</span>, <span class="hlFld-ContribAuthor ">Xuehai  Pang</span>, <span class="hlFld-ContribAuthor ">Lingling  Peng</span>, <span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Lei  Fan</span>, <span class="hlFld-ContribAuthor ">Yu  Gong</span>, <span class="hlFld-ContribAuthor ">Fanyuan  Kang</span>, <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of deuterated Tivozanib for improving pharmacokinetic properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (11)
                                     , 2425-2428. <a href="https://doi.org/10.1016/j.bmcl.2015.03.088" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.088%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bdeuterated%252BTivozanib%252Bfor%252Bimproving%252Bpharmacokinetic%252Bproperties%26aulast%3DGuo%26aufirst%3DShiwei%26date%3D2015%26volume%3D25%26issue%3D11%26spage%3D2425%26epage%3D2428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Ruixue  Xu</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Hongxia  Jiang</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Yongmei  Xie</span>, <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A Simple and Cost-Effective Method for the Regioselective Deuteration of Phenols. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (15)
                                     , 3370-3373. <a href="https://doi.org/10.1002/ejoc.201500192" title="DOI URL">https://doi.org/10.1002/ejoc.201500192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201500192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201500192%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BSimple%252Band%252BCost-Effective%252BMethod%252Bfor%252Bthe%252BRegioselective%252BDeuteration%252Bof%252BPhenols%26aulast%3DZhan%26aufirst%3DMiao%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D15%26spage%3D3370%26epage%3D3373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jimei  Ma</span>, <span class="hlFld-ContribAuthor ">Shaohua  Xiang</span>, <span class="hlFld-ContribAuthor ">Hong  Jiang</span>, <span class="hlFld-ContribAuthor ">Xue-Wei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Stereoselective
              C
              -Glycosylation of Glycals with Sodium Arylsulfinates. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (5)
                                     , 949-952. <a href="https://doi.org/10.1002/ejoc.201403550" title="DOI URL">https://doi.org/10.1002/ejoc.201403550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201403550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201403550%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium-Catalyzed%252BStereoselective%252BC%252B-Glycosylation%252Bof%252BGlycals%252Bwith%252BSodium%252BArylsulfinates%26aulast%3DMa%26aufirst%3DJimei%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D5%26spage%3D949%26epage%3D952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Hongxia  Jiang</span>, <span class="hlFld-ContribAuthor ">Xuehai  Pang</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Ruixue  Xu</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Yu  Gong</span>, <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient method for the Ru(0)-catalyzed regioselective deuteration of N-alkyl-substituted anilines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (36)
                                     , 5070-5073. <a href="https://doi.org/10.1016/j.tetlet.2014.07.071" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.07.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.07.071%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bconvenient%252Bmethod%252Bfor%252Bthe%252BRu%2525280%252529-catalyzed%252Bregioselective%252Bdeuteration%252Bof%252BN-alkyl-substituted%252Banilines%26aulast%3DZhan%26aufirst%3DMiao%26date%3D2014%26volume%3D55%26issue%3D36%26spage%3D5070%26epage%3D5073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <i>O</i>-Aryl glycoside SGLT2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>C</i>-Aryl glycoside SGLT2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Metabolites of <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed mechanism of formation of the putative methine-quinone metabolite from <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Predicted metabolic sites (A–C) of <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Deuteration strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>23</b> and <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (COCl)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, DMF(cat.), 5–10 °C; (b) anisole, AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −10 to 0 °C; (c) AlCl<sub>3</sub>, NaBH<sub>4</sub>, THF, 70 °C; (d) AlCl<sub>3</sub>, NaBD<sub>4</sub>, THF, 70 °C; (e) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −20 to 0 °C; (f) <i>tert</i>-butylchlorodimethylsilane, triethylamine, acetonitrile, 0 to 5 °C; (g) <i>n</i>-BuLi, THF, PhCH<sub>3</sub>, −78 °C, then 2,3,4,6-tetra-<i>O</i>-trimethylsilyl-β-<span class="smallcaps smallerCapital">d</span>-gluconolactone followed by MeOH and concentrated hydrochloric acid.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>11</b> and <b>25</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (h) Et<sub>3</sub>SiH, BF<sub>3</sub>·OEt<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, −20 to −10 °C; (i) Et<sub>3</sub>SiD, BF<sub>3</sub>·OEt<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, −20 to −10 °C.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>29</b>–<b>33</b>, <b>5</b>, <b>13</b>, and <b>34</b>–<b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (j) 4.6 N aqueous NaOH, ROH, THF, −5 to 15 °C; (k) TsOR (<b>29</b>–<b>33</b>), Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40 °C.</p></p></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compound <b>41</b> on blood glucose levels in glucose-loaded Sprague–Dawley rats (<i>n</i> = 5 per group). Rats were fasted overnight and treated with a single oral dose of compound (0.1–10 mg/kg of <b>41</b>) 1 h prior to receiving the glucose challenge (20%, 2 g/kg, p.o.). Blood samples were obtained at −60, 0, 30, 60, 90, and 120 min. Blood glucose levels were then measured using a glucometer. Values of AUC (0–2 h) stand for baseline-corrected values calculated using the trapezoidal rule. Values represent the mean ± SD. * <i>p</i> < 0.01 and ** <i>p</i> < 0.05 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Rat 24 h UGE following treatment with <b>41</b>. Male Sprague–Dawley rats (<i>n</i> = 5 per group) were randomized to receive one of five doses of compound <b>41</b> (0.1, 0.3, 1, 3, and 10 mg/kg) by oral gavage. The test compound was dissolved in 30% PEG400. Control rats were given 30% PEG400 only. One hour postdosing, a glucose solution (2 g/kg, 10 mL/kg) was administered by oral gavage. Following compound administration, urine was collected over 24 h for measurement of UGE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Overlay of the HPLC chromatograms showing the metabolites of <b>41</b>, <b>13</b>, <b>5</b>, and <b>11</b>. Compound <b>11</b> was used as a reference.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/medium/jm-2013-01780b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0011.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Conversion of parent compounds into metabolites. 1, 2, and 3 on <i>x</i> axis refer to the parent compound, the hydroxylation metabolite (<b>12</b>), and the dealkylation metabolite (<b>11</b>), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401780b/production/images/large/jm-2013-01780b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401780b&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization diabetes fact sheet (no. 312).</span><a href="http://www.who.int/mediacentre/factsheets/fs312" class="extLink">http://www.who.int/mediacentre/factsheets/fs312</a> (accessed August<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization+diabetes+fact+sheet+%28no.+312%29.http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs312+%28accessed+August+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Facchini, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Insulin resistance as a predictor of age-related diseases</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">3574</span><span class="NLM_x">–</span> <span class="NLM_lpage">3578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1210%2Fjc.86.8.3574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=11502781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFektrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=3574-3578&author=F.+S.+Facchiniauthor=N.+Huaauthor=F.+Abbasiauthor=G.+M.+Reaven&title=Insulin+resistance+as+a+predictor+of+age-related+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin resistance as a predictor of age-related diseases</span></div><div class="casAuthors">Facchini, Francesco S.; Hua, Nancy; Abbasi, Fahim; Reaven, Gerald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3574-3578</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The current study was initiated to evaluate the ability of insulin resistance to predict a variety of age-related diseases.  Baseline measurements of insulin resistance and related variables were made between 1988-1995 in 208 apparently healthy, nonobese (body mass index < 30 kg/m2) individuals, who were then evaluated 4-11 yr later (mean ± SEM = 6.3 ± 0.2 yr) for the appearance of the following age-related diseases: hypertension, coronary heart disease, stroke, cancer, and type 2 diabetes.  The effect of insulin resistance on the development of clin. events was evaluated by dividing the study group into tertiles of insulin resistance at baseline and comparing the events in these 3 groups.  Clin. endpoints (n = 40) were identified in 37 individuals (18%) of those evaluated, including 12 with hypertension, 3 with hypertension + type 2 diabetes, 9 with cancer, 7 with coronary heart disease, 4 with stroke, and 2 with type 2 diabetes.  Twenty-eight out of the total 40 clin. events were seen in 25 individuals (36%) in the most insulin-resistant tertile, with the other 12 occurring in the group with an intermediate degree of insulin resistance.  Furthermore, insulin resistance was an independent predictor of all clin. events, using both multiple logistic regression and Cox's proportional hazards anal.  The fact that an age-related clin. event developed in approx. 1 out of 3 healthy individuals in the upper tertile of insulin resistance at baseline, followed for an av. of 6 yr, whereas no clin. events were obsd. in the most insulin-sensitive tertile, should serve as a strong stimulus to further efforts to define the role of insulin resistance in the genesis of age-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCdrUQGFn67Vg90H21EOLACvtfcHk0lgzdV1GmzNBcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFektrc%253D&md5=7ebe20852848a49ad461baa16a96d484</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1210%2Fjc.86.8.3574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.86.8.3574%26sid%3Dliteratum%253Aachs%26aulast%3DFacchini%26aufirst%3DF.%2BS.%26aulast%3DHua%26aufirst%3DN.%26aulast%3DAbbasi%26aufirst%3DF.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DInsulin%2520resistance%2520as%2520a%2520predictor%2520of%2520age-related%2520diseases%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2001%26volume%3D86%26spage%3D3574%26epage%3D3578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Stumvoll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Haeften, T. W.</span><span> </span><span class="NLM_article-title">Type 2 diabetes: Principles of pathogenesis and therapy</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2FS0140-6736%2805%2961032-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=15823385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtF2iu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=1333-1346&author=M.+Stumvollauthor=B.+J.+Goldsteinauthor=T.+W.+van+Haeften&title=Type+2+diabetes%3A+Principles+of+pathogenesis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Type 2 diabetes: principles of pathogenesis and therapy</span></div><div class="casAuthors">Stumvoll, Michael; Goldstein, Barry J.; van Haeften, Timon W.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">9467</span>),
    <span class="NLM_cas:pages">1333-1346</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Type 2 diabetes mellitus has become an epidemic, and virtually no physician is without patients who have the disease.  Whereas insulin insensitivity is an early phenomenon partly related to obesity, pancreas β-cell function declines gradually over time already before the onset of clin. hyperglycemia.  Several mechanisms have been proposed, including increased non-esterified fatty acids, inflammatory cytokines, adipokines, and mitochondrial dysfunction for insulin resistance, and glucotoxicity, lipotoxicity, and amyloid formation for β-cell dysfunction.  Moreover, the disease has a strong genetic component, but only a handful of genes have been identified so far: genes for calpain 10, potassium inward-rectifier 6·2, peroxisome proliferator-activated receptor γ, insulin receptor substrate-1, and others.  Management includes not only diet and exercise, but also combinations of anti-hyperglycemic drug treatment with lipid-lowering, antihypertensive, and anti platelet therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIpI_NflPwPbVg90H21EOLACvtfcHk0lgzdV1GmzNBcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtF2iu7g%253D&md5=ed0ca5b0572e2c2aabd2caf05eb53254</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2961032-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252961032-X%26sid%3Dliteratum%253Aachs%26aulast%3DStumvoll%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DB.%2BJ.%26aulast%3Dvan%2BHaeften%26aufirst%3DT.%2BW.%26atitle%3DType%25202%2520diabetes%253A%2520Principles%2520of%2520pathogenesis%2520and%2520therapy%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D1333%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Davidson, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, A. L.</span><span> </span><span class="NLM_article-title">An overview of metformin in the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2FS0002-9343%2896%2900353-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=9209206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaK2sXhtleltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1997&pages=99-110&author=M.+B.+Davidsonauthor=A.+L.+Peters&title=An+overview+of+metformin+in+the+treatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of metformin in the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Davidson, Mayer B.; Peters, Anne L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-110</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica</span>)
        </div><div class="casAbstract">A review with 87 refs.  Type 2 diabetes mellitus results from impaired insulin secretion and reduced peripheral insulin sensitivity.  Treatment options include diet, oral antihyperglycemic agents, and insulin.  Metformin, an oral biguanide, ameliorates hyperglycemia by improving peripheral sensitivity to insulin, and reducing gastrointestinal glucose absorption and hepatic glucose prodn.  Unlike sulfonylureas, it does not stimulate insulin secretion, aggravate hyperinsulinemia, or cause hypoglycemia or wt. gain (wt. stabilizes or decreases).  It also has beneficial effects on serum lipid profiles.  In lean or overweight type 2 diabetic patients uncontrolled by diet, metformin monotherapy significantly improves glycemic control, compared with placebo, and to similar extents as sulfonylurea monotherapy.  In secondary sulfonylurea failure, combination metformin-sulfonylurea treatment significantly improves glycemic control beyond that achieved with either agent alone.  Metformin-sulfonylurea also appears to be as effective as insulin or insulin plus sulfonylurea, suggesting that such combination therapy may obviate or substantially delay insulin therapy.  Limited data suggest that metformin-insulin therapy may improve glycemic control, possibly reducing insulin requirements, in type 2 diabetic patients uncontrolled by insulin alone following secondary sulfonylurea failure.  Gastrointestinal side effects are common, but usually tolerated.  Lactic acidosis risk is minimal, provided that contraindications, particularly renal impairment, and prescribing guidelines are respected.  Aside from elevated plasma metformin levels with cimetidine and synergistic hypoglycemia with sulfonylureas, few interactions occur.  Thus, metformin is safe and effective both as monotherapy or in combination with other antihyperglycemic agents in type 2 diabetic patients requiring addnl. glycemic control, and may be advantageous when wt. control is desirable and/or hyperlipidemia exists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptjLpFKfhhbrVg90H21EOLACvtfcHk0ljE4R6jOUVISw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtleltr8%253D&md5=a1d71c37a53efaa908ec5d996cb18215</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0002-9343%2896%2900353-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9343%252896%252900353-1%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DM.%2BB.%26aulast%3DPeters%26aufirst%3DA.%2BL.%26atitle%3DAn%2520overview%2520of%2520metformin%2520in%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DAm.%2520J.%2520Med.%26date%3D1997%26volume%3D102%26spage%3D99%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Horii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kameda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, K.</span><span> </span><span class="NLM_article-title">Synthesis and R-<span class="smallcaps smallerCapital">d</span>-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00156a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=1038-1046&author=S.+Horiiauthor=H.+Fukaseauthor=T.+Matsuoauthor=Y.+Kamedaauthor=N.+Asanoauthor=K.+Matsui&title=Synthesis+and+R-d-glucosidase+inhibitory+activity+of+N-substituted+valiolamine+derivatives+as+potential+oral+antidiabetic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm00156a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00156a023%26sid%3Dliteratum%253Aachs%26aulast%3DHorii%26aufirst%3DS.%26aulast%3DFukase%26aufirst%3DH.%26aulast%3DMatsuo%26aufirst%3DT.%26aulast%3DKameda%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DN.%26aulast%3DMatsui%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520R-d-glucosidase%2520inhibitory%2520activity%2520of%2520N-substituted%2520valiolamine%2520derivatives%2520as%2520potential%2520oral%2520antidiabetic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D1038%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Davis, S. N.</span><span> </span><span class="NLM_article-title">The role of glimepiride in the effective management of type 2 diabetes</span> <span class="citation_source-journal">J. Diabetes Complications</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2Fj.jdiacomp.2004.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A280%3ADC%252BD2crlvFaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=367-376&author=S.+N.+Davis&title=The+role+of+glimepiride+in+the+effective+management+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of glimepiride in the effective management of Type 2 diabetes</span></div><div class="casAuthors">Davis Stephen N</div><div class="citationInfo"><span class="NLM_cas:title">Journal of diabetes and its complications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">367-76</span>
        ISSN:<span class="NLM_cas:issn">1056-8727</span>.
    </div><div class="casAbstract">Type 2 diabetes mellitus, a disorder of impaired insulin secretion and insulin resistance, has reached epidemic proportions.  The effective management of Type 2 diabetes is of vital concern to clinicians.  The identification of high-risk individuals and lifestyle management can help control diabetes; however, most patients require pharmacologic intervention.  The goals of pharmacologic therapy are to achieve adequate glycemic control while avoiding hypoglycemia and weight gain and to minimize the risk of future micro- and macrovascular complications.  There are a number of available glucose-lowering agents from which to choose.  This review focuses on the sulfonylureas, the first oral agents introduced for the management of Type 2 diabetes, which are effective, well-tolerated, and well-established drugs, Second-generation sulfonylureas are now widely used in the management of Type 2 diabetes.  The most recent addition, glimepiride, can be used in combination with metformin, the thiazolidinediones, alpha-glucosidase inhibitors, and insulin.  The unique properties of glimepiride may provide advantages over other currently available insulin secretagogues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRvH-kEH8I5Bcr74wzj5o5fW6udTcc2ea22DtW9l1sjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crlvFaktg%253D%253D&md5=771d37140741af70b01d9ca62a3ec111</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jdiacomp.2004.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdiacomp.2004.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DS.%2BN.%26atitle%3DThe%2520role%2520of%2520glimepiride%2520in%2520the%2520effective%2520management%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Diabetes%2520Complications%26date%3D2004%26volume%3D18%26spage%3D367%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torsten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urs, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoph, R.</span><span> </span><span class="NLM_article-title">Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor γ activity: A combined virtual screening and biological assay approach</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=398-406&author=S.+Marcoauthor=P.+Michaelauthor=R.+Adrianauthor=H.+Hubertauthor=K.+Sanderauthor=A.+Hugoauthor=S.+Torstenauthor=A.+M.+Ursauthor=R.+Christoph&title=Sulfonylureas+and+glinides+exhibit+peroxisome+proliferator-activated+receptor+%CE%B3+activity%3A+A+combined+virtual+screening+and+biological+assay+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DS.%26aulast%3DMichael%26aufirst%3DP.%26aulast%3DAdrian%26aufirst%3DR.%26aulast%3DHubert%26aufirst%3DH.%26aulast%3DSander%26aufirst%3DK.%26aulast%3DHugo%26aufirst%3DA.%26aulast%3DTorsten%26aufirst%3DS.%26aulast%3DUrs%26aufirst%3DA.%2BM.%26aulast%3DChristoph%26aufirst%3DR.%26atitle%3DSulfonylureas%2520and%2520glinides%2520exhibit%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520activity%253A%2520A%2520combined%2520virtual%2520screening%2520and%2520biological%2520assay%2520approach%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D398%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ajjan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, P. J.</span><span> </span><span class="NLM_article-title">The cardiovascular safety of rosiglitazone</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1517%2F14740338.7.4.367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Cgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=367-376&author=R.+A.+Ajjanauthor=P.+J.+Grant&title=The+cardiovascular+safety+of+rosiglitazone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The cardiovascular safety of rosiglitazone</span></div><div class="casAuthors">Ajjan, Ramzi A.; Grant, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">367-376</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Thiazolidinediones (rosiglitazone, pioglitazone) influence insulin sensitivity and are used for the treatment of Type 2 diabetes.  Rosiglitazone achieves sustained improvements in glycemic control, while having pleiotropic effects on cardiovascular risk factors.  However, anal. of cardiovascular outcomes has been controversial.  Review the cardiovascular safety of rosiglitazone by conducting a literature search.  We conducted a PubMed search and critically reviewed published work on cardiovascular outcome of rosiglitazone, including clin. studies and meta-analyses.  The meta-anal. by Nissen and Wolski suggested increased cardiovascular risk in users of rosiglitazone, but this was not supported by an interim anal. of the RECORD trial designed to evaluate this, and several other reports failed to shed conclusive light on this issue.  The cardiovascular benefits of pioglitazone have also been in doubt due to the failure of the PROactive trial to reach the primary cardiovascular end points, although this study reported a significant redn. in secondary end points.  All of this has left diabetes care in some disarray, with weak evidence for adverse cardiovascular effects driving the reduced use of rosiglitazone, an agent that has important sustained effects on glycemic control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xDKtFqnMgbVg90H21EOLACvtfcHk0lj1045H6Kr7-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Cgs78%253D&md5=cecc4f9a6fc57e8c36df921c0787ccd6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F14740338.7.4.367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.7.4.367%26sid%3Dliteratum%253Aachs%26aulast%3DAjjan%26aufirst%3DR.%2BA.%26aulast%3DGrant%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520cardiovascular%2520safety%2520of%2520rosiglitazone%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2008%26volume%3D7%26spage%3D367%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Momose, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoda, T.</span><span> </span><span class="NLM_article-title">Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=1440-1445&author=Y.+Momoseauthor=K.+Meguroauthor=H.+Ikedaauthor=C.+Hatanakaauthor=S.+Oiauthor=T.+Shoda&title=Studies+on+antidiabetic+agents.+X.+Synthesis+and+biological+activities+of+pioglitazone+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMomose%26aufirst%3DY.%26aulast%3DMeguro%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DHatanaka%26aufirst%3DC.%26aulast%3DOi%26aufirst%3DS.%26aulast%3DShoda%26aufirst%3DT.%26atitle%3DStudies%2520on%2520antidiabetic%2520agents.%2520X.%2520Synthesis%2520and%2520biological%2520activities%2520of%2520pioglitazone%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D1440%26epage%3D1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-R]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonsauthor=F.+Marsilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+S.+Royauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifluoromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-R%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluorophenyl%29butan-2-amine%3A+A+potent%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifluoromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-R%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluorophenyl%2529butan-2-amine%253A%2520A%2520potent%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dicker, D.</span><span> </span><span class="NLM_article-title">DPP-4 inhibitors. Impact on glycemic control and cardiovascular risk factors</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">S276</span><span class="NLM_x">–</span> <span class="NLM_lpage">S278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=S276-S278&author=D.+Dicker&title=DPP-4+inhibitors.+Impact+on+glycemic+control+and+cardiovascular+risk+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDicker%26aufirst%3DD.%26atitle%3DDPP-4%2520inhibitors.%2520Impact%2520on%2520glycemic%2520control%2520and%2520cardiovascular%2520risk%2520factors%26jtitle%3DDiabetes%2520Care%26date%3D2011%26volume%3D34%26spage%3DS276%26epage%3DS278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Vallon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koepsell, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieg, T.</span><span> </span><span class="NLM_article-title">SGLT2 mediates glucose reabsorption in the early proximal tubule</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1681%2FASN.2010030246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVChsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=104-112&author=V.+Vallonauthor=K.+A.+Plattauthor=R.+Cunardauthor=J.+Schrothauthor=J.+Whaleyauthor=S.+C.+Thomsonauthor=H.+Koepsellauthor=T.+Rieg&title=SGLT2+mediates+glucose+reabsorption+in+the+early+proximal+tubule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">SGLT2 mediates glucose reabsorption in the early proximal tubule</span></div><div class="casAuthors">Vallon, Volker; Platt, Kenneth A.; Cunard, Robyn; Schroth, Jana; Whaley, Jean; Thomson, Scott C.; Koepsell, Hermann; Rieg, Timo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-112</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Mutations in the gene encoding for the Na+-glucose co-transporter SGLT2 (SLC5A2) assoc. with familial renal glucosuria, but the role of SGLT2 in the kidney is incompletely understood.  Here, we detd. the localization of SGLT2 in the mouse kidney and generated and characterized SGLT2-deficient mice.  In wild-type (WT) mice, immunohistochem. localized SGLT2 to the brush border membrane of the early proximal tubule.  Sglt2-/- mice had glucosuria, polyuria, and increased food and fluid intake without differences in plasma glucose concns., GFR, or urinary excretion of other proximal tubular substrates (including amino acids) compared with WT mice.  SGLT2 deficiency did not assoc. with vol. depletion, suggested by similar body wt., BP, and hematocrit; however, plasma renin concns. were modestly higher and plasma aldosterone levels were lower in Sglt2-/- mice.  Whole-kidney clearance studies showed that fractional glucose reabsorption was significantly lower in Sglt2-/- mice compared with WT mice and varied in Sglt2-/- mice between 10 and 60%, inversely with the amt. of filtered glucose.  Free-flow micropuncture revealed that for early proximal collections, 78 ± 6% of the filtered glucose was reabsorbed in WT mice compared with no reabsorption in Sglt2-/- mice.  For late proximal collections, fractional glucose reabsorption was 93 ± 1% in WT and 21 ± 6% in Sglt2-/- mice, resp.  These results demonstrate that SGLT2 mediates glucose reabsorption in the early proximal tubule and most of the glucose reabsorption by the kidney, overall.  This mouse model mimics and explains the glucosuric phenotype of individuals carrying SLC5A2 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0glw1C3NSKLVg90H21EOLACvtfcHk0lg3s1CqxnzP0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVChsrY%253D&md5=dbc09afbe725f7d7eea6244231fa2fe5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1681%2FASN.2010030246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2010030246%26sid%3Dliteratum%253Aachs%26aulast%3DVallon%26aufirst%3DV.%26aulast%3DPlatt%26aufirst%3DK.%2BA.%26aulast%3DCunard%26aufirst%3DR.%26aulast%3DSchroth%26aufirst%3DJ.%26aulast%3DWhaley%26aufirst%3DJ.%26aulast%3DThomson%26aufirst%3DS.%2BC.%26aulast%3DKoepsell%26aufirst%3DH.%26aulast%3DRieg%26aufirst%3DT.%26atitle%3DSGLT2%2520mediates%2520glucose%2520reabsorption%2520in%2520the%2520early%2520proximal%2520tubule%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2011%26volume%3D22%26spage%3D104%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hediger, M. A.</span><span> </span><span class="NLM_article-title">The human kidney low affinity Na<sup>+</sup>/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for <span class="smallcaps smallerCapital">d</span>-glucose</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1994&pages=397-404&author=Y.+Kanaiauthor=W.-S.+Leeauthor=G.+Youauthor=D.+Brownauthor=M.+A.+Hediger&title=The+human+kidney+low+affinity+Na%2B%2Fglucose+cotransporter+SGLT2.+Delineation+of+the+major+renal+reabsorptive+mechanism+for+d-glucose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DW.-S.%26aulast%3DYou%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DHediger%26aufirst%3DM.%2BA.%26atitle%3DThe%2520human%2520kidney%2520low%2520affinity%2520Na%252B%252Fglucose%2520cotransporter%2520SGLT2.%2520Delineation%2520of%2520the%2520major%2520renal%2520reabsorptive%2520mechanism%2520for%2520d-glucose%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1994%26volume%3D93%26spage%3D397%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Powell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaCosta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doree, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeter-Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mseeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhring, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brommage, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shadoan, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambrowicz, B.</span><span> </span><span class="NLM_article-title">Improved glycemic control in mice lacking Sglt1 and Sglt2</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">E117</span><span class="NLM_x">–</span> <span class="NLM_lpage">E130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2013&pages=E117-E130&author=D.+R.+Powellauthor=C.+M.+DaCostaauthor=J.+Gayauthor=Z.+M.+Dingauthor=M.+Smithauthor=J.+Greerauthor=D.+Doreeauthor=S.+Jeter-Jonesauthor=F.+Mseehauthor=L.+A.+Rodriguezauthor=A.+Harrisauthor=L.+Buhringauthor=K.+A.+Plattauthor=P.+Vogelauthor=R.+Brommageauthor=M.+K.+Shadoanauthor=A.+T.+Sandsauthor=B.+Zambrowicz&title=Improved+glycemic+control+in+mice+lacking+Sglt1+and+Sglt2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DDaCosta%26aufirst%3DC.%2BM.%26aulast%3DGay%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DZ.%2BM.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DGreer%26aufirst%3DJ.%26aulast%3DDoree%26aufirst%3DD.%26aulast%3DJeter-Jones%26aufirst%3DS.%26aulast%3DMseeh%26aufirst%3DF.%26aulast%3DRodriguez%26aufirst%3DL.%2BA.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DBuhring%26aufirst%3DL.%26aulast%3DPlatt%26aufirst%3DK.%2BA.%26aulast%3DVogel%26aufirst%3DP.%26aulast%3DBrommage%26aufirst%3DR.%26aulast%3DShadoan%26aufirst%3DM.%2BK.%26aulast%3DSands%26aufirst%3DA.%2BT.%26aulast%3DZambrowicz%26aufirst%3DB.%26atitle%3DImproved%2520glycemic%2520control%2520in%2520mice%2520lacking%2520Sglt1%2520and%2520Sglt2%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2013%26volume%3D304%26spage%3DE117%26epage%3DE130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chao, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">SGLT2 inhibition–a novel strategy for diabetes treatment</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=551-559&author=E.+C.+Chaoauthor=R.+R.+Henry&title=SGLT2+inhibition%E2%80%93a+novel+strategy+for+diabetes+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DE.%2BC.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DSGLT2%2520inhibition%25E2%2580%2593a%2520novel%2520strategy%2520for%2520diabetes%2520treatment%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D551%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Toggenburger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G.</span><span> </span><span class="NLM_article-title">Phlorizin as a probe of the small-intestinal Na<sup>+</sup>, <span class="smallcaps smallerCapital">d</span>-glucose cotransporter. A model</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">688</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=688&publication_year=1982&pages=557-571&author=G.+Toggenburgerauthor=M.+Kesslerauthor=G.+Semenza&title=Phlorizin+as+a+probe+of+the+small-intestinal+Na%2B%2C+d-glucose+cotransporter.+A+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToggenburger%26aufirst%3DG.%26aulast%3DKessler%26aufirst%3DM.%26aulast%3DSemenza%26aufirst%3DG.%26atitle%3DPhlorizin%2520as%2520a%2520probe%2520of%2520the%2520small-intestinal%2520Na%252B%252C%2520d-glucose%2520cotransporter.%2520A%2520model%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1982%26volume%3D688%26spage%3D557%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ehrenkranz, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J.</span><span> </span><span class="NLM_article-title">Phlorizin: A review</span> <span class="citation_source-journal">Diabetes/Metab. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1002%2Fdmrr.532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=15624123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs12gs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=31-38&author=J.+R.+Ehrenkranzauthor=N.+G.+Lewisauthor=C.+R.+Kahnauthor=J.+Roth&title=Phlorizin%3A+A+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phlorizin: a review</span></div><div class="casAuthors">Ehrenkranz, Joel R. L.; Lewis, Norman G.; Kahn, C. Ronald; Roth, Jesse</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/Metabolism Research and Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-38</span>CODEN:
                <span class="NLM_cas:coden">DMRRFM</span>;
        ISSN:<span class="NLM_cas:issn">1520-7552</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The dihydrochalcone phlorizin is a natural product and dietary constituent found in a no. of fruit trees.  It has been used as a pharmaceutical and tool for physiol. research for over 150 years.  Phlorizin's principal pharmacol. action is to produce renal glycosuria and block intestinal glucose absorption through inhibition of the sodium-glucose symporters located in the proximal renal tubule and mucosa of the small intestine.  This review covers the role phlorizin has played in the history of diabetes mellitus and its use as an agent to understand fundamental concepts in renal physiol. as well as summarizes the physiol. of cellular glucose transport and the pathophysiol. of renal glycosuria.  It reviews the biol. and pathobiol. of glucose transporters and discusses the medical botany of phlorizin and the potential effects of plant flavonoids, such as phlorizin, on human metab.  Lastly, it describes the clin. pharmacol. and toxicol. of phlorizin, including investigational uses of phlorizin and phlorizin analogs in the treatment of diabetes, obesity, and stress hyperglycemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpOKzj4-WFbVg90H21EOLACvtfcHk0lgzJZu5BK_t2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs12gs7c%253D&md5=03f04faab4da2f9ac1e5383036f98649</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.532%26sid%3Dliteratum%253Aachs%26aulast%3DEhrenkranz%26aufirst%3DJ.%2BR.%26aulast%3DLewis%26aufirst%3DN.%2BG.%26aulast%3DKahn%26aufirst%3DC.%2BR.%26aulast%3DRoth%26aufirst%3DJ.%26atitle%3DPhlorizin%253A%2520A%2520review%26jtitle%3DDiabetes%252FMetab.%2520Res.%2520Rev.%26date%3D2005%26volume%3D21%26spage%3D31%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Oku, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuronuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endou, H.</span><span> </span><span class="NLM_article-title">T-1095, an inhibitor of renal Na<sup>+</sup>-glucose cotransporters, may provide a novel approach to treating diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1794</span><span class="NLM_x">–</span> <span class="NLM_lpage">1800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=1794-1800&author=A.+Okuauthor=K.+Uetaauthor=K.+Arakawaauthor=T.+Ishiharaauthor=M.+Nawanoauthor=Y.+Kuronumaauthor=M.+Matsumotoauthor=A.+Saitoauthor=K.+Tsujiharaauthor=M.+Anaiauthor=T.+Asanoauthor=Y.+Kanaiauthor=H.+Endou&title=T-1095%2C+an+inhibitor+of+renal+Na%2B-glucose+cotransporters%2C+may+provide+a+novel+approach+to+treating+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOku%26aufirst%3DA.%26aulast%3DUeta%26aufirst%3DK.%26aulast%3DArakawa%26aufirst%3DK.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DNawano%26aufirst%3DM.%26aulast%3DKuronuma%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DA.%26aulast%3DTsujihara%26aufirst%3DK.%26aulast%3DAnai%26aufirst%3DM.%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DEndou%26aufirst%3DH.%26atitle%3DT-1095%252C%2520an%2520inhibitor%2520of%2520renal%2520Na%252B-glucose%2520cotransporters%252C%2520may%2520provide%2520a%2520novel%2520approach%2520to%2520treating%2520diabetes%26jtitle%3DDiabetes%26date%3D1999%26volume%3D48%26spage%3D1794%26epage%3D1800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Tsujihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oku, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, A.</span><span> </span><span class="NLM_article-title">Na<sup>+</sup>-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4′-dehydroxyphlorizin derivatives substituted on the B ring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5311</span><span class="NLM_x">–</span> <span class="NLM_lpage">5324</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990175n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5311-5324&author=K.+Tsujiharaauthor=M.+Honguauthor=K.+Saitoauthor=H.+Kawanishiauthor=K.+Kuriyamaauthor=M.+Matsumotoauthor=A.+Okuauthor=K.+Uetaauthor=M.+Tsudaauthor=A.+Saito&title=Na%2B-glucose+cotransporter+%28SGLT%29+inhibitors+as+antidiabetic+agents.+4.+Synthesis+and+pharmacological+properties+of+4%E2%80%B2-dehydroxyphlorizin+derivatives+substituted+on+the+B+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm990175n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990175n%26sid%3Dliteratum%253Aachs%26aulast%3DTsujihara%26aufirst%3DK.%26aulast%3DHongu%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DKawanishi%26aufirst%3DH.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DOku%26aufirst%3DA.%26aulast%3DUeta%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DA.%26atitle%3DNa%252B-glucose%2520cotransporter%2520%2528SGLT%2529%2520inhibitors%2520as%2520antidiabetic%2520agents.%25204.%2520Synthesis%2520and%2520pharmacological%2520properties%2520of%25204%25E2%2580%25B2-dehydroxyphlorizin%2520derivatives%2520substituted%2520on%2520the%2520B%2520ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5311%26epage%3D5324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Katsuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1124%2Fjpet.106.110296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=17050778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFCiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=323-330&author=K.+Katsunoauthor=Y.+Fujimoriauthor=Y.+Takemuraauthor=M.+Hiratochiauthor=F.+Itohauthor=Y.+Komatsuauthor=H.+Fujikuraauthor=M.+Isaji&title=Sergliflozin%2C+a+novel+selective+inhibitor+of+low-affinity+sodium+glucose+cotransporter+%28SGLT2%29%2C+validates+the+critical+role+of+SGLT2+in+renal+glucose+reabsorption+and+modulates+plasma+glucose+level"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level</span></div><div class="casAuthors">Katsuno, Kenji; Fujimori, Yoshikazu; Takemura, Yukiko; Hiratochi, Masahiro; Itoh, Fumiaki; Komatsu, Yoshimitsu; Fujikura, Hideki; Isaji, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-330</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The low-affinity sodium glucose cotransporter (SGLT2), which is expressed specifically in the kidney, plays a major role in renal glucose resorption in the proximal tubule.  We have discovered sergliflozin, a prodrug of a novel selective SGLT2 inhibitor, based on benzylphenol glucoside.  In structure, it belongs to a new category of SGLT2 inhibitors and its skeleton differs from that of phlorizin, a nonselective SGLT inhibitor.  We investigated its pharmacol. properties and potencies in vitro and in vivo.  By examg. a Chinese hamster ovary-K1 cell line stably expressing either human SGLT2 or human high-affinity sodium glucose cotransporter (SGLT1), we found sergliflozin-A (active form) to be a highly selective and potent inhibitor of human SGLT2.  At pharmacol. doses, sergliflozin, sergliflozin-A, and its aglycon had no effects on facilitative glucose transporter 1 activity, which was inhibited by phloretin (the aglycon of phlorizin).  The transport max. for glucose in the kidney was reduced by sergliflozin-A in normal rats.  As a result of this effect, orally administered sergliflozin increased urinary glucose excretion in mice, rats, and dogs in a dose-dependent manner.  In an oral glucose tolerance test in diabetic rats, sergliflozin exhibited glucose-lowering effects independently of insulin secretion.  Any glucose excretion induced by sergliflozin did not affect normoglycemia or electrolyte balance.  These data indicate that selective inhibition of SGLT2 increases urinary glucose excretion by inhibiting renal glucose resorption.  As a representative of a new category of antidiabetic drugs, sergliflozin may provide a new and unique approach to the treatment of diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpROCQYQ6yzj7Vg90H21EOLACvtfcHk0lhTs4G9E-uGAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFCiug%253D%253D&md5=d56b754818c4ef783c2b764b066b7fdd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.110296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.110296%26sid%3Dliteratum%253Aachs%26aulast%3DKatsuno%26aufirst%3DK.%26aulast%3DFujimori%26aufirst%3DY.%26aulast%3DTakemura%26aufirst%3DY.%26aulast%3DHiratochi%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DFujikura%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DSergliflozin%252C%2520a%2520novel%2520selective%2520inhibitor%2520of%2520low-affinity%2520sodium%2520glucose%2520cotransporter%2520%2528SGLT2%2529%252C%2520validates%2520the%2520critical%2520role%2520of%2520SGLT2%2520in%2520renal%2520glucose%2520reabsorption%2520and%2520modulates%2520plasma%2520glucose%2520level%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D323%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Fujimori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa-Takemura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1124%2Fjpet.108.140210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=18583547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1amsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=268-276&author=Y.+Fujimoriauthor=K.+Katsunoauthor=I.+Nakashimaauthor=Y.+Ishikawa-Takemuraauthor=H.+Fujikuraauthor=M.+Isaji&title=Remogliflozin+etabonate%2C+in+a+novel+category+of+selective+low-affinity+sodium+glucose+cotransporter+%28SGLT2%29+inhibitors%2C+exhibits+antidiabetic+efficacy+in+rodent+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models</span></div><div class="casAuthors">Fujimori, Yoshikazu; Katsuno, Kenji; Nakashima, Ikumi; Ishikawa-Takemura, Yukiko; Fujikura, Hideki; Isaji, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">268-276</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The low-affinity sodium glucose cotransporter (SGLT2) plays an important role in renal glucose reabsorption and is a remarkable transporter as a mol. target for the treatment of diabetes.  We have discovered remogliflozin etabonate, which is a novel category of selective SGLT2 inhibitors.  Remogliflozin etabonate is a prodrug based on benzylpyrazole glucoside and is metabolized to its active form, remogliflozin, in the body.  We identified remogliflozin to be a potent and highly selective SGLT2 inhibitor by examg. COS-7 cells transiently expressing either high-affinity sodium glucose cotransporter (SGLT1) or SGLT2.  Orally administered remogliflozin etabonate increased urinary glucose excretion in a dose-dependent manner in both mice and rats.  By increasing urinary glucose excretion, remogliflozin etabonate inhibited the increase in plasma glucose after glucose loading without stimulating insulin secretion in normal rats.  Remogliflozin etabonate also showed antihyperglycemic effects in both streptozotocin-induced diabetic rats in oral glucose tolerance and in db/db mice in the fed condition.  Chronic treatment with remogliflozin etabonate reduced the levels of fasting plasma glucose and glycated Hb, and it ameliorated glucosuria in db/db mice.  In high-fat diet-fed Goto-Kakizaki rats, remogliflozin etabonate improved hyperglycemia, hyperinsulinemia, hypertriglyceridemia, and insulin resistance.  This study demonstrates that treatment with remogliflozin etabonate exhibits antidiabetic efficacy in several rodent models and suggests that remogliflozin etabonate may be a new and useful drug for the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNsPxNw9fLtrVg90H21EOLACvtfcHk0lg0dhx4sZaiqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1amsLfL&md5=04b95fbb060ff066f943a96e7308ca2c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.140210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.140210%26sid%3Dliteratum%253Aachs%26aulast%3DFujimori%26aufirst%3DY.%26aulast%3DKatsuno%26aufirst%3DK.%26aulast%3DNakashima%26aufirst%3DI.%26aulast%3DIshikawa-Takemura%26aufirst%3DY.%26aulast%3DFujikura%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DRemogliflozin%2520etabonate%252C%2520in%2520a%2520novel%2520category%2520of%2520selective%2520low-affinity%2520sodium%2520glucose%2520cotransporter%2520%2528SGLT2%2529%2520inhibitors%252C%2520exhibits%2520antidiabetic%2520efficacy%2520in%2520rodent%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D268%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girotra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshpande, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullockaran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obermeier, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discenza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterau, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janovitz, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flint, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, W. N.</span><span> </span><span class="NLM_article-title">Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701272q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFWgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1145-1149&author=W.+Mengauthor=B.+A.+Ellsworthauthor=A.+A.+Nirschlauthor=P.+J.+McCannauthor=M.+Patelauthor=R.+N.+Girotraauthor=G.+Wuauthor=P.+M.+Sherauthor=E.+P.+Morrisonauthor=S.+A.+Billerauthor=R.+Zahlerauthor=P.+P.+Deshpandeauthor=A.+Pullockaranauthor=D.+L.+Haganauthor=N.+Morganauthor=J.+R.+Taylorauthor=M.+T.+Obermeierauthor=W.+G.+Humphreysauthor=A.+Khannaauthor=L.+Discenzaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=S.+Hanauthor=J.+R.+Wetterauauthor=E.+B.+Janovitzauthor=O.+P.+Flintauthor=J.+M.+Whaleyauthor=W.+N.+Washburn&title=Discovery+of+dapagliflozin%3A+A+potent%2C+selective+renal+sodium-dependent+glucose+cotransporter+2+%28SGLT2%29+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Meng, Wei; Ellsworth, Bruce A.; Nirschl, Alexandra A.; McCann, Peggy J.; Patel, Manorama; Girotra, Ravindar N.; Wu, Gang; Sher, Philip M.; Morrison, Eamonn P.; Biller, Scott A.; Zahler, Robert; Deshpande, Prashant P.; Pullockaran, Annie; Hagan, Deborah L.; Morgan, Nathan; Taylor, Joseph R.; Obermeier, Mary T.; Humphreys, William G.; Khanna, Ashish; Discenza, Lorell; Robertson, James G.; Wang, Aiying; Han, Songping; Wetterau, John R.; Janovitz, Evan B.; Flint, Oliver P.; Whaley, Jean M.; Washburn, William N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1145-1149</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The C-aryl glucoside 6 (dapagliflozin) was identified as a potent and selective hSGLT2 inhibitor which reduced blood glucose levels in a dose-dependent manner by as much as 55% in hyperglycemic streptozotocin (STZ) rats.  These findings, combined with a favorable ADME profile, have prompted clin. evaluation of dapagliflozin for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDq_QPSZ3cf7Vg90H21EOLACvtfcHk0lhI6xPQLY_wyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFWgtrY%253D&md5=8b31ec17acef23a7507ce6a7d9184eb9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm701272q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701272q%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26aulast%3DNirschl%26aufirst%3DA.%2BA.%26aulast%3DMcCann%26aufirst%3DP.%2BJ.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DGirotra%26aufirst%3DR.%2BN.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DSher%26aufirst%3DP.%2BM.%26aulast%3DMorrison%26aufirst%3DE.%2BP.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DDeshpande%26aufirst%3DP.%2BP.%26aulast%3DPullockaran%26aufirst%3DA.%26aulast%3DHagan%26aufirst%3DD.%2BL.%26aulast%3DMorgan%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DJ.%2BR.%26aulast%3DObermeier%26aufirst%3DM.%2BT.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DDiscenza%26aufirst%3DL.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DWetterau%26aufirst%3DJ.%2BR.%26aulast%3DJanovitz%26aufirst%3DE.%2BB.%26aulast%3DFlint%26aufirst%3DO.%2BP.%26aulast%3DWhaley%26aufirst%3DJ.%2BM.%26aulast%3DWashburn%26aufirst%3DW.%2BN.%26atitle%3DDiscovery%2520of%2520dapagliflozin%253A%2520A%2520potent%252C%2520selective%2520renal%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520%2528SGLT2%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1145%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Nomura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda-Tsukimoto, M.</span><span> </span><span class="NLM_article-title">Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6355</span><span class="NLM_x">–</span> <span class="NLM_lpage">6360</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100332n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVartbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6355-6360&author=S.+Nomuraauthor=S.+Sakamakiauthor=M.+Honguauthor=E.+Kawanishiauthor=Y.+Kogaauthor=T.+Sakamotoauthor=Y.+Yamamotoauthor=K.+Uetaauthor=H.+Kimataauthor=K.+Nakayamaauthor=M.+Tsuda-Tsukimoto&title=Discovery+of+canagliflozin%2C+a+novel+C-glucoside+with+thiophene+ring%2C+as+sodium-dependent+glucose+cotransporter+2+inhibitor+for+the+treatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Canagliflozin, a Novel C-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Co-transporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus</span></div><div class="casAuthors">Nomura, Sumihiro; Sakamaki, Shigeki; Hongu, Mitsuya; Kawanishi, Eiji; Koga, Yuichi; Sakamoto, Toshiaki; Yamamoto, Yasuo; Ueta, Kiichiro; Kimata, Hirotaka; Nakayama, Keiko; Tsuda-Tsukimoto, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6355-6360</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We discovered that aryl C-glucosides, e.g. I, bearing a heteroarom. ring formed metabolically more stable inhibitors for sodium-dependent glucose co-transporter 2 (SGLT2).  Thiophene I (canagliflozin) was a highly potent and selective SGLT2 inhibitor and showed pronounced anti-hyperglycemic effects in high-fat diet fed KK (HF-KK) mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLQqM2z47sI7Vg90H21EOLACvtfcHk0lhI6xPQLY_wyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVartbk%253D&md5=33c3a6bce5ae74799d051b6f8c06da7e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm100332n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100332n%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DS.%26aulast%3DSakamaki%26aufirst%3DS.%26aulast%3DHongu%26aufirst%3DM.%26aulast%3DKawanishi%26aufirst%3DE.%26aulast%3DKoga%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DUeta%26aufirst%3DK.%26aulast%3DKimata%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DTsuda-Tsukimoto%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520canagliflozin%252C%2520a%2520novel%2520C-glucoside%2520with%2520thiophene%2520ring%252C%2520as%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6355%26epage%3D6360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Imamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosakai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Discovery of ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3263</span><span class="NLM_x">–</span> <span class="NLM_lpage">3279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2Fj.bmc.2012.03.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=22507206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFCqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3263-3279&author=M.+Imamuraauthor=K.+Nakanishiauthor=T.+Suzukiauthor=K.+Ikegaiauthor=R.+Shirakiauthor=T.+Ogiyamaauthor=T.+Murakamiauthor=E.+Kurosakiauthor=A.+Nodaauthor=Y.+Kobayashiauthor=M.+Yokotaauthor=T.+Koideauthor=K.+Kosakaiauthor=Y.+Ohkuraauthor=M.+Takeuchiauthor=H.+Tomiyamaauthor=M.+Ohta&title=Discovery+of+ipragliflozin+%28ASP1941%29%3A+A+novel+C-glucoside+with+benzothiophene+structure+as+a+potent+and+selective+sodium+glucose+co-transporter+2+%28SGLT2%29+inhibitor+for+the+treatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Imamura, Masakazu; Nakanishi, Keita; Suzuki, Takayuki; Ikegai, Kazuhiro; Shiraki, Ryota; Ogiyama, Takashi; Murakami, Takeshi; Kurosaki, Eiji; Noda, Atsushi; Kobayashi, Yoshinori; Yokota, Masayuki; Koide, Tomokazu; Kosakai, Kazuhiro; Ohkura, Yasufumi; Takeuchi, Makoto; Tomiyama, Hiroshi; Ohta, Mitsuaki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3263-3279</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of C-glucosides with various heteroaroms. has been synthesized and its inhibitory activity toward SGLTs was evaluated.  Upon screening several compds., the benzothiophene deriv. I (R =H) was found to have potent inhibitory activity against SGLT2 and good selectivity vs. SGLT1.  Through further optimization of 14a, a novel benzothiophene deriv. I (R = F) (ipragliflozin, ASP1941) was discovered as a highly potent and selective SGLT2 inhibitor that reduced blood glucose levels in a dose-dependent manner in diabetic models KK-Ay mice and STZ rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFrm7CoAIzfbVg90H21EOLACvtfcHk0ljS-VX17Xl5iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFCqtLs%253D&md5=3552a64a85d0f769a10e1ad8e1dd8736</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.051%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIkegai%26aufirst%3DK.%26aulast%3DShiraki%26aufirst%3DR.%26aulast%3DOgiyama%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DKurosaki%26aufirst%3DE.%26aulast%3DNoda%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DYokota%26aufirst%3DM.%26aulast%3DKoide%26aufirst%3DT.%26aulast%3DKosakai%26aufirst%3DK.%26aulast%3DOhkura%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DTomiyama%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520ipragliflozin%2520%2528ASP1941%2529%253A%2520A%2520novel%2520C-glucoside%2520with%2520benzothiophene%2520structure%2520as%2520a%2520potent%2520and%2520selective%2520sodium%2520glucose%2520co-transporter%25202%2520%2528SGLT2%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3263%26epage%3D3279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Goodwin, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shadoan, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almstead, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhring, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaCosta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenhagen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mseeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nouraldeen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span> </span><span class="NLM_article-title">Novel <span class="smallcaps smallerCapital">l</span>-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6201</span><span class="NLM_x">–</span> <span class="NLM_lpage">6204</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900951n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6201-6204&author=N.+C.+Goodwinauthor=R.+Mabonauthor=B.+A.+Harrisonauthor=M.+K.+Shadoanauthor=Z.+Y.+Almsteadauthor=Y.+Xieauthor=J.+Healyauthor=L.+M.+Buhringauthor=C.+M.+DaCostaauthor=J.+Bardenhagenauthor=F.+Mseehauthor=Q.+Liuauthor=A.+Nouraldeenauthor=A.+G.+E.+Wilsonauthor=S.+D.+Kimballauthor=D.+R.+Powellauthor=D.+B.+Rawlins&title=Novel+l-xylose+derivatives+as+selective+sodium-dependent+glucose+cotransporter+2+%28SGLT2%29+inhibitors+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel L-Xylose Derivatives as Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Goodwin, Nicole C.; Mabon, Ross; Harrison, Bryce A.; Shadoan, Melanie K.; Almstead, Zheng Y.; Xie, Yiling; Healy, Jason; Buhring, Lindsey M.; DaCosta, Christopher M.; Bardenhagen, Jennifer; Mseeh, Faika; Liu, Qingyun; Nouraldeen, Amr; Wilson, Alan G. E.; Kimball, S. David; Powell, David R.; Rawlins, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6201-6204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prevalence of diabetes throughout the world continues to increase and has become a major health issue.  Recently there have been several reports of inhibitors directed toward the sodium-dependent glucose cotransporter 2 (SGLT2) as a method of maintaining glucose homeostasis in diabetic patients.  Herein we report the discovery of the novel O-xyloside 7c (I) that inhibits SGLT2 in vitro and urinary glucose reabsorption in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCyi0ZZIAswLVg90H21EOLACvtfcHk0ljS-VX17Xl5iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltb3O&md5=120dfc29a33db5857cb6876b35b9edf4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm900951n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900951n%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DN.%2BC.%26aulast%3DMabon%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DShadoan%26aufirst%3DM.%2BK.%26aulast%3DAlmstead%26aufirst%3DZ.%2BY.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHealy%26aufirst%3DJ.%26aulast%3DBuhring%26aufirst%3DL.%2BM.%26aulast%3DDaCosta%26aufirst%3DC.%2BM.%26aulast%3DBardenhagen%26aufirst%3DJ.%26aulast%3DMseeh%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DNouraldeen%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DA.%2BG.%2BE.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26atitle%3DNovel%2520l-xylose%2520derivatives%2520as%2520selective%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520%2528SGLT2%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6201%26epage%3D6204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boustany-Kari, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klenotic, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leininger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masterson, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Préville, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobol, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steppan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuma, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugnait, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span> </span><span class="NLM_article-title">Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2952</span><span class="NLM_x">–</span> <span class="NLM_lpage">2960</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200049r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2952-2960&author=V.+Mascittiauthor=T.+S.+Maurerauthor=R.+P.+Robinsonauthor=J.+Bianauthor=C.+M.+Boustany-Kariauthor=T.+Brandtauthor=B.+M.+Collmanauthor=A.+S.+Kalgutkarauthor=M.+K.+Klenoticauthor=M.+T.+Leiningerauthor=A.+Loweauthor=R.+J.+Maguireauthor=V.+M.+Mastersonauthor=Z.+Miaoauthor=E.+Mukaiyamaauthor=J.+D.+Patelauthor=J.+C.+Pettersenauthor=C.+Pr%C3%A9villeauthor=B.+Samasauthor=L.+Sheauthor=Z.+Sobolauthor=C.+M.+Steppanauthor=B.+D.+Stevensauthor=B.+A.+Thumaauthor=M.+Tugnaitauthor=D.+Zengauthor=T.+Zhu&title=Discovery+of+a+clinical+candidate+from+the+structurally+unique+dioxa-bicyclo%5B3.2.1%5Doctane+class+of+sodium-dependent+glucose+cotransporter+2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm200049r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200049r%26sid%3Dliteratum%253Aachs%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DBoustany-Kari%26aufirst%3DC.%2BM.%26aulast%3DBrandt%26aufirst%3DT.%26aulast%3DCollman%26aufirst%3DB.%2BM.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKlenotic%26aufirst%3DM.%2BK.%26aulast%3DLeininger%26aufirst%3DM.%2BT.%26aulast%3DLowe%26aufirst%3DA.%26aulast%3DMaguire%26aufirst%3DR.%2BJ.%26aulast%3DMasterson%26aufirst%3DV.%2BM.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DMukaiyama%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DJ.%2BD.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DPr%25C3%25A9ville%26aufirst%3DC.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DShe%26aufirst%3DL.%26aulast%3DSobol%26aufirst%3DZ.%26aulast%3DSteppan%26aufirst%3DC.%2BM.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DTugnait%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520clinical%2520candidate%2520from%2520the%2520structurally%2520unique%2520dioxa-bicyclo%255B3.2.1%255Doctane%2520class%2520of%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2952%26epage%3D2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welihinda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechanic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2Fj.phrs.2011.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Wltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=284-293&author=W.+Zhangauthor=A.+Welihindaauthor=J.+Mechanicauthor=H.+Dingauthor=L.+Zhuauthor=Y.+Luauthor=Z.+Dengauthor=Z.+Shengauthor=B.+Lvauthor=Y.+Chenauthor=J.+Y.+Robergeauthor=B.+Seedauthor=Y.+Wang&title=EGT1442%2C+a+potent+and+selective+SGLT2+inhibitor%2C+attenuates+blood+glucose+and+HbA1c+levels+in+db%2Fdb+mice+and+prolongs+the+survival+of+stroke-prone+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats</span></div><div class="casAuthors">Zhang, Wenbin; Welihinda, Ajith; Mechanic, Jordan; Ding, Haifeng; Zhu, Liangcheng; Lu, Yuan; Deng, Zhongping; Sheng, Zelin; Lv, Binhua; Chen, Yuanwei; Roberge, Jacques Y.; Seed, Brian; Wang, Yong-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sodium glucose co-transporter 2 (SGLT2) is a renal type III integral membrane protein that co-transports sodium and glucose from filtrate to epithelium in the proximal tubule.  Human subjects with homozygous or compd. heterozygous mutations in SLC5A2 exhibit glucosuria without hypoglycemia or other obvious morbidity, suggesting that blockade of SGLT2 has the potential to promote normalization of blood glucose without hypoglycemia in the setting of type 2 diabetes.  This report presents the in vitro and in vivo pharmacol. activities of EGT1442, a recently discovered SGLT2 inhibitor in the C-aryl glucoside class.  The inhibitory effects of EGT1442 for human SGLT1 and SGLT2 were evaluated in an AMG uptake assay and the in vivo efficacy of treatment with EGT1442 was investigated in rats and dogs after a single dose and in db/db mice after chronic administration.  The effect of EGT1442 on median survival of SHRSP rats was also evaluated.  The IC50 values for EGT1442 against human SGLT1 and SGLT2 are 5.6 μM and 2 nM, resp.  In normal rats and dogs a saturable urinary glucose excretion was produced with an ED50 of 0.38 and 0.09 mg/kg, resp.  Following chronic administration to db/db mice, EGT1442 dose-dependently reduced HbA1c and blood glucose concn. without affecting body mass or insulin level.  Addnl., EGT1442 significantly prolonged the median survival of SHRSP rats.  EGT1442 showed favorable properties both in vitro and in vivo and could be beneficial to the management of type 2 diabetic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwfZffvAqMWLVg90H21EOLACvtfcHk0lhJRdgg8o2qYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Wltb8%253D&md5=f89fa5f6bb03598d318ba6287bece6aa</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2011.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2011.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWelihinda%26aufirst%3DA.%26aulast%3DMechanic%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DLv%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DSeed%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DEGT1442%252C%2520a%2520potent%2520and%2520selective%2520SGLT2%2520inhibitor%252C%2520attenuates%2520blood%2520glucose%2520and%2520HbA1c%2520levels%2520in%2520db%252Fdb%2520mice%2520and%2520prolongs%2520the%2520survival%2520of%2520stroke-prone%2520rats%26jtitle%3DPharmacol.%2520Res.%26date%3D2011%26volume%3D63%26spage%3D284%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Cai, M.; Liu, Q.; Xu, G.; Lv, B.; Seed, B.; Roberge, J. Y.</span><span> </span><span class="NLM_article-title">Crystalline form of benzylbenzene SGLT2 inhibitor</span>. PCT Int. Appl. WO2011153953, 2011.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cai%2C+M.%3B+Liu%2C+Q.%3B+Xu%2C+G.%3B+Lv%2C+B.%3B+Seed%2C+B.%3B+Roberge%2C+J.+Y.+Crystalline+form+of+benzylbenzene+SGLT2+inhibitor.+PCT+Int.+Appl.+WO2011153953%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DM.%26atitle%3DCrystalline%2520form%2520of%2520benzylbenzene%2520SGLT2%2520inhibitor" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Mayer, P.</span><span> </span><span class="NLM_article-title">Chances and risks of SGLT2 inhibitors</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1-4&author=P.+Mayer&title=Chances+and+risks+of+SGLT2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DP.%26atitle%3DChances%2520and%2520risks%2520of%2520SGLT2%2520inhibitors%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2011%26spage%3D1%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Dahl, S. G.</span><span> </span><span class="NLM_article-title">Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects</span> <span class="citation_source-journal">Ther. Drug Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1097%2F00007691-198204000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=6122292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaL38Xks1GktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1982&pages=33-40&author=S.+G.+Dahl&title=Active+metabolites+of+neuroleptic+drugs%3A+possible+contribution+to+therapeutic+and+toxic+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Active metabolites of neuroleptic drugs:  possible contribution to therapeutic and toxic effects</span></div><div class="casAuthors">Dahl, Svein G.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Drug Monitoring</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">TDMODV</span>;
        ISSN:<span class="NLM_cas:issn">0163-4356</span>.
    </div><div class="casAbstract">A review and discussion with 43 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogZx9aJ1HshLVg90H21EOLACvtfcHk0liCVd1wz5jivw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xks1GktLk%253D&md5=96c8b59bcdfd3ffc373cac297bf63698</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1097%2F00007691-198204000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007691-198204000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%26aufirst%3DS.%2BG.%26atitle%3DActive%2520metabolites%2520of%2520neuroleptic%2520drugs%253A%2520possible%2520contribution%2520to%2520therapeutic%2520and%2520toxic%2520effects%26jtitle%3DTher.%2520Drug%2520Monit.%26date%3D1982%26volume%3D4%26spage%3D33%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Rogan, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badawi, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devanesan, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meza, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higginbotham, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalieri, E. L.</span><span> </span><span class="NLM_article-title">Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: Potential biomarkers of susceptibility to cancer</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=697-702&author=E.+G.+Roganauthor=A.+F.+Badawiauthor=P.+D.+Devanesanauthor=J.+L.+Mezaauthor=J.+A.+Edneyauthor=W.+W.+Westauthor=S.+M.+Higginbothamauthor=E.+L.+Cavalieri&title=Relative+imbalances+in+estrogen+metabolism+and+conjugation+in+breast+tissue+of+women+with+carcinoma%3A+Potential+biomarkers+of+susceptibility+to+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRogan%26aufirst%3DE.%2BG.%26aulast%3DBadawi%26aufirst%3DA.%2BF.%26aulast%3DDevanesan%26aufirst%3DP.%2BD.%26aulast%3DMeza%26aufirst%3DJ.%2BL.%26aulast%3DEdney%26aufirst%3DJ.%2BA.%26aulast%3DWest%26aufirst%3DW.%2BW.%26aulast%3DHigginbotham%26aufirst%3DS.%2BM.%26aulast%3DCavalieri%26aufirst%3DE.%2BL.%26atitle%3DRelative%2520imbalances%2520in%2520estrogen%2520metabolism%2520and%2520conjugation%2520in%2520breast%2520tissue%2520of%2520women%2520with%2520carcinoma%253A%2520Potential%2520biomarkers%2520of%2520susceptibility%2520to%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2003%26volume%3D24%26spage%3D697%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworetzky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivarao, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tertyshnikova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoeckler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M. W.</span><span> </span><span class="NLM_article-title">Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: Identification of (S)-N-[1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl]-3-(4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3778</span><span class="NLM_x">–</span> <span class="NLM_lpage">3781</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034111v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3778-3781&author=Y.+Wuauthor=C.+D.+Davisauthor=S.+Dworetzkyauthor=W.+C.+Fitzpatrickauthor=D.+Hardenauthor=H.+Heauthor=R.+J.+Knoxauthor=A.+E.+Newtonauthor=T.+Philipauthor=C.+Polsonauthor=D.+V.+Sivaraoauthor=L.+Sunauthor=S.+Tertyshnikovaauthor=D.+Weaverauthor=S.+Yeolaauthor=M.+Zoecklerauthor=M.+W.+Sinz&title=Fluorine+substitution+can+block+CYP3A4+metabolism-dependent+inhibition%3A+Identification+of+%28S%29-N-%5B1-%284-fluoro-3-morpholin-4-ylphenyl%29ethyl%5D-3-%284-fluorophenyl%29acrylamide+as+an+orally+bioavailable+KCNQ2+opener+devoid+of+CYP3A4+metabolism-dependent+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm034111v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034111v%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDavis%26aufirst%3DC.%2BD.%26aulast%3DDworetzky%26aufirst%3DS.%26aulast%3DFitzpatrick%26aufirst%3DW.%2BC.%26aulast%3DHarden%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DNewton%26aufirst%3DA.%2BE.%26aulast%3DPhilip%26aufirst%3DT.%26aulast%3DPolson%26aufirst%3DC.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTertyshnikova%26aufirst%3DS.%26aulast%3DWeaver%26aufirst%3DD.%26aulast%3DYeola%26aufirst%3DS.%26aulast%3DZoeckler%26aufirst%3DM.%26aulast%3DSinz%26aufirst%3DM.%2BW.%26atitle%3DFluorine%2520substitution%2520can%2520block%2520CYP3A4%2520metabolism-dependent%2520inhibition%253A%2520Identification%2520of%2520%2528S%2529-N-%255B1-%25284-fluoro-3-morpholin-4-ylphenyl%2529ethyl%255D-3-%25284-fluorophenyl%2529acrylamide%2520as%2520an%2520orally%2520bioavailable%2520KCNQ2%2520opener%2520devoid%2520of%2520CYP3A4%2520metabolism-dependent%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3778%26epage%3D3781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Benz, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsriku, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, G. K.</span><span> </span><span class="NLM_article-title">Novel pathways associated with quinone-induced stress in breast cancer cells</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1080%2F03602530600959391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=17145690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCnur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=601-613&author=C.+C.+Benzauthor=C.+Atsrikuauthor=C.+Yauauthor=D.+Brittonauthor=B.+Schillingauthor=B.+W.+Gibsonauthor=M.+A.+Baldwinauthor=G.+K.+Scott&title=Novel+pathways+associated+with+quinone-induced+stress+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel pathways associated with quinone-induced stress in breast cancer cells</span></div><div class="casAuthors">Benz, Christopher C.; Atsriku, Christian; Yau, Christina; Britton, David; Schilling, Birgit; Gibson, Bradford W.; Baldwin, Michael A.; Scott, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-613</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Hormone-dependent breast cancers that overexpress the ligand-binding nuclear transcription factor, estrogen receptor (ER), represent the most common form of breast epithelial malignancy.  Exposure of breast epithelial cells to a redox-cycling and arylating quinone induces mitogen-activated protein kinase phosphorylation of the cytoskeletal filament protein, cytokeratin-8, along with thiol arylation of H3 nuclear histones.  Exogenous or endogenous quinones can also induce ligand-independent nuclear translocation and phosphorylation of ER; with excess exposure, these quinones can arylate ER zinc fingers, impairing ER DNA-binding and altering ER-inducible gene expression.  Immunoaffinity enrichment for low abundance proteins such as ER, coupled with modern mass spectrometry techniques, promises to improve understanding of the protein-modifications produced by endogenous and exogenous quinone exposure and their role in the development or progression of epithelial malignancies such as breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHRQrQ26pwCLVg90H21EOLACvtfcHk0liCVd1wz5jivw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCnur7O&md5=833ab1c5127c9598e94adfd5db8e5386</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F03602530600959391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03602530600959391%26sid%3Dliteratum%253Aachs%26aulast%3DBenz%26aufirst%3DC.%2BC.%26aulast%3DAtsriku%26aufirst%3DC.%26aulast%3DYau%26aufirst%3DC.%26aulast%3DBritton%26aufirst%3DD.%26aulast%3DSchilling%26aufirst%3DB.%26aulast%3DGibson%26aufirst%3DB.%2BW.%26aulast%3DBaldwin%26aufirst%3DM.%2BA.%26aulast%3DScott%26aufirst%3DG.%2BK.%26atitle%3DNovel%2520pathways%2520associated%2520with%2520quinone-induced%2520stress%2520in%2520breast%2520cancer%2520cells%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2006%26volume%3D38%26spage%3D601%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Yao, M.; Cao, K.; Zhang, D.; Rodrigues, D.; Humphreys, W. G.; Zhu, M.</span><span> </span><span class="NLM_article-title">Identification of the human UDP-glucuronosyltransferase enzymes involved in glucuronidation of dapagliflozin</span>. <span class="NLM_conf-name">American Association of Pharmaceutical Scientists Annual Meeting</span>, <span class="NLM_conf-loc">Los Angeles, CA</span>, <span class="NLM_conf-date">November 8–12</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span> <span class="NLM_fpage">T3130</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=T3130&conference=American+Association+of+Pharmaceutical+Scientists+Annual+Meeting&author=M.+Yao&author=K.+Cao&author=D.+Zhang&author=D.+Rodrigues&author=W.+G.+Humphreys&author=M.+Zhu&title=Identification+of+the+human+UDP-glucuronosyltransferase+enzymes+involved+in+glucuronidation+of+dapagliflozin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520the%2520human%2520UDP-glucuronosyltransferase%2520enzymes%2520involved%2520in%2520glucuronidation%2520of%2520dapagliflozin%26date%3D2009%26spage%3DT3130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Obermeier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koplowitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komoroski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasichayanula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discenza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span> </span><span class="NLM_article-title">In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II (SGLT2) inhibitor, in animals and humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=405-414&author=M.+Obermeierauthor=M.+Yaoauthor=A.+Khannaauthor=B.+Koplowitzauthor=M.+Zhuauthor=W.+Liauthor=B.+Komoroskiauthor=S.+Kasichayanulaauthor=L.+Discenzaauthor=W.+Washburnauthor=W.+Mengauthor=B.+A.+Ellsworthauthor=J.+M.+Whaleyauthor=W.+G.+Humphreys&title=In+vitro+characterization+and+pharmacokinetics+of+dapagliflozin+%28BMS-512148%29%2C+a+potent+sodium-glucose+cotransporter+type+II+%28SGLT2%29+inhibitor%2C+in+animals+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermeier%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DM.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DKoplowitz%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKomoroski%26aufirst%3DB.%26aulast%3DKasichayanula%26aufirst%3DS.%26aulast%3DDiscenza%26aufirst%3DL.%26aulast%3DWashburn%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26aulast%3DWhaley%26aufirst%3DJ.%2BM.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26atitle%3DIn%2520vitro%2520characterization%2520and%2520pharmacokinetics%2520of%2520dapagliflozin%2520%2528BMS-512148%2529%252C%2520a%2520potent%2520sodium-glucose%2520cotransporter%2520type%2520II%2520%2528SGLT2%2529%2520inhibitor%252C%2520in%2520animals%2520and%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D405%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0ljlfSLFWV6XLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Maltais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanoury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shawgo, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Town, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brummel, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazhanisamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span> </span><span class="NLM_article-title">In vitro and in vivo isotope effects with hepatitis C protease inhibitors: Enhanced plasma exposure of deuterated telaprevir versus telaprevir in rats</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">8001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=4993-8001&author=F.+Maltaisauthor=Y.+C.+Jungauthor=M.+Chenauthor=J.+Tanouryauthor=R.+B.+Perniauthor=N.+Maniauthor=L.+Laitinenauthor=H.+Huangauthor=S.+Liaoauthor=H.+Gaoauthor=H.+Tsaoauthor=E.+Blockauthor=C.+Maauthor=R.+S.+Shawgoauthor=C.+Townauthor=C.+L.+Brummelauthor=D.+Howeauthor=S.+Pazhanisamyauthor=S.+Raybuckauthor=M.+Namchukauthor=Y.+L.+Bennani&title=In+vitro+and+in+vivo+isotope+effects+with+hepatitis+C+protease+inhibitors%3A+Enhanced+plasma+exposure+of+deuterated+telaprevir+versus+telaprevir+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DJung%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DLaitinen%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DTsao%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DE.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DShawgo%26aufirst%3DR.%2BS.%26aulast%3DTown%26aufirst%3DC.%26aulast%3DBrummel%26aufirst%3DC.%2BL.%26aulast%3DHowe%26aufirst%3DD.%26aulast%3DPazhanisamy%26aufirst%3DS.%26aulast%3DRaybuck%26aufirst%3DS.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520isotope%2520effects%2520with%2520hepatitis%2520C%2520protease%2520inhibitors%253A%2520Enhanced%2520plasma%2520exposure%2520of%2520deuterated%2520telaprevir%2520versus%2520telaprevir%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D52%26spage%3D4993%26epage%3D8001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Sanderson, K.</span><span> </span><span class="NLM_article-title">Big interest in heavy drugs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1038%2F458269a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=19295573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlynsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=269&author=K.+Sanderson&title=Big+interest+in+heavy+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Big interest in heavy drugs</span></div><div class="casAuthors">Sanderson, Katharine</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7236</span>),
    <span class="NLM_cas:pages">269</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA-NMuykVs_7Vg90H21EOLACvtfcHk0ljlfSLFWV6XLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlynsbg%253D&md5=da6280b542e188604884ca4b43e925c6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2F458269a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F458269a%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DK.%26atitle%3DBig%2520interest%2520in%2520heavy%2520drugs%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Yarnell, A. T.</span><span> </span><span class="NLM_article-title">Heavy-hydrogen drugs turn heads, again. Firms seek to improve drug candidates by selective deuterium substitution</span> <span class="citation_source-journal">Chem. Eng. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/doi/10.1021/cen-v087n025.p036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=36-39&author=A.+T.+Yarnell&title=Heavy-hydrogen+drugs+turn+heads%2C+again.+Firms+seek+to+improve+drug+candidates+by+selective+deuterium+substitution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcen-v087n025.p036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcen-v087n025.p036%26sid%3Dliteratum%253Aachs%26aulast%3DYarnell%26aufirst%3DA.%2BT.%26atitle%3DHeavy-hydrogen%2520drugs%2520turn%2520heads%252C%2520again.%2520Firms%2520seek%2520to%2520improve%2520drug%2520candidates%2520by%2520selective%2520deuterium%2520substitution%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2009%26volume%3D87%26spage%3D36%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Schneider, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillgenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koytchev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alken, R.-G.</span><span> </span><span class="NLM_article-title">Enhanced plasma concentration by selective deuteration of rofecoxib in rats</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401780b&amp;key=16724516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADC%252BD28XltF2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2006&pages=295-300&author=F.+Schneiderauthor=M.+Hillgenbergauthor=R.+Koytchevauthor=R.-G.+Alken&title=Enhanced+plasma+concentration+by+selective+deuteration+of+rofecoxib+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced plasma concentration by selective deuteration of rofecoxib in rats</span></div><div class="casAuthors">Schneider, Frank; Hillgenberg, Moritz; Koytchev, Rossen; Alken, Rudolf-Giesbert</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel Forschung</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-300</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">The plasma concns. of BDD-11602 (4-[4-(methanesulfonyl)phenyl]-3-(pentadeuterophenyl)-5H-furan-2-one), a rofecoxib deriv. in which the positions 2', 3', 4', 5' and 6' of the Ph ring were deuterated, and rofecoxib (4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one, CAS 162011-90-7) were compared in order to explore the effects of selective deuteration on the systemic bioavailability.  The COX-2 selectivity in vitro was also compared.  Following oral gavage administration of 0.1, 1 or 10 mg/kg BDD-11602 to Sprague Dawley rats, AUCo-t (area under the curve) and Cmax (max. concn.) values were statistically significant higher than those of rofecoxib at the same doses.  The overall increase in AUCo-t and Cmax for BDD-11602 over rofecoxib was 1.53-fold and 1.60-fold, resp.  BDD-11602 and rofecoxib inhibited COX-2-derived PGE(2) synthesis with IC50 values of 173 nmol/1 and 169 nmol/1, resp.  IC50 values for inhibition of human platelet COX-1 were estd. to be above 1 μmol/l for both compds.  The substitution of hydrogen by deuterium on the positions 2', 3', 4', 5' and 6' in BDD-11602 leads to superior oral availability compared to the non-deuterated compd., whereas the COX-2 selectivity is not affected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLsIVPsmwYBrVg90H21EOLACvtfcHk0lhxFIEAmIJguw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltF2hurY%253D&md5=55f8165f69f41ed6113c6761297a1fd1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DHillgenberg%26aufirst%3DM.%26aulast%3DKoytchev%26aufirst%3DR.%26aulast%3DAlken%26aufirst%3DR.-G.%26atitle%3DEnhanced%2520plasma%2520concentration%2520by%2520selective%2520deuteration%2520of%2520rofecoxib%2520in%2520rats%26jtitle%3DArzneim.%2520Forsch.%26date%3D2006%26volume%3D56%26spage%3D295%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Buteau, K. C.</span><span> </span><span class="NLM_article-title">Deuterated drugs: Unexpectedly nonobvious?</span> <span class="citation_source-journal">J. High Tech. Law</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=22-74&author=K.+C.+Buteau&title=Deuterated+drugs%3A+Unexpectedly+nonobvious%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButeau%26aufirst%3DK.%2BC.%26atitle%3DDeuterated%2520drugs%253A%2520Unexpectedly%2520nonobvious%253F%26jtitle%3DJ.%2520High%2520Tech.%2520Law%26date%3D2009%26spage%3D22%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Seed, B.; Lv, B.; Roberge, J. Y.; Chen, Y.; Peng, K.; Dong, J.; Xu, B.; Du, J.; Zhang, L.; Tang, X.; Xu, G.; Feng, Y.; Xu, M.</span><span> </span><span class="NLM_article-title">Deuterated benzylbenzene derivatives and methods of use</span>. PCT Int. Appl. WO2010009243,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Seed&author=B.+Lv&author=J.+Y.+Roberge&author=Y.+Chen&author=K.+Peng&author=J.+Dong&author=B.+Xu&author=J.+Du&author=L.+Zhang&author=X.+Tang&author=G.+Xu&author=Y.+Feng&author=M.+Xu&title=Deuterated+benzylbenzene+derivatives+and+methods+of+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSeed%26aufirst%3DB.%26atitle%3DDeuterated%2520benzylbenzene%2520derivatives%2520and%2520methods%2520of%2520use%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Smonou, I.</span><span> </span><span class="NLM_article-title">One step reduction of diaryl ketones to hydrocarbons by etherated boron trifluoride-triethylsilane system</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1080%2F00397919408010207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaK2cXltVyjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=1999-2002&author=I.+Smonou&title=One+step+reduction+of+diaryl+ketones+to+hydrocarbons+by+etherated+boron+trifluoride-triethylsilane+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">One step reduction of diaryl ketones to hydrocarbons by etherated boron trifluoride-triethylsilane system</span></div><div class="casAuthors">Smonou, Ioulia</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1999-2002</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">A convenient one-step redn. of diaryl ketones to hydrocarbons using etherated B trifluoride-triethylsilane is described.  This method also works with aryl ketones bearing strongly electron-withdrawing substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMfYLQpY0JYrVg90H21EOLACvtfcHk0lhxFIEAmIJguw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVyjtLY%253D&md5=c3fc47455dd030a5dea219f1ea0c2685</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1080%2F00397919408010207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919408010207%26sid%3Dliteratum%253Aachs%26aulast%3DSmonou%26aufirst%3DI.%26atitle%3DOne%2520step%2520reduction%2520of%2520diaryl%2520ketones%2520to%2520hydrocarbons%2520by%2520etherated%2520boron%2520trifluoride-triethylsilane%2520system%26jtitle%3DSynth.%2520Commun.%26date%3D1994%26volume%3D24%26spage%3D1999%26epage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Nordlander, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balk, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laikos, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwanath, V. M.</span><span> </span><span class="NLM_article-title">Friedel–Crafts acylation with N-(trifluoroacetyl)-Cu-amino acid chlorides. Application to the preparation of β-arylalkylamines and 3-substituted 1,2,3,4-tetrahydroisoquinolines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4107</span><span class="NLM_x">–</span> <span class="NLM_lpage">4111</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00196a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=4107-4111&author=J.+E.+Nordlanderauthor=M.+J.+Payneauthor=F.+Njorogeauthor=M.+A.+Balkauthor=G.+D.+Laikosauthor=V.+M.+Vishwanath&title=Friedel%E2%80%93Crafts+acylation+with+N-%28trifluoroacetyl%29-Cu-amino+acid+chlorides.+Application+to+the+preparation+of+%CE%B2-arylalkylamines+and+3-substituted+1%2C2%2C3%2C4-tetrahydroisoquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo00196a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00196a001%26sid%3Dliteratum%253Aachs%26aulast%3DNordlander%26aufirst%3DJ.%2BE.%26aulast%3DPayne%26aufirst%3DM.%2BJ.%26aulast%3DNjoroge%26aufirst%3DF.%26aulast%3DBalk%26aufirst%3DM.%2BA.%26aulast%3DLaikos%26aufirst%3DG.%2BD.%26aulast%3DVishwanath%26aufirst%3DV.%2BM.%26atitle%3DFriedel%25E2%2580%2593Crafts%2520acylation%2520with%2520N-%2528trifluoroacetyl%2529-Cu-amino%2520acid%2520chlorides.%2520Application%2520to%2520the%2520preparation%2520of%2520%25CE%25B2-arylalkylamines%2520and%25203-substituted%25201%252C2%252C3%252C4-tetrahydroisoquinolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D4107%26epage%3D4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Davis, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of the AB ring segments of daunomycin and 4-demethoxydaunomycin</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00084a042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=1184-1190&author=F.+A.+Davisauthor=C.+Clarkauthor=A.+Kumarauthor=B.-C.+Chen&title=Asymmetric+synthesis+of+the+AB+ring+segments+of+daunomycin+and+4-demethoxydaunomycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjo00084a042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00084a042%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DF.%2BA.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DB.-C.%26atitle%3DAsymmetric%2520synthesis%2520of%2520the%2520AB%2520ring%2520segments%2520of%2520daunomycin%2520and%25204-demethoxydaunomycin%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D1184%26epage%3D1190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Sandanayaka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krohn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyvan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enache, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onua, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldorsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigthorsdottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorlaksdottir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigthorsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinnsdottir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembower, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andresson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselyov, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900838g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=573-585&author=V.+Sandanayakaauthor=B.+Mamatauthor=R.+K.+Mishraauthor=J.+Wingerauthor=M.+Krohnauthor=L.+Zhouauthor=M.+Keyvanauthor=L.+Enacheauthor=D.+Sullinsauthor=E.+Onuaauthor=J.+Zhangauthor=G.+Halldorsdottirauthor=H.+Sigthorsdottirauthor=A.+Thorlaksdottirauthor=G.+Sigthorssonauthor=M.+Thorsteinnsdottirauthor=D.+R.+Daviesauthor=L.+J.+Stewartauthor=D.+E.+Zembowerauthor=T.+Andressonauthor=A.+S.+Kiselyovauthor=J.+Singhauthor=M.+E.+Gurney&title=Discovery+of+4-%5B%282S%29-2-%7B%5B4-%284-chlorophenoxy%29phenoxy%5Dmethyl%7D-1-pyrrolidinyl%5Dbutanoic+acid+%28DG-051%29+as+a+novel+leukotriene+A4+hydrolase+inhibitor+of+leukotriene+B4+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm900838g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900838g%26sid%3Dliteratum%253Aachs%26aulast%3DSandanayaka%26aufirst%3DV.%26aulast%3DMamat%26aufirst%3DB.%26aulast%3DMishra%26aufirst%3DR.%2BK.%26aulast%3DWinger%26aufirst%3DJ.%26aulast%3DKrohn%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DKeyvan%26aufirst%3DM.%26aulast%3DEnache%26aufirst%3DL.%26aulast%3DSullins%26aufirst%3DD.%26aulast%3DOnua%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHalldorsdottir%26aufirst%3DG.%26aulast%3DSigthorsdottir%26aufirst%3DH.%26aulast%3DThorlaksdottir%26aufirst%3DA.%26aulast%3DSigthorsson%26aufirst%3DG.%26aulast%3DThorsteinnsdottir%26aufirst%3DM.%26aulast%3DDavies%26aufirst%3DD.%2BR.%26aulast%3DStewart%26aufirst%3DL.%2BJ.%26aulast%3DZembower%26aufirst%3DD.%2BE.%26aulast%3DAndresson%26aufirst%3DT.%26aulast%3DKiselyov%26aufirst%3DA.%2BS.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%25204-%255B%25282S%2529-2-%257B%255B4-%25284-chlorophenoxy%2529phenoxy%255Dmethyl%257D-1-pyrrolidinyl%255Dbutanoic%2520acid%2520%2528DG-051%2529%2520as%2520a%2520novel%2520leukotriene%2520A4%2520hydrolase%2520inhibitor%2520of%2520leukotriene%2520B4%2520biosynthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D573%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Guthikonda, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cama, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzmann, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, B. G.</span><span> </span><span class="NLM_article-title">Structure–activity relationships in the 2-arylcarbapenem series: Synthesis of 1-methyl-2-arylcarbapenems</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00388a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=871-880&author=R.+N.+Guthikondaauthor=L.+D.+Camaauthor=M.+Quesadaauthor=M.+F.+Woodsauthor=T.+N.+Salzmannauthor=B.+G.+Christensen&title=Structure%E2%80%93activity+relationships+in+the+2-arylcarbapenem+series%3A+Synthesis+of+1-methyl-2-arylcarbapenems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm00388a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00388a022%26sid%3Dliteratum%253Aachs%26aulast%3DGuthikonda%26aufirst%3DR.%2BN.%26aulast%3DCama%26aufirst%3DL.%2BD.%26aulast%3DQuesada%26aufirst%3DM.%26aulast%3DWoods%26aufirst%3DM.%2BF.%26aulast%3DSalzmann%26aufirst%3DT.%2BN.%26aulast%3DChristensen%26aufirst%3DB.%2BG.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520in%2520the%25202-arylcarbapenem%2520series%253A%2520Synthesis%2520of%25201-methyl-2-arylcarbapenems%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D871%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Horton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priebe, W.</span><span> </span><span class="NLM_article-title">Synthetic routes to higher-carbon sugars. Reaction of lactones with 2-lithio-1,3-dithiane</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401780b&amp;key=10.1016%2FS0008-6215%2800%2985593-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaL3MXmtVCgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1981&pages=27-41&author=D.+Hortonauthor=W.+Priebe&title=Synthetic+routes+to+higher-carbon+sugars.+Reaction+of+lactones+with+2-lithio-1%2C3-dithiane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic routes to higher-carbon sugars.  Reaction of lactones with 2-lithio-1,3-dithiane</span></div><div class="casAuthors">Horton, Derek; Priebe, Waldemar</div><div class="citationInfo"><span class="NLM_cas:title">Carbohydrate Research</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-41</span>CODEN:
                <span class="NLM_cas:coden">CRBRAT</span>;
        ISSN:<span class="NLM_cas:issn">0008-6215</span>.
    </div><div class="casAbstract">The per(trimethylsilyl) ether of D-glucono-1,5-lactone reacted with 2-lithio-1,3-dithiane to give, after removal of protecting groups 62% dithianylglucopyranose (I) as a single tautomer; this product is formally a deriv. of a 7-carbon, 1,2-dicarbonyl sugar.  The cryst. 2,3,4,6-tetraacetate (II) of I was readily obtained, again as a single tautomer, and forcing conditions of acetylation led to the acyclic, enol hexaacetate in admixt. with the cyclic pentaacetate (III) of I.  Desulfurization of II with Raney nickel gave 1-deoxy-D-gluco-heptulose as its α-pyranose 3,4,5,7-tetraacetate, whereas similar desulfurization of III was accompanied by removal of the tertiary acetoxy group, providing stereospecific access to the C-β-D-glucosyl compd. 2,6-anhydro-1-deoxy-D-glycero-D-gulo-heptitol as its 3,4,5,7-tetraacetate.  To explore the effects of chain substituents on the tautomeric behavior of the lactone-derived adducts, the simple lactones 5-pentanolide, 4-butanolide, and 4-pentanolide were treated with 2-lithio-1,3-dithiane, and the tautomeric compns. of the products were examd. before and after aceylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozQhppJY48brVg90H21EOLACvtfcHk0lgc98eVVCsY2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmtVCgsrg%253D&md5=9d7fd4236865922ae73e144d75fa72b6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0008-6215%2800%2985593-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6215%252800%252985593-7%26sid%3Dliteratum%253Aachs%26aulast%3DHorton%26aufirst%3DD.%26aulast%3DPriebe%26aufirst%3DW.%26atitle%3DSynthetic%2520routes%2520to%2520higher-carbon%2520sugars.%2520Reaction%2520of%2520lactones%2520with%25202-lithio-1%252C3-dithiane%26jtitle%3DCarbohydr.%2520Res.%26date%3D1981%26volume%3D94%26spage%3D27%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Czernecki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ville, G.</span><span> </span><span class="NLM_article-title">C-glycosides. 7. Stereospecific C-glycosylation of aromatic and heterocyclic rings</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00264a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=610-612&author=S.+Czerneckiauthor=G.+Ville&title=C-glycosides.+7.+Stereospecific+C-glycosylation+of+aromatic+and+heterocyclic+rings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo00264a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00264a020%26sid%3Dliteratum%253Aachs%26aulast%3DCzernecki%26aufirst%3DS.%26aulast%3DVille%26aufirst%3DG.%26atitle%3DC-glycosides.%25207.%2520Stereospecific%2520C-glycosylation%2520of%2520aromatic%2520and%2520heterocyclic%2520rings%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D610%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kraus, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, M. T.</span><span> </span><span class="NLM_article-title">A direct synthesis of C-glycosyl compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00239a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm401780b&amp;key=1%3ACAS%3A528%3ADyaL1cXpsVyntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=752-753&author=G.+A.+Krausauthor=M.+T.+Molina&title=A+direct+synthesis+of+C-glycosyl+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A direct synthesis of c-glycosyl compounds</span></div><div class="casAuthors">Kraus, George A.; Molina, Maria Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">752-3</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">C-Glycosides I (R = Ph, 2-pyridyl, CH2:CH, p-MeOC6H4, p-MeC6H4, m-MeOC6H4) were prepd. in 60-95% yields by treating the lactone II with organometallic reagents in THF followed by redn. with Et3SiH and BF3.Et2O in CH2Cl2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAuoINT8Nwl7Vg90H21EOLACvtfcHk0liqTrnkrKnuUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXpsVyntA%253D%253D&md5=0da20fb6b1b53eb49c8f8bb11d643c3b</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo00239a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00239a009%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%2BA.%26aulast%3DMolina%26aufirst%3DM.%2BT.%26atitle%3DA%2520direct%2520synthesis%2520of%2520C-glycosyl%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D752%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, G.</span><span> </span><span class="NLM_article-title">Convergent C-glycolipid synthesis via the Ramberg-Bäcklund reaction: Active antiproliferative glycolipids</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">2149</span><span class="NLM_x">–</span> <span class="NLM_lpage">2151</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol991211f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=2149-2151&author=G.+Yangauthor=R.+W.+Franckauthor=H.-S.+Byunauthor=R.+Bittmanauthor=P.+Samadderauthor=G.+Arthur&title=Convergent+C-glycolipid+synthesis+via+the+Ramberg-B%C3%A4cklund+reaction%3A+Active+antiproliferative+glycolipids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol991211f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol991211f%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DFranck%26aufirst%3DR.%2BW.%26aulast%3DByun%26aufirst%3DH.-S.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DSamadder%26aufirst%3DP.%26aulast%3DArthur%26aufirst%3DG.%26atitle%3DConvergent%2520C-glycolipid%2520synthesis%2520via%2520the%2520Ramberg-B%25C3%25A4cklund%2520reaction%253A%2520Active%2520antiproliferative%2520glycolipids%26jtitle%3DOrg.%2520Lett.%26date%3D1999%26volume%3D1%26spage%3D2149%26epage%3D2151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Oikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, A.</span><span> </span><span class="NLM_article-title">Involvement of Diels–Alder reactions in the biosynthesis of secondary natural products: The late stage of the biosynthesis of the phytotoxins solanapyrones</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1225-1232&author=H.+Oikawaauthor=Y.+Suzukiauthor=K.+Katayamaauthor=A.+Nayaauthor=C.+Sakanoauthor=A.+Ichihara&title=Involvement+of+Diels%E2%80%93Alder+reactions+in+the+biosynthesis+of+secondary+natural+products%3A+The+late+stage+of+the+biosynthesis+of+the+phytotoxins+solanapyrones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOikawa%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DKatayama%26aufirst%3DK.%26aulast%3DNaya%26aufirst%3DA.%26aulast%3DSakano%26aufirst%3DC.%26aulast%3DIchihara%26aufirst%3DA.%26atitle%3DInvolvement%2520of%2520Diels%25E2%2580%2593Alder%2520reactions%2520in%2520the%2520biosynthesis%2520of%2520secondary%2520natural%2520products%253A%2520The%2520late%2520stage%2520of%2520the%2520biosynthesis%2520of%2520the%2520phytotoxins%2520solanapyrones%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1999%26spage%3D1225%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Synthesis of a novel triptycene-based molecular tweezer and its complexation with paraquat derivatives</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol070017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=895-898&author=X.+Pengauthor=H.+Luauthor=T.+Hanauthor=C.+Chen&title=Synthesis+of+a+novel+triptycene-based+molecular+tweezer+and+its+complexation+with+paraquat+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fol070017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol070017n%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520triptycene-based%2520molecular%2520tweezer%2520and%2520its%2520complexation%2520with%2520paraquat%2520derivatives%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D895%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="note"><p class="first last">The published in vitro data for dapagliflozin <b>5</b> give an EC<sub>50</sub> value of 1.1 nM for SGLT2 and a selectivity (<i>h</i>SGLT1/<i>h</i>SGLT2) of 1200-fold (ref <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">22</a>). However, in our assays, we observed a 3.2 nM IC<sub>50</sub> value and 981-fold selectivity for <i>h</i>SGLT2.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i55"><a href="/doi/suppl/10.1021/jm401780b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_84814"></div></div></div></div></div><hr /></hr><p class="last">HPLC-MS chromatographic metabolic monitoring for <b>41</b>, metabolic process confirmation for <b>41</b> and <b>5</b> by HPLC-MS chromatography, and <sup>1</sup>H and <sup>13</sup>C NMR spectra for all new compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401780b/suppl_file/jm401780b_si_001.pdf">jm401780b_si_001.pdf (2.81 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401780b&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-4%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm401780b%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401780b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a7303bcb3cca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
